"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,S,US D0338512 S,152-455-385-680-37X,1993-08-17,1993,US 57929490 F,1990-09-07,US 57929490 F,1990-09-07,Golf stance training device,,CROW ROBERT F;;CROW ROBERT F,CROW ROBERT F;;CROW ROBERT F,,https://lens.org/152-455-385-680-37X,Design Right,yes,2,3,1,1,0,,,D21/234,1,0,,,"Golf World, May 15, 1959, p. 8, Pro Stance.",EXPIRED
2,US,A,US 730881 A,002-148-290-514-644,1903-06-16,1903,US 1902/0121309 A,1902-08-28,US 1902/0121309 A,1902-08-28,COTTON-COMPRESS.,,CROW ROBERT DOUGLAS,CROW ROBERT DOUGLAS,,https://lens.org/002-148-290-514-644,Granted Patent,no,0,1,1,1,0,B30B9/32;;B30B9/32,,,0,0,,,,EXPIRED
3,GB,A,GB 1221308 A,068-418-503-662-715,1971-02-03,1971,GB 5132167 A,1967-11-10,GB 5132167 A,1967-11-10,IMPROVEMENTS IN OR RELATING TO FASTENERS,"1,221,308. Releasable fastening. McMURDO INSTRUMENT CO. Ltd. 8 Nov., 1968 [10 Nov., 1967], (No. 51321/67. Heading E2A. A manually fastenable and releasable fastening device includes a resilient arm 12, extending between a mounting portion 10 adapted to be secured to one of two members to be fastened together and an engaging portion 14, said arm being arranged to be resiliently deformable in two perpendicular directions of which in use one is parallel to the direction of separation of said members by manual pressure in a direction towards said members exerted on a first portion thereof to cause said engaging portion to engage a keeper formed in or secured to the other of said members, and to be deformable by manual pressure towards said members exerted on another portion 24 thereof the release said engaging portion from said keeper. In the construction shown the portion of the arm which is laterally deformed is bowed and extends in an arc of approximately 180‹ and the remainder of the arm is substantial L-shaped. In a modification however the L-shaped part of the arm is connected to the mounting portion by a substantially S-shaped portion which is the portion which is deformed. The arm and the mounting portion can be integrally made from a plastics material or metal.",MCMURDO INSTR COMPANY LTD,CROW ROBERT PATRICK,,https://lens.org/068-418-503-662-715,Granted Patent,no,0,1,1,1,0,F16B2/22,F16B2/22,E2A AE14A         -;;E2A AGU           AGU;;E2A A352          AGU;;E2A A353          AGU,0,0,,,,EXPIRED
4,US,B2,US 7252149 B2,099-911-166-081-314,2007-08-07,2007,US 86807604 A,2004-06-15,US 86807604 A,2004-06-15,Safety valve lock out system and method,"A safety valve lock out system and method. In a described embodiment, a method of locking out a safety valve in a subterranean well includes the steps of: flowing a hardenable fluid into the safety valve; and preventing a closure device of the safety valve from closing with the hardenable fluid.",HALLIBURTON ENERGY SERV INC,CROW ROBERT W,HALLIBURTON ENERGY SERVICES INC (2004-06-08),https://lens.org/099-911-166-081-314,Granted Patent,yes,4,1,2,2,0,E21B34/102;;E21B2200/05;;E21B34/102;;E21B2200/05,E21B34/06;;E21B34/00;;E21B34/10,166/373;;166/285;;166/323;;166/320,0,0,,,,INACTIVE
5,US,A,US 924223 A,104-836-715-220-228,1909-06-08,1909,US 1908/0431760 A,1908-05-09,US 1908/0431760 A,1908-05-09,COMBINED BALING AND COMPRESS MACHINE.,,CROW ROBERT D,CROW ROBERT D,,https://lens.org/104-836-715-220-228,Granted Patent,no,0,1,1,1,0,B30B1/103;;B30B1/103,B30B1/10,,0,0,,,,EXPIRED
6,US,A,US 673616 A,033-532-729-192-68X,1901-05-07,1901,US 1900/0035458 A,1900-11-05,US 1900/0035458 A,1900-11-05,LAPEL-SPRING FOR COATS.,,CROW ROBERT DOUGLAS,CROW ROBERT DOUGLAS,,https://lens.org/033-532-729-192-68X,Granted Patent,no,0,0,1,1,0,A41D27/06;;A41D27/06,,,0,0,,,,EXPIRED
7,NO,L,NO 814173 L,109-110-513-657-113,1982-06-09,1982,NO 814173 A,1981-12-07,US 21404180 A,1980-12-08,SIKKERHETSVENTIL,,OTIS ENG CO,CROW ROBERT W,,https://lens.org/109-110-513-657-113,Abstract,no,0,0,7,7,0,E21B34/101;;E21B34/102;;E21B2200/05;;E21B34/102;;E21B34/101;;E21B2200/05,E21B34/00;;E21B34/10,,0,0,,,,EXPIRED
8,US,A,US 3626308 A,133-710-594-126-021,1971-12-07,1971,US 3626308D A,1969-12-23,US 88768569 A,1969-12-23,WIDE-BAND DOUBLER AND SINE WAVE QUADRATURE GENERATOR,,NASA,CROW ROBERT B,,https://lens.org/133-710-594-126-021,Granted Patent,no,8,10,1,1,0,H03H7/18;;H03H7/18;;H03L7/0812;;H03L7/0812,H03H7/18;;H03L7/081,328/166,0,0,,,,EXPIRED
9,US,A,US 1488382 A,120-957-579-912-561,1924-03-25,1924,US 54419722 A,1922-03-16,US 54419722 A,1922-03-16,Clothespin,,CROW ROBERT O,CROW ROBERT O,,https://lens.org/120-957-579-912-561,Granted Patent,no,0,4,1,1,0,D06F55/00;;D06F55/00;;Y10T24/44855;;Y10T24/44855;;Y10T24/44863;;Y10T24/44863,D06F55/00,C3P PD9D7D2       PD9A;;C3P PD9D8         PD9A,0,0,,,,EXPIRED
10,US,A,US 739838 A,188-318-270-644-059,1903-09-29,1903,US 1903/0162929 A,1903-06-24,US 1903/0162929 A,1903-06-24,COTTON-PRESS.,,CROW ROBERT DOUGLAS,CROW ROBERT DOUGLAS,,https://lens.org/188-318-270-644-059,Granted Patent,no,0,4,1,1,0,B30B9/32;;B30B9/32,,,0,0,,,,EXPIRED
11,NO,B,NO 160625 B,039-966-380-579-246,1989-01-30,1989,NO 814173 A,1981-12-07,US 21404180 A,1980-12-08,OVERFLATESTYRT PRODUKSJONSSIKRINGSVENTIL.,,OTIS ENG CO,CROW ROBERT W,,https://lens.org/039-966-380-579-246,Unknown,no,0,1,7,7,0,E21B34/101;;E21B34/102;;E21B2200/05;;E21B34/102;;E21B34/101;;E21B2200/05,E21B34/00;;E21B34/10,,0,0,,,,EXPIRED
12,US,B1,US 6643509 B1,084-889-167-915-760,2003-11-04,2003,US 52278700 A,2000-03-10,US 52278700 A;;US 12490899 P,1999-03-17,Civil aviation communication system,"
    A civil aviation communication system has a satellite subsystem including a constellation of satellites. A ground subsystem communicates with the satellite subsystem. The ground subsystem includes a number of networked ground stations at selected locations. An airborne communication subsystem is included in the aircraft. The airborne subsystem transmits to the satellite subsystem in a first frequency band. The airborne subsystem receives transmissions from the satellite subsystem in a second frequency band. The airborne subsystem communicates with a ground based system in a third frequency band. The third frequency band is between the first frequency band and the second frequency band. 
",CROW ROBERT PALMER,CROW ROBERT PALMER,,https://lens.org/084-889-167-915-760,Granted Patent,yes,14,9,1,1,0,H04B7/18508;;H04B7/18508,H04B7/185,455/431;;455/427,0,0,,,,EXPIRED
13,US,A,US 4454510 A,080-982-641-391-839,1984-06-12,1984,US 24617481 A,1981-03-23,US 24617481 A;;US 97075678 A,1978-12-18,"Discrete address beacon, navigation and landing system (DABNLS)","An aircraft surveillance, navigation, landing, guidance and collision avoidance system is provided which takes the form of a two-way data communication link between each of a plurality of controlled aircraft and a ground station, and appropriate measuring equipment at the ground station which provides three-dimensional position data on the ground for air traffic control purposes; and which also provides three-dimensional position data in the aircraft for navigation, landing guidance and collision avoidance purposes, as well as a two-way air/ground data link for miscellaneous data and control purposes. The system of the invention comprises the combination of a ground transmitter/receiver station and airborne transponders mounted in the aircraft. The ground transmitter broadcasts discrete aircraft addressed interrogation pulses which are coded to contain position and/or other data. The transponders in all aircraft receive and decode the interrogation pulses, and the discretely addressed aircraft transmits appropriately timed reply pulses to the ground receiver which contain altitude and other data. Other aircraft utilize the received position information for collision avoidance purposes. The ground receiver measures the incident angles of the reply signal pulses and their precise time delays with respect to the interrogation pulses, so as to provide aircraft position and other data to the ground station, and to provide additional data for transmission to the aircraft on the following interrogation pulses.",CROW ROBERT P,CROW ROBERT P,,https://lens.org/080-982-641-391-839,Granted Patent,yes,10,135,1,1,0,G01S13/79;;G01S13/79;;G09B9/006;;G09B9/006,G01S13/79;;G09B9/00,343  5GC;;343/455;;343/456;;X343  65 R;;X343  5LS,0,0,,,,EXPIRED
14,US,A,US 2784262 A,098-662-629-081-441,1957-03-05,1957,US 39836353 A,1953-12-15,US 39836353 A,1953-12-15,Transistor amplifier,,MOTOROLA INC,CROW ROBERT P,,https://lens.org/098-662-629-081-441,Granted Patent,no,3,23,1,1,0,H03F3/26;;H03F3/26,H03F3/26,,0,0,,,,EXPIRED
15,US,A,US 3413597 A,131-625-365-105-383,1968-11-26,1968,US 61821367 A,1967-02-23,US 61821367 A;;US 48035665 A,1965-08-17,Ground speed and time-to-station indicator for use with dme,,RCA CORP,CROW ROBERT P,SPERRY CORPORATION A CORP. OF DE (1981-01-09),https://lens.org/131-625-365-105-383,Granted Patent,no,0,7,1,2,0,G01S7/04;;G01S13/60;;G01S13/785;;H03K23/002;;G01S7/04;;G01S13/60;;G01S13/785;;H03K23/002,G01S7/04;;G01S13/60;;G01S13/78;;H03K23/00,340/27,0,0,,,,EXPIRED
16,US,A,US 2932794 A,173-016-540-281-836,1960-04-12,1960,US 44649354 A,1954-07-29,US 44649354 A,1954-07-29,Subcarrier separation system,,MOTOROLA INC,CROW ROBERT P,,https://lens.org/173-016-540-281-836,Granted Patent,no,9,13,1,1,0,H03H11/348;;H03H11/348,H03H11/34,,0,0,,,,EXPIRED
17,US,A,US 5627546 A,093-590-076-268-174,1997-05-06,1997,US 52334895 A,1995-09-05,US 52334895 A,1995-09-05,Combined ground and satellite system for global aircraft surveillance guidance and navigation,"The present invention provides a combined ground and satellite system for global aircraft surveillance, navigation, landing guidance and collision avoidance which comprises a satellite subsystem consisting of both a satellite constellation and associated ground stations, and a ground subsystem consisting of a network of ground stations, together with an airborne subsystem comprised of a transponder unit located in each of the aircraft using the system. A high speed two-way data link is provided between each of the subsystems using spread spectrum technology to permit overlaying and operation of the system in an existing band of narrow channels with minimum mutual interference. The system of the invention is reliable because of the redundant subsystems, and is not subject to failure. Also, the system provides for computations to be made on the ground, rather than in the aircraft, thereby reducing the size and complexity of the airborne equipment. The system also achieves a high degree of precision, as compared with the prior art systems. The system also provides air/ground data communication.",CROW; ROBERT P.,CROW ROBERT P,,https://lens.org/093-590-076-268-174,Granted Patent,yes,9,173,1,1,0,G01S13/765;;G01S13/86;;G01S13/91;;G08G5/0013;;G08G5/0043;;G08G5/0082;;H04B7/18508;;H04B7/1851;;H04K3/255;;H04K3/90;;H04B7/18506;;G01S13/935;;G01S13/933;;G08G5/0013;;H04B7/1851;;H04K3/90;;G01S13/91;;G01S13/86;;H04K3/255;;G08G5/0043;;G08G5/0082;;G01S13/765;;H04B7/18508;;H04B7/18506;;G01S13/933;;G01S13/935,G01S13/76;;G01S13/86;;G01S13/91;;G01S13/933;;G01S13/935;;G08G5/00;;H04B7/185,342/352;;342/32;;342/49;;342/353;;342/456;;364/439;;364/451,1,0,,,"Paper Robert P. Crow Integrated Global Surveillance and Navigation System presented to Institute of Navigation Convention (Jun. 4, 1994) (copy attached).",EXPIRED
18,CA,A,CA 1162144 A,023-061-305-305-889,1984-02-14,1984,CA 386710 A,1981-09-25,US 21404180 A,1980-12-08,WELL SAFETY VALVE,"WELL SAFETY VALVE A well safety valve, connectable in a tubing string for controlling fluid flow therethrough, in which the valve closure means is operated by a longitudinally movable, telescoping tubular operating member. High differential pressure across the closed valve closure means causes the tubular operator to telescope preventing damage to the closure means. The telescoping tubular operator extends automatically upon release of the high differential pressure. A piston rod type equalizing valve is provided which is engageable with the tubular operator in order to reduce pressure differential across the closure means prior to closure member opening forces being applied to the closure member by the tubular operator.",OTIS ENG CO,CROW ROBERT W,,https://lens.org/023-061-305-305-889,Granted Patent,no,0,0,7,7,0,E21B34/101;;E21B34/102;;E21B2200/05;;E21B34/102;;E21B34/101;;E21B2200/05,E21B34/00;;E21B34/10,166-41,0,0,,,,EXPIRED
19,CA,A,CA 596592 A,048-718-210-581-806,1960-04-19,1960,CA 596592D A,,CA 596592T A,,DETECTOR CIRCUIT,,MOTOROLA INC,CROW ROBERT P,,https://lens.org/048-718-210-581-806,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
20,US,A,US 4677694 A,041-790-562-896-248,1987-07-07,1987,US 88653286 A,1986-07-16,US 88653286 A,1986-07-16,Facial protector for batting helmet,"A protective flap for a batting helmet. The protective flap attaches to a batting helmet or is fabricated with the helmet, and extends alongside the cheek and jaw of the batter. The protective flap can attach to the ear cover of the batting helmet, and extends forwardly to an outer end approximately aligned with the front of the batter's chin or nose. The upper edge of the protective flap is spaced below the visor of the helmet to allow substantially unobstructed vision but this spacing is less than the diameter of the ball in play, to prevent the ball from striking the batter's cheek or eye.",CROW ROBERT W,CROW ROBERT W,C-FLAP INC (2001-09-05);;MARKWORT SPORTING GOODS COMPANY (2003-09-04),https://lens.org/041-790-562-896-248,Granted Patent,yes,4,69,3,3,0,A42B3/20;;A42B3/20,A42B3/00;;A63B71/10;;A42B3/18;;A42B3/20;;A42B3/32,2/9;;2/10;;2/425,0,0,,,,EXPIRED
21,NO,C,NO 160625 C,076-641-003-468-272,1989-05-10,1989,NO 814173 A,1981-12-07,US 21404180 A,1980-12-08,OVERFLATESTYRT PRODUKSJONSSIKRINGSVENTIL.,,OTIS ENG CO,CROW ROBERT W,,https://lens.org/076-641-003-468-272,Granted Patent,no,0,0,7,7,0,E21B34/101;;E21B34/102;;E21B2200/05;;E21B34/102;;E21B34/101;;E21B2200/05,E21B34/00;;E21B34/10,,0,0,,,,EXPIRED
22,CA,A,CA 610400 A,097-518-462-290-272,1960-12-13,1960,CA 610400D A,,CA 610400T A,,SUBCARRIER SEPARATION SYSTEM,,MOTOROLA INC,CROW ROBERT P,,https://lens.org/097-518-462-290-272,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
23,US,A,US 4603973 A,145-671-332-287-614,1986-08-05,1986,US 57406384 A,1984-01-26,US 57406384 A,1984-01-26,Visibility enhancement system,"A system for viewing a lighted scene through a diffusive medium, such as rain, fog, snow, blowing dust, or sand, by overcoming the effects of light backscatter. The system uses a flash lamp which operates in response to short electric pulses at a high repetition rate to give the appearance of continuous illumination. The scene is viewed through a panel which operates as a high-speed optical shutter. The panel serves to block the reflected light (backscatter) from the nearby particles of the diffusive medium and passes the reflected light from the distant objects which make up the scene.",CROW ROBERT P,CROW ROBERT P,,https://lens.org/145-671-332-287-614,Granted Patent,yes,12,14,1,1,0,G02F1/1313;;G01S17/18;;G02F1/1313;;G01S17/18,G01S17/18;;G02F1/13,G2J JB7N          JB7N,0,0,,,,EXPIRED
24,CA,A,CA 586821 A,014-958-893-730-207,1959-11-10,1959,CA 586821D A,,CA 586821T A,,FREQUENCY SHIFT TRANSMITTER,,MOTOROLA INC,CROW ROBERT P,,https://lens.org/014-958-893-730-207,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
25,US,A,US 2750451 A,057-077-104-400-943,1956-06-12,1956,US 21535551 A,1951-03-13,US 21535551 A,1951-03-13,Audio system,,MOTOROLA INC,CROW ROBERT P,,https://lens.org/057-077-104-400-943,Granted Patent,no,10,7,1,1,0,H03G7/02;;H03G7/02,H03G7/02,,0,0,,,,EXPIRED
26,US,A,US 4484682 A,132-114-750-791-350,1984-11-27,1984,US 50149683 A,1983-06-06,US 50149683 A,1983-06-06,Container with magnet for holding it in position,"A portable container for food and miscellany capable of protecting and preserving its contents in the rough handling environment of the construction worker. The container comprises an insulated hollow body with a compartmented, covered tray therein and a hinged, insulated lid for closing the body and for holding the tray in place within the body. The body also has a permanent magnet in the bottom thereof for holding the container in place on a magnetically attractable surface.",CROW ROBERT T,CROW ROBERT T,,https://lens.org/132-114-750-791-350,Granted Patent,yes,15,95,1,1,0,A45C11/20;;A45C13/00;;Y10S206/818;;A45C13/00;;A45C11/20;;Y10S206/818,A45C11/20;;A45C13/00,206/545;;206/541;;206/818;;220/69;;248/206.5;;335/285;;335/286;;335/303,0,0,,,,EXPIRED
27,US,A,US 5657393 A,196-551-225-030-77X,1997-08-12,1997,US 9943793 A,1993-07-30,US 9943793 A,1993-07-30,Beamed linear array microphone system,A sound enhancement system including a beamed linear array microphone system for the acoustic pickup of voice and music from substantial distances with a relatively narrow sound pickup beam and with the avoidance of acoustic feedback. The acceptance beam angle is relatively constant over the desired sound octaves. Response outside of the acceptance beam is relatively low. The system includes a microprocessor-controlled circuit for processing the signals from a multiplicity of microphone elements in the linear array for application to a loudspeaker.,CROW; ROBERT P.,CROW ROBERT P,,https://lens.org/196-551-225-030-77X,Granted Patent,yes,7,113,1,1,0,H04R3/005;;H04R3/005;;H04R1/406;;H04R1/406;;H04R2201/403;;H04R2201/403;;H04R2201/405;;H04R2201/405,H04R3/00,381/92;;367/123;;367/125;;367/126,1,1,125-109-631-709-625,10.1109/icassp.1990.115968,"Alvarado, Victor M. and Silverman, Harvey F., Experimental Results Showing The Effects of Optimal Spacing Between Element of a Linear Microphone Array, IEEE, Feb. 1990. CH 2847 2/90/0000 0837.",EXPIRED
28,US,A,US 2884973 A,013-879-017-127-465,1959-05-05,1959,US 69106857 A,1957-10-18,US 69106857 A,1957-10-18,Cutter and feeder for a potato planter,,CROW ROBERT F,CROW ROBERT F,,https://lens.org/013-879-017-127-465,Granted Patent,no,2,7,1,1,0,A01C9/08;;Y10T83/2096;;Y10T83/6542;;Y10T83/2081;;Y10T83/2096;;Y10T83/6542;;Y10T83/2081;;A01C9/08,A01C9/08,,0,0,,,,EXPIRED
29,US,A,US 1488383 A,148-400-761-670-704,1924-03-25,1924,US 60566922 A,1922-12-08,US 60566922 A,1922-12-08,Paper clip,,HUGH GORDON MAXWELL JR,CROW ROBERT O,,https://lens.org/148-400-761-670-704,Granted Patent,no,0,10,1,1,0,B42F1/08;;Y10T24/205;;Y10T24/44786;;Y10T24/205;;Y10T24/44786;;B42F1/08,B42F1/08,,0,0,,,,EXPIRED
30,US,A,US 3665317 A,098-260-307-225-033,1972-05-23,1972,US 3665317D A,1970-04-07,US 2637270 A,1970-04-07,SEQUENTIAL AGC SYSTEM FOR SIGNAL RECEIVER,,RCA CORP,CROW ROBERT PALMER,SP-COMMERCIAL FLIGHT INC. A DE CORP (1986-11-12);;SPERRY CORPORATION A CORP. OF DE (1981-01-09);;HONEYWELL INC (1988-05-06),https://lens.org/098-260-307-225-033,Granted Patent,no,0,8,1,1,0,H03G3/3068;;H03G3/3068,H03G3/30,325/319;;325/404;;325/405;;325/409;;325/410;;325/414;;330/25;;330 30   D;;330 38   M;;330/97;;330/100,0,0,,,,EXPIRED
31,US,A,US 2891156 A,142-904-291-417-595,1959-06-16,1959,US 60008756 A,1956-07-25,US 60008756 A,1956-07-25,Detector circuit,,MOTOROLA INC,CROW ROBERT P,,https://lens.org/142-904-291-417-595,Granted Patent,no,6,12,1,1,0,H03D3/14;;H03D3/14,H03D3/14,,0,0,,,,EXPIRED
32,CA,A,CA 571198 A,027-300-448-845-867,1959-02-24,1959,CA 571198D A,,CA 571198T A,,TRANSISTOR AMPLIFIER,,MOTOROLA INC,CROW ROBERT P,,https://lens.org/027-300-448-845-867,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
33,US,S,US D0309512 S,069-897-790-774-492,1990-07-24,1990,US 6641487 F,1987-06-25,US 6641487 F,1987-06-25,Cheek flap for a helmet,,CROW ROBERT W,CROW ROBERT W,MARKWORT SPORTING GOODS COMPANY (2003-09-04),https://lens.org/069-897-790-774-492,Design Right,yes,9,29,1,1,0,,,D29/16,0,0,,,,EXPIRED
34,US,A1,US 2005/0274529 A1,142-478-806-079-89X,2005-12-15,2005,US 86807604 A,2004-06-15,US 86807604 A,2004-06-15,Safety valve lock out system and method,"A safety valve lock out system and method. In a described embodiment, a method of locking out a safety valve in a subterranean well includes the steps of: flowing a hardenable fluid into the safety valve; and preventing a closure device of the safety valve from closing with the hardenable fluid.",CROW ROBERT W,CROW ROBERT W,HALLIBURTON ENERGY SERVICES INC (2004-06-08),https://lens.org/142-478-806-079-89X,Patent Application,yes,4,1,2,2,0,E21B34/102;;E21B2200/05;;E21B34/102;;E21B2200/05,E21B34/00;;E21B34/06;;E21B34/10,166/373;;166/162;;166/332.8,0,0,,,,INACTIVE
35,US,A,US 4376464 A,074-531-224-027-913,1983-03-15,1983,US 21404180 A,1980-12-08,US 21404180 A,1980-12-08,Well safety valve,"A well safety valve, connectable in a tubing string for controlling fluid flow therethrough, in which the valve closure means is operated by a longitudinally movable, telescoping tubular operating member. High differential pressure across the closed valve closure means causes the tubular operator to telescope preventing damage to the closure means. The telescoping tubular operator extends automatically upon release of the high differential pressure. A piston rod type equalizing valve is provided which is engageable with the tubular operator in order to reduce pressure differential across the closure means prior to closure member opening forces being applied to the closure member by the tubular operator.",OTIS ENG CO,CROW ROBERT W,OTIS ENGINEERING CORPORATION A CORP. OF DE (1981-06-08);;HALLIBURTON COMPANY (1993-06-24),https://lens.org/074-531-224-027-913,Granted Patent,yes,3,26,7,7,0,E21B34/101;;E21B34/102;;E21B2200/05;;E21B34/102;;E21B34/101;;E21B2200/05,E21B34/00;;E21B34/10,166/324,0,0,,,,EXPIRED
36,US,A,US 3239835 A,000-494-369-858-043,1966-03-08,1966,US 32285863 A,1963-11-12,US 32285863 A,1963-11-12,Dme with automatic search velocity control,,RCA CORP,CROW ROBERT P,SPERRY CORPORATION A CORP. OF DE (1981-01-09),https://lens.org/000-494-369-858-043,Granted Patent,no,0,5,1,1,0,G01S13/787;;G01S13/787,G01S13/78,H4D D265          R;;H4D D27X          R;;H4D D341          R;;H4D D407          R;;H4D D415          R;;H4D D417          R;;H4D D418          R;;H4D D426          R;;H4D D440          R;;H4D D442          R;;H4D D443          R;;H4D D445          R;;H4D D451          R;;H4D D454          R;;H4D D456          R;;H4D D457          R,0,0,,,,EXPIRED
37,US,A,US 1411843 A,040-444-999-590-024,1922-04-04,1922,US 45439821 A,1921-03-22,US 45439821 A,1921-03-22,Piston,,CROW ROBERT D,CROW ROBERT D,,https://lens.org/040-444-999-590-024,Granted Patent,no,0,0,1,1,0,F02F3/105;;F05C2201/021;;F02F3/105;;F05C2201/021,F02F3/10,C3P PD9D8         PD9A,0,0,,,,EXPIRED
38,US,A,US 2894208 A,092-365-867-186-653,1959-07-07,1959,US 53269155 A,1955-09-06,US 53269155 A,1955-09-06,Frequency shift transmitter,,MOTOROLA INC,CROW ROBERT P,,https://lens.org/092-365-867-186-653,Granted Patent,no,5,9,1,1,0,H04B3/542;;H04L27/12;;H04B3/542;;H04L27/12,H04B3/54;;H04L27/12,,0,0,,,,EXPIRED
39,US,B1,US 11827135 B1,117-825-888-212-670,2023-11-28,2023,US 202117464548 A,2021-09-01,US 202117464548 A;;US 202163183457 P,2021-05-03,System for transportation of food in a vehicle,"A system for transporting food within a vehicle comprises providing a recessed cavity within the floor of the vehicle and placing a food container within the recessed cavity. In certain embodiments, the recessed cavity may be provided within the trunk or flatbed of the vehicle and may include a heat-resistant and/or non-slip lining. In some further embodiments, the recess may include a cover having a top surface matching that of the vehicle floor, that may situate within the recessed cavity when not in use.",CROW JR ROBERT ELVIN,CROW JR ROBERT ELVIN,,https://lens.org/117-825-888-212-670,Granted Patent,yes,32,0,1,1,0,B60N3/101;;B60N3/101;;B62D33/02;;B62D25/20,B60N3/10;;B62D25/20;;B62D33/02,,0,0,,,,ACTIVE
40,US,A,US 2695717 A,070-932-168-498-607,1954-11-30,1954,US 23587651 A,1951-07-09,US 23587651 A,1951-07-09,Dual wheel remover,,CROW ROBERT J H,CROW ROBERT J H,,https://lens.org/070-932-168-498-607,Granted Patent,no,11,9,1,1,0,B60B29/004;;B60B29/004,B60B29/00,,0,0,,,,EXPIRED
41,CA,A,CA 1211705 A,150-788-483-005-020,1986-09-23,1986,CA 457116 A,1984-06-21,US 53521483 A,1983-09-23,APPARATUS AND METHODS FOR ORIENTING DEVICES IN SIDE POCKET MANDRELS,Apparatus and methods for installing a well tool device in the offset receptacle of a side pocket mandrel in predetermined oriented relation therein.,OTIS ENG CO,HILTS ROBERT L;;CROW ROBERT W,,https://lens.org/150-788-483-005-020,Granted Patent,no,0,0,11,12,0,E21B23/03;;E21B23/03,E21B23/03,166-42,0,0,,,,EXPIRED
42,AU,A,AU 1984/030959 A,057-376-644-451-098,1985-03-28,1985,AU 1984/030959 A,1984-07-23,US 53521483 A,1983-09-23,ORIENTING DEVICES IN SIDE POCKET MANDRELS,,OTIS ENG CO,HILTS ROBERT LORNE;;CROW ROBERT W,,https://lens.org/057-376-644-451-098,Patent Application,no,0,0,11,12,0,E21B23/03;;E21B23/03,E21B23/03,,0,0,,,,EXPIRED
43,GB,A,GB 2147034 A,018-657-463-409-997,1985-05-01,1985,GB 8416597 A,1984-06-29,US 53521483 A,1983-09-23,APPARATUS AND METHODS FOR ORIENTING DEVICES IN SIDE POCKET MANDRELS,,OTIS ENG CO,HOLTS ROBERT L;;CROW ROBERT W,,https://lens.org/018-657-463-409-997,Patent Application,no,3,1,11,12,0,E21B23/03;;E21B23/03,E21B23/03,E1F FKB           FKB,0,0,,,,EXPIRED
44,GB,B,GB 2156880 B,011-719-383-441-045,1986-09-24,1986,GB 8510447 A,1985-04-24,US 53521483 A,1983-09-23,APPARATUS AND METHODS FOR ORIENTING DEVICES IN SIDE POCKET MANDRELS,,OTIS ENG CO,HOLTS ROBERT L;;CROW ROBERT W,,https://lens.org/011-719-383-441-045,Granted Patent,no,0,0,11,12,0,E21B23/03;;E21B23/03,E21B23/03,E1FKB,0,0,,,,EXPIRED
45,GB,A,GB 2156880 A,083-567-732-033-456,1985-10-16,1985,GB 8510447 A,1985-04-24,US 53521483 A,1983-09-23,APPARATUS AND METHODS FOR ORIENTING DEVICES IN SIDE POCKET MANDRELS,,OTIS ENG CO,HOLTS ROBERT L;;CROW ROBERT W,,https://lens.org/083-567-732-033-456,Patent Application,no,6,2,11,12,0,E21B23/03;;E21B23/03,E21B23/03,E1F FKB           FKB,0,0,,,,EXPIRED
46,AU,B2,AU 560730 B2,163-670-787-133-054,1987-04-16,1987,AU 1984/030959 A,1984-07-23,US 53521483 A,1983-09-23,ORIENTING DEVICES IN SIDE POCKET MANDRELS,,OTIS ENG CO,HILTS ROBERT LORNE;;CROW ROBERT W,,https://lens.org/163-670-787-133-054,Granted Patent,no,0,2,11,12,0,E21B23/03;;E21B23/03,E21B23/03,,0,0,,,,EXPIRED
47,GB,B,GB 2147034 B,132-993-786-517-576,1986-09-24,1986,GB 8416597 A,1984-06-29,US 53521483 A,1983-09-23,APPARATUS AND METHODS FOR ORIENTING DEVICES IN SIDE POCKET MANDRELS,,OTIS ENG CO,HOLTS ROBERT L;;CROW ROBERT W,,https://lens.org/132-993-786-517-576,Granted Patent,no,0,0,11,12,0,E21B23/03;;E21B23/03,E21B23/03,E1FKB,0,0,,,,EXPIRED
48,US,A,US 4524833 A,158-290-185-371-324,1985-06-25,1985,US 53521483 A,1983-09-23,US 53521483 A,1983-09-23,Apparatus and methods for orienting devices in side pocket mandrels,Apparatus and methods for installing a well tool device in the offset receptacle of a side pocket mandrel in predetermined oriented relation therein.,OTIS ENG CO,HILTS ROBERT L;;CROW ROBERT W,OTIS ENGINEERING CORPORATION A CORP OF DE (1983-11-01),https://lens.org/158-290-185-371-324,Granted Patent,yes,17,23,11,12,0,E21B23/03;;E21B23/03,E21B23/03,166/381;;166/117.5,0,0,,,,EXPIRED
49,US,A,US 3320612 A,080-769-787-458-976,1967-05-16,1967,US 48046565 A,1965-08-17,US 48046565 A,1965-08-17,Dme with stepper type servo motor,,RCA CORP,CROW ROBERT P;;DOV MALKIN,SPERRY CORPORATION A CORP. OF DE (1981-01-09),https://lens.org/080-769-787-458-976,Granted Patent,no,2,4,1,1,0,G01S13/785;;G01S13/785,G01S13/78,H4D D265          R;;H4D D341          R;;H4D D407          R;;H4D D415          R;;H4D D417          R;;H4D D418          R;;H4D D426          R;;H4D D430          R;;H4D D440          R;;H4D D442          R;;H4D D443          R;;H4D D445          R;;H4D D446          R;;H4D D453          R;;H4D D454          R,0,0,,,,EXPIRED
50,US,A1,US 2017/0157741 A1,141-048-846-322-51X,2017-06-08,2017,US 201514962403 A,2015-12-08,US 201514962403 A,2015-12-08,METHOD OF STANDARDIZING GRINDER BURN ETCH TESTING,"A method of standardizing a grinder burn etch test may include machining a test sample of substantially equivalent chemical composition and heat treatment to a manufactured part to be audited for grinder burn and receiving data on an expected range of thermal damage that may be caused on the manufactured part during grinding by grinder burn. The method may also include preparing the test sample by laser heat treating at least a portion of the test sample to create a range of thermal damage across predetermined areas on the test sample, wherein the range of thermal damage on the test sample encompasses the expected range of thermal damage that may be caused on the manufactured part during grinding by grinder burn. The method may still further include testing a grinder burn etch bath with the test sample to determine whether the etch bath can detect thermal damage across at least a threshold percentage of the expected range of thermal damage that may be caused on the manufactured part.",CATERPILLAR INC,CROW JONATHAN ROBERT;;JACOBSON TRENTON G,CATERPILLAR INC (2015-12-02),https://lens.org/141-048-846-322-51X,Patent Application,yes,5,0,2,2,0,B24B49/14;;B24B49/14;;G01N25/72;;G01N25/72,B24B49/14;;G01N25/72,,0,0,,,,ACTIVE
51,EP,B1,EP 0692610 B1,095-292-637-791-318,1999-11-03,1999,EP 95304843 A,1995-07-11,US 27417594 A,1994-07-12,"Downhole tool, downhole sleeve valve and method of stimulating a subterranean formation",,HALLIBURTON ENERGY SERV INC,SHY PERRY C;;CROW ROBERT W,"HALLIBURTON ENERGY SERVICES, INC. (1999-06-16)",https://lens.org/095-292-637-791-318,Granted Patent,yes,1,3,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
52,GB,B,GB 2282616 B,133-441-542-841-880,1997-01-29,1997,GB 9417101 A,1994-08-24,US 13436093 A,1993-10-08,Packer set safety valve for controlling dual fluid flows,,HALLIBURTON CO,WHITE PAT M;;CROW ROBERT W,,https://lens.org/133-441-542-841-880,Granted Patent,no,0,0,4,4,0,E21B33/1295;;E21B34/10;;E21B34/10;;E21B33/1295,E21B33/1295;;E21B34/10,E1F FLH           FLH;;E1F F303          FLH;;E1F F304          FLH,0,0,,,,EXPIRED
53,US,A,US 2710378 A,131-314-424-030-628,1955-06-07,1955,US 22361251 A,1951-04-28,US 22361251 A,1951-04-28,Frequency modulation system,,MOTOROLA INC,DOREMUS JOHN A;;CROW ROBERT P,,https://lens.org/131-314-424-030-628,Granted Patent,no,5,0,1,1,0,H03C3/14;;H03C3/14,H03C3/14,,0,0,,,,EXPIRED
54,EP,A2,EP 0692610 A2,011-540-288-917-500,1996-01-17,1996,EP 95304843 A,1995-07-11,US 27417594 A,1994-07-12,Downhole sleeve valve and stimulation tool,"A sleeve valve assembly for a downhole tool has a cylindrical housing (101) within which a sleeve valve member (114) is axially slidable within a radially expanded section (109) of the housing. The radially expanded section (109) of the housing presents an inwardly extending stop shoulder (110) at one point along its length and an annular expansion notch (112b) at another point. The sleeve valve member (114) includes a radially projecting chamfered boss (119) about its circumference. A portion of the sleeve valve is longitudinally slotted (117) so as to form collets (118). An outwardly biased C-ring (122) is disposed about the sleeve valve member (114) within the radially expanded section (109). The C-ring (122) is initially disposed to be free to travel axially along the radially expanded section between the boss (119) and the stop shoulder (110). As the sleeve valve is moved toward an open position, the boss (119), C-ring (122) and stop shoulder (110) engage each other such that the sleeve valve is releasably snagged against further axial movement toward the open position. A significant axial force upon the sleeve valve is required to effect unsnagging. Upon application of increased axial force, the collets (118) of the sliding sleeve member (114) are forced radially inward to permit the boss (119) to slip past the C-ring (122). A stimulation tool incorporating such a sleeve valve assembly is described which permits acid to be selectively communicated into the surrounding formation. A stimulation tool constructed in accordance with the present invention is particularly useful for acid stimulation applications in horizontal well conduits as the snagging feature of the sleeve valve assembly provides a positive indication that lateral acid flow ports within the shifter tool have been placed adjacent complementary flow ports in the surrounding housing.",HALLIBURTON CO,SHY PERRY C;;CROW ROBERT W,"HALLIBURTON ENERGY SERVICES, INC. (1999-06-16)",https://lens.org/011-540-288-917-500,Patent Application,yes,0,9,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
55,CA,A1,CA 2153643 A1,163-628-704-301-077,1996-01-13,1996,CA 2153643 A,1995-07-11,US 27417594 A,1994-07-12,Sleeve Valve Flow Control Device with Locator Shifter,,HALLIBURTON CO,SHY PERRY C;;CROW ROBERT W,,https://lens.org/163-628-704-301-077,Patent Application,no,0,0,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
56,US,A,US 3233239 A,168-001-108-087-329,1966-02-01,1966,US 12459661 A,1961-07-17,US 12459661 A,1961-07-17,Induction field transmitter,,MOTOROLA INC,CROW ROBERT P;;KELLEY WALTER A,,https://lens.org/168-001-108-087-329,Granted Patent,no,7,5,1,1,0,E05F15/77;;E05F15/77;;E05Y2400/66;;E05Y2400/66;;E05Y2800/00;;E05Y2800/00,E05F15/20,,0,0,,,,EXPIRED
57,CA,A,CA 761618 A,016-154-113-552-630,1967-06-20,1967,CA 761618D A,,CA 761618T A,,DISTANCE MEASURING EQUIPMENT WITH FAST SEARCH,,RCA CORP,CROW ROBERT P;;SOFEN IRVING A,,https://lens.org/016-154-113-552-630,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
58,DE,T2,DE 60008315 T2,027-477-623-787-849,2004-12-09,2004,DE 60008315 T,2000-05-19,US 32341199 A,1999-06-01,Verfahren zur Herstellung von Methylchlorid,,DOW CORNING,CROW ROBERT DENNIS;;ROBERTS NEIL PHILIP,,https://lens.org/027-477-623-787-849,Granted Patent,no,0,0,10,10,0,C07C17/16;;C07C17/16,C07C17/16;;C07C19/03,,0,0,,,,EXPIRED
59,US,A,US 4733596 A,055-112-892-175-49X,1988-03-29,1988,US 899987 A,1987-01-30,US 899987 A,1987-01-30,Add-on missile container for military vehicles,"For use on a military vehicle a missile container wherein a pop-up rack scture is utilized to carry individual missiles. When the container cover is opened a linkage mechanism elevates the pop-up rack structure to present the missiles above the container, such that the soldier can readily remove the missiles from the rack structure and load same into a missile launcher located on the vehicle.",US ARMY,CROW III ROBERT A;;KORPI JOHN,UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SECRETARY OF THE ARMY (1987-01-26),https://lens.org/055-112-892-175-49X,Granted Patent,yes,7,11,1,1,0,F41A9/24;;F42B39/28;;F41A9/24;;F42B39/28,F41A9/24;;F42B39/28,89/34;;89/1.804;;206/3,0,0,,,,EXPIRED
60,CA,A1,CA 2185416 A1,078-224-760-939-620,1997-05-21,1997,CA 2185416 A,1996-09-12,US 56107095 A,1995-11-20,SEAT ASSEMBLY FOR MASS TRANSIT VEHICLE,A mass transit seat assembly of modular construction. The seat assembly includes a universal seat frame which is formed of roll formed steel members and which is usable in combination with a variety of support bracketry so that a single common seat frame may be utilized to provide a variety of seating positions and seating attitudes within the vehicle. The seat frame includes side rails and cross rails extending between the side rails. Fastener assemblies mounted on the associated bracket hardware include nuts slidably positioned within the respective cross rails and bolts extending upwardly through the bracket for threaded engagement with to the nuts. The invention provides an improved cantilever support assembly by virtue of which a single cantilever construction may be utilized to satisfy a wide variety of seating requirements; an improved wall mount bracket arrangement wherein the wall mount bracket is releasably secured to the cross rails utilizing fastener assemblies; an improved and simplified means of mounting the seat shell to the seat frame; and an improved seat frame in which all of the cross rails are identical and therefor interchangeable.,AMERICAN SEATING CO,MCDOWELL KEITH;;PHILLIPS MICHAEL;;CROW ROBERT,,https://lens.org/078-224-760-939-620,Patent Application,no,0,0,2,2,0,,B60N2/24;;B61D33/00,,0,0,,,,EXPIRED
61,CA,A,CA 571164 A,143-770-097-739-414,1959-02-24,1959,CA 571164D A,,CA 571164T A,,TRANSISTOR CIRCUIT,,MOTOROLA INC,CROW ROBERT P;;DOREMUS JOHN A,,https://lens.org/143-770-097-739-414,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
62,NO,L,NO 952738 L,174-542-480-195-245,1996-01-15,1996,NO 952738 A,1995-07-10,US 27417594 A,1994-07-12,Strömningsstyreanordning med hylseventil,,HALLIBURTON CO,SHY PERRY C;;CROW ROBERT W,,https://lens.org/174-542-480-195-245,Abstract,no,0,0,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
63,DE,D1,DE 60008315 D1,187-767-698-225-709,2004-03-25,2004,DE 60008315 T,2000-05-19,US 32341199 A,1999-06-01,Verfahren zur Herstellung von Methylchlorid,,DOW CORNING,CROW ROBERT DENNIS;;ROBERTS NEIL PHILIP,,https://lens.org/187-767-698-225-709,Granted Patent,no,0,0,10,10,0,C07C17/16;;C07C17/16,C07C17/16;;C07C19/03,,0,0,,,,EXPIRED
64,EP,A3,EP 0622521 A3,198-306-401-883-573,1995-09-13,1995,EP 94302703 A,1994-04-15,US 5289993 A,1993-04-26,Combination packer/safety valve assembly for gas storage wells.,"A combination packer/safety valve assembly (28) is connectable to the bottom end of a tubing string (36) and lowerable therewith into the casing string portion of a gas storage well to control the upward flow through the casing string (16) of pressurized gas stored in a subterranean cavern (12) below the casing string (16). The assembly comprises a body portion lowerable into the casing string (16) and having a normally closed first internal passage (128,52) through which, when opened, pressurized well fluid may internally traverse said body portion (30), and a second internal passage for receiving a pressurized control fluid (42) from a source thereof; first means (150,136) carried by said body portion (30) and operative to open said normally closed first passage (128,52) during the presence of a predetermined first control fluid pressure within said second internal passage; and second means (38,40) carried by said body portion (30) and operative to anchor and seal said body portion (30) within the casing string (16) in response to a predetermined second control fluid pressure created within said second internal passage and different from said predetermined first control fluid pressure.",HALLIBURTON CO,WHITE PAT MURPHY;;CROW ROBERT WESLEY,,https://lens.org/198-306-401-883-573,Search Report,yes,9,0,3,3,0,E21B33/1294;;E21B33/1295;;E21B34/10;;E21B34/10;;E21B33/1295;;E21B33/1294,E21B33/129;;E21B33/1295;;E21B34/10,,0,0,,,,DISCONTINUED
65,EP,A2,EP 1057802 A2,066-761-705-583-658,2000-12-06,2000,EP 00110708 A,2000-05-19,US 32341199 A,1999-06-01,Process for manufacturing methyl chloride,"A process for manufacturing methyl chloride is disclosed. The process comprises contacting hydrogen chloride with at least a stoichiometric amount of methanol split into at least two portions with a first portion having 60 to 95 percent of the methanol added to the process in the presence of a first liquid medium at a temperature in the range of 115°C. to 170°C. to form a gaseous mixture containing methyl chloride, contacting the gaseous mixture with a second methanol portion and adding to a second liquid medium at a temperature in the range of 100°C. to 160°C., and recovering the methyl chloride.",DOW CORNING,CROW ROBERT DENNIS;;ROBERTS NEIL PHILIP,,https://lens.org/066-761-705-583-658,Patent Application,yes,0,4,10,10,0,C07C17/16;;C07C17/16,C07C17/16;;C07C19/03,,0,0,,,,EXPIRED
66,JP,A,JP 2000344692 A,049-122-021-656-708,2000-12-12,2000,JP 2000149292 A,2000-05-22,US 32341199 A,1999-06-01,PRODUCTION OF METHYL CHLORIDE,"PROBLEM TO BE SOLVED: To produce methylene chloride while suppressing the byproduction of diethyl ether to reduce the disposal cost by using a step to form a gaseous mixture containing methylene chloride by contacting methanol with hydrogen chloride. SOLUTION: This process comprises (A) a step divided into at least two parts wherein the 1st part 4 comprises the formation of a gaseous mixture 12 containing methylene chloride by contacting at least stoichiometrical amount of methanol containing 60-95% of the methanol 8 added to a process with hydrogen chloride 2 in the presence of a 1st liquid medium 6 at 115-170 deg.C, (B) a step to contact the above gaseous mixture 12 with the 2nd methanol 14 and add the product to the 2nd liquid medium 16 at 100-160 deg.C and (C) a step to recover the produced methylene chloride.",DOW CORNING,CROW ROBERT DENNIS;;ROBERTS NEIL PHILIP,,https://lens.org/049-122-021-656-708,Patent Application,no,7,1,10,10,0,C07C17/16;;C07C17/16,C07C17/16;;C07C19/03,,0,0,,,,EXPIRED
67,US,A,US 3048659 A,134-313-926-245-279,1962-08-07,1962,US 80304559 A,1959-03-30,US 80304559 A,1959-03-30,Microphone preamplifier,,MOTOROLA INC,CROW ROBERT P;;VOLLINK GILBERT J,,https://lens.org/134-313-926-245-279,Granted Patent,no,6,7,1,1,0,H03F3/183;;H03F3/183,H03F3/183,,0,0,,,,EXPIRED
68,JP,A,JP 2011241233 A,151-202-538-594-332,2011-12-01,2011,JP 2011197090 A,2011-09-09,US 32341199 A,1999-06-01,PROCESS FOR MANUFACTURING METHYL CHLORIDE,PROBLEM TO BE SOLVED: To provide a process for manufacturing methyl chloride.SOLUTION: The process consists essentially of: contacting hydrogen chloride with at least a stoichiometric amount of methanol split into at least two portions with a first portion comprising about 60 to 95% of the methanol added to the process in the presence of a first liquid medium at a temperature in the range of 115 to 170°C to form a gaseous mixture containing methyl chloride; contacting the gaseous mixture with a second methanol portion and adding to a second liquid medium at a temperature in the range of about 100 to 160°C; and recovering the methyl chloride.,DOW CORNING,CROW ROBERT DENNIS;;ROBERTS NEIL PHILIP,,https://lens.org/151-202-538-594-332,Patent Application,no,2,2,10,10,0,C07C17/16;;C07C17/16,C07C17/16;;C07C17/38;;C07C19/03,,0,0,,,,PENDING
69,NO,D0,NO 952738 D0,177-763-846-190-165,1995-07-10,1995,NO 952738 A,1995-07-10,US 27417594 A,1994-07-12,Strömningsstyreanordning med hylseventil,,HALLIBURTON CO,SHY PERRY C;;CROW ROBERT W,,https://lens.org/177-763-846-190-165,Patent Application,no,0,0,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
70,US,A,US 5305828 A,190-765-379-937-871,1994-04-26,1994,US 5289993 A,1993-04-26,US 5289993 A,1993-04-26,Combination packer/safety valve assembly for gas storage wells,"A combination packer/safety valve assembly is connectable to the bottom end of a tubing string and lowerable therewith into the casing string portion of a gas storage well to control the upward flow through the casing string of pressurized gas stored in a subterranean cavern below the casing string. In response to the delivery through the tubing string to the interior of the assembly of control fluid at a first predetermined pressure a normally closed, axially extending interior passage of the assembly is opened to permit upward flow therethrough of pressurized gas for delivery to the well surface through the casing string. An increase of the control fluid pressure to a higher, predetermined second magnitude radially extends an anchor slip and packer structure externally carried by the assembly body into an anchored, sealing engagement with the interior surface of the casing string, and a locking structure automatically functions to hold the anchor slip and packer structure in this radially extended orientation. A subsequent increase of the control fluid pressure to a still higher, predetermined third magnitude causes the anchor slip and packer structure to be driven back to a radially retracted position, thereby releasing the assembly for upward retrieval movement with the tubing string through the casing string.",HALLIBURTON CO,WHITE PAT M;;CROW ROBERT W,HALLIBURTON COMPANY (1993-12-01),https://lens.org/190-765-379-937-871,Granted Patent,yes,5,47,3,3,0,E21B33/1294;;E21B33/1295;;E21B34/10;;E21B34/10;;E21B33/1295;;E21B33/1294,E21B33/129;;E21B33/1295;;E21B34/10,166/120;;166/151;;166/184,0,0,,,,EXPIRED
71,DK,T3,DK 0692610 T3,048-054-809-452-067,2000-04-10,2000,DK 95304843 T,1995-07-11,US 27417594 A,1994-07-12,"Borehulsredskab, borehulsglideventil og fremgangsmåde til stimulering af en underjordisk formation",,HALLIBURTON ENERGY SERV INC,CROW ROBERT W;;SHY PERRY C,,https://lens.org/048-054-809-452-067,Granted Patent,no,0,0,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
72,US,A,US 3321757 A,094-703-192-923-521,1967-05-23,1967,US 48035665 A,1965-08-17,US 48035665 A,1965-08-17,Dme with ground speed and time-tostation indicator,,RCA CORP,CROW ROBERT P;;FUJIMOTO KAY K,SPERRY CORPORATION A CORP. OF DE (1981-01-09),https://lens.org/094-703-192-923-521,Granted Patent,no,2,16,1,2,0,G01S7/04;;G01S7/04;;G01S13/60;;G01S13/60;;G01S13/785;;G01S13/785;;H03K23/002;;H03K23/002,G01S7/04;;G01S13/60;;G01S13/78;;H03K23/00,H4D D265          R;;H4D D341          R;;H4D D415          R;;H4D D417          R;;H4D D418          R;;H4D D426          R;;H4D D430          R;;H4D D440          R;;H4D D442          R;;H4D D443          R;;H4D D445          R;;H4D D446          R;;H4D D453          R;;H4D D454          R,0,0,,,,EXPIRED
73,US,A,US 2809236 A,122-222-483-813-468,1957-10-08,1957,US 39688253 A,1953-12-08,US 39688253 A,1953-12-08,Telephone apparatus,,MOTOROLA INC,RUSSELL STEWART JAMES;;CROW ROBERT P,,https://lens.org/122-222-483-813-468,Granted Patent,no,2,1,1,1,0,H04Q3/0016;;H04Q3/0016,H04Q3/00,,0,0,,,,EXPIRED
74,US,A1,US 2004/0074641 A1,181-330-086-469-470,2004-04-22,2004,US 27287502 A,2002-10-17,US 27287502 A,2002-10-17,Gravel packing apparatus having an integrated joint connection and method for use of same,"
    A gravel packing apparatus comprises multiple joints each having substantially the same construction and each having a perforated outer tubular ( 150, 152 ) positioned around a sand control screen ( 154, 156 ) including a slurry passageway ( 190, 194 ) and a production pathway ( 188, 192 ) therebetween. First and second transition members ( 210, 204 ) are disposed at opposite ends of each joint. When two such joints are connected together, the second transition member ( 204 ) of one joint is proximate the first transition member ( 210 ) of the next joint such that a fluid traveling from the slurry passageway ( 190 ) of one joint to the slurry passageway ( 194 ) of the next joint travels from the exterior to the interior of the second transition member ( 204 ) of the one joint and from the interior to the exterior of the first transition member ( 210 ) of the next joint. 
",HEJL DAVID A.;;CROW ROBERT W.,HEJL DAVID A;;CROW ROBERT W,HALLIBURTON ENERGY SERVICES INC (2002-12-18),https://lens.org/181-330-086-469-470,Patent Application,yes,54,25,2,2,0,E21B43/045;;E21B43/045,E21B43/04,166/278;;166/51;;166/236,0,0,,,,EXPIRED
75,GB,A,GB 2282616 A,183-970-005-786-14X,1995-04-12,1995,GB 9417101 A,1994-08-24,US 13436093 A,1993-10-08,Packer set safety valve for controlling dual fluid flows,"A packer set safety valve assembly (2) for controlling annular and tubing flows within a subterranean wellbore comprises securing means (60), that is remotely actuatable, to secure the assembly within the wellbore; control means (22), also remotely actuatable, for selective control of fluid flow in the dual flow paths; and unsecuring means (28, 58), remotely actuatable, to unsecure the assembly from within the wellbore. The assembly is preferably a ""fail closed"" design which prevents flows through the dual flow paths when the fluid flow control means is not actuated to allow flow. <IMAGE>",HALLIBURTON CO,WHITE PAT M;;CROW ROBERT W,,https://lens.org/183-970-005-786-14X,Patent Application,no,6,3,4,4,0,E21B33/1295;;E21B34/10;;E21B34/10;;E21B33/1295,E21B33/1295;;E21B34/10,E1F FLH           FLH;;E1F F303          FLH;;E1F F304          FLH,0,0,,,,EXPIRED
76,US,B2,US 10183377 B2,022-501-848-933-507,2019-01-22,2019,US 201514962403 A,2015-12-08,US 201514962403 A,2015-12-08,Method of standardizing grinder burn etch testing,"A method of standardizing a grinder burn etch test may include machining a test sample of substantially equivalent chemical composition and heat treatment to a manufactured part to be audited for grinder burn and receiving data on an expected range of thermal damage that may be caused on the manufactured part during grinding by grinder burn. The method may also include preparing the test sample by laser heat treating at least a portion of the test sample to create a range of thermal damage across predetermined areas on the test sample, wherein the range of thermal damage on the test sample encompasses the expected range of thermal damage that may be caused on the manufactured part during grinding by grinder burn. The method may still further include testing a grinder burn etch bath with the test sample to determine whether the etch bath can detect thermal damage across at least a threshold percentage of the expected range of thermal damage that may be caused on the manufactured part.",CATERPILLAR INC,CROW JONATHAN ROBERT;;JACOBSON TRENTON G,CATERPILLAR INC (2015-12-02),https://lens.org/022-501-848-933-507,Granted Patent,yes,13,0,2,2,0,B24B49/14;;B24B49/14;;G01N25/72;;G01N25/72,G01K15/00;;B24B49/14;;G01N25/72,,0,0,,,,ACTIVE
77,US,A,US 3246325 A,052-508-608-309-49X,1966-04-12,1966,US 31144563 A,1963-09-25,US 31144563 A,1963-09-25,Dme with fast search,,RCA CORP,SOFEN IRVING A;;CROW ROBERT P,SPERRY CORPORATION A CORP. OF DE (1981-01-09),https://lens.org/052-508-608-309-49X,Granted Patent,no,4,2,1,1,0,G01S13/785;;G01S13/785,G01S13/78,H4D D265          R;;H4D D341          R;;H4D D407          R;;H4D D415          R;;H4D D417          R;;H4D D418          R;;H4D D426          R;;H4D D440          R;;H4D D442          R;;H4D D443          R;;H4D D445          R;;H4D D451          R;;H4D D454          R;;H4D D456          R;;H4D D457          R,0,0,,,,EXPIRED
78,EP,A2,EP 0622521 A2,059-061-140-659-262,1994-11-02,1994,EP 94302703 A,1994-04-15,US 5289993 A,1993-04-26,Combination packer/safety valve assembly for gas storage wells.,"A combination packer/safety valve assembly (28) is connectable to the bottom end of a tubing string (36) and lowerable therewith into the casing string portion of a gas storage well to control the upward flow through the casing string (16) of pressurized gas stored in a subterranean cavern (12) below the casing string (16). The assembly comprises a body portion lowerable into the casing string (16) and having a normally closed first internal passage (128,52) through which, when opened, pressurized well fluid may internally traverse said body portion (30), and a second internal passage for receiving a pressurized control fluid (42) from a source thereof; first means (150,136) carried by said body portion (30) and operative to open said normally closed first passage (128,52) during the presence of a predetermined first control fluid pressure within said second internal passage; and second means (38,40) carried by said body portion (30) and operative to anchor and seal said body portion (30) within the casing string (16) in response to a predetermined second control fluid pressure created within said second internal passage and different from said predetermined first control fluid pressure.",HALLIBURTON CO,WHITE PAT MURPHY;;CROW ROBERT WESLEY,,https://lens.org/059-061-140-659-262,Patent Application,yes,0,0,3,3,0,E21B33/1294;;E21B33/1295;;E21B34/10;;E21B34/10;;E21B33/1295;;E21B33/1294,E21B33/129;;E21B33/1295;;E21B34/10,,0,0,,,,DISCONTINUED
79,US,A,US 2940051 A,077-502-882-124-121,1960-06-07,1960,US 52895955 A,1955-08-17,US 52895955 A,1955-08-17,Neutralized transistor amplifier,,MOTOROLA INC,KORN JR HUGO;;CROW ROBERT P,,https://lens.org/077-502-882-124-121,Granted Patent,no,5,4,1,1,0,H03F1/14;;H03F1/14,H03F1/14,,0,0,,,,EXPIRED
80,CA,C,CA 2185416 C,198-401-175-513-43X,2001-04-10,2001,CA 2185416 A,1996-09-12,US 56107095 A,1995-11-20,SEAT ASSEMBLY FOR MASS TRANSIT VEHICLE,A mass transit seat assembly of modular construction. The seat assembly includes a universal seat frame which is formed of roll formed steel members and which is usable in combination with a variety of support bracketry so that a single common seat frame may be utilized to provide a variety of seating positions and seating attitudes within the vehicle. The seat frame includes side rails and cross rails extending between the side rails. Fastener assemblies mounted on the associated bracket hardware include nuts slidably positioned within the respective cross rails and bolts extending upwardly through the bracket for threaded engagement with to the nuts. The invention provides an improved cantilever support assembly by virtue of which a single cantilever construction may be utilized to satisfy a wide variety of seating requirements; an improved wall mount bracket arrangement wherein the wall mount bracket is releasably secured to the cross rails utilizing fastener assemblies; an improved and simplified means of mounting the seat shell to the seat frame; and an improved seat frame in which all of the cross rails are identical and therefor interchangeable.,,MCDOWELL KEITH;;PHILLIPS MICHAEL;;CROW ROBERT,,https://lens.org/198-401-175-513-43X,Granted Patent,no,0,1,2,2,0,,B60N2/24;;B61D33/00,,0,0,,,,EXPIRED
81,US,A,US 3324467 A,069-265-358-325-465,1967-06-06,1967,US 48035765 A,1965-08-17,US 48035765 A,1965-08-17,Controller for stepper type servomotor in dme,,RCA CORP,CROW ROBERT P;;MASSE MICHEL S,SPERRY CORPORATION A CORP. OF DE (1981-01-09),https://lens.org/069-265-358-325-465,Granted Patent,no,1,4,1,1,0,G01S13/785;;H02P8/20;;H03K23/002;;G01S13/785;;H02P8/20;;H03K23/002,G01S13/78;;H02P8/20;;H03K23/00,,0,0,,,,EXPIRED
82,CA,A,CA 524579 A,112-244-480-194-897,1956-05-01,1956,CA 524579D A,,CA 524579T A,,FREQUENCY MODULATION SYSTEM,,MOTOROLA INC,DOREMUS JOHN A;;CROW ROBERT P,,https://lens.org/112-244-480-194-897,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
83,CA,A,CA 571966 A,115-920-233-784-160,1959-03-10,1959,CA 571966D A,,CA 571966T A,,DIAL TELEPHONE SWITCHING SYSTEM,,MOTOROLA INC,STEWART JAMES R;;CROW ROBERT P,,https://lens.org/115-920-233-784-160,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
84,CA,A,CA 893527 A,123-995-977-161-990,1972-02-22,1972,CA 893527D A,,CA 893527T A,,METHOD OF TREATING WELL EQUIPMENT,,DRESSER IND,MCQUEEN ROBERT W;;CROW MORGAN L,,https://lens.org/123-995-977-161-990,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
85,US,B2,US 6814139 B2,193-960-835-293-751,2004-11-09,2004,US 27287502 A,2002-10-17,US 27287502 A,2002-10-17,Gravel packing apparatus having an integrated joint connection and method for use of same,"
    A gravel packing apparatus comprises multiple joints each having substantially the same construction and each having a perforated outer tubular (  150, 152  ) positioned around a sand control screen (  154, 156  ) including a slurry passageway (  190, 194  ) and a production pathway (  188, 192  ) therebetween. First and second transition members (  210, 204  ) are disposed at opposite ends of each joint. When two such joints are connected together, the second transition member (  204  ) of one joint is proximate the first transition member (  210  ) of the next joint such that a fluid traveling from the slurry passageway (  190  ) of one joint to the slurry passageway (  194  ) of the next joint travels from the exterior to the interior of the second transition member (  204  ) of the one joint and from the interior to the exterior of the first transition member (  210  ) of the next joint. 
",HALLIBURTON ENERGY SERV INC,HEJL DAVID A;;CROW ROBERT W,HALLIBURTON ENERGY SERVICES INC (2002-12-18),https://lens.org/193-960-835-293-751,Granted Patent,yes,62,33,2,2,0,E21B43/045;;E21B43/045,E21B43/04,166/51;;166/278;;166/235;;166/236,11,3,068-598-658-441-918;;159-802-522-515-353;;130-528-674-159-261,10.2118/23741-ms;;10.2118/58775-ms;;10.2118/68205-ms,"Restarick of Otis Engineering Copr.; ""Mechanical Fluid-Loss Control Systems Used During Sand Control Operations""; 1992; pp. 21-36.;;Halliburton Energy Services, Inc.; ""Sand Control Screens""; 1994; 4 pages.;;Ebinger of Ely & Associates Inc.; ""Frac Pack Technology Still Evolving""; 1995; pp. 60-70; Oil & Gas Journal.;;Hailey and Cox of Haliburton Energy Services, Inc. and Johnson of BP Exploration (Alaska); ""Screenless Single Trip Multizone Sand Control Tool System Saves Rig Time""; Feb. 2000; pp. 1-11; Society of Petroleum Engineers Inc.;;Halliburton Energy Services, Inc.; ""Caps Sand Control Service for Horizontal Completions Improves Gravel Pack Reliability and Increases Production Potential from Horizontal Completions""; Aug. 2000; 2 pages.;;Halliburton Energy Services, Inc.; ""CAPS Concertric Annular Packaging Service for Sand Control""; Aug. 2000; 4 pages.;;Saldungaray of Schlumberger, TRONCOSO and SANTOSO of Repsol-YPF; ""Simultaneous Gravel Packing and Filter Cake Removal in Horizontal Wells Applying Shunt Tubes and Novel Carrier and Breaker Fluid""; Mar. 2001: pp. 1-6; Society of Petroleum Engineers, Inc.;;Schlumberger, ""QUANTUM Zonal Isolation Tool""; pp. 12-13; Sand Face Completions Catalog.;;Halliburton Energy Services, Inc.; ""Absolute Isolation System (AIS) Components""; 1 page.;;OSCA Corporate Headquarters; ""HPR-ISO System""; 2000; 1 page; Technical Bulletin.;;OSCA Corporate Headquarters; ""The ISO System""; 2000; 1 page; Technical Bulletin.",EXPIRED
86,EP,A3,EP 1057802 A3,022-362-945-877-052,2001-02-28,2001,EP 00110708 A,2000-05-19,US 32341199 A,1999-06-01,Process for manufacturing methyl chloride,"A process for manufacturing methyl chloride is disclosed. The process comprises contacting hydrogen chloride with at least a stoichiometric amount of methanol split into at least two portions with a first portion having 60 to 95 percent of the methanol added to the process in the presence of a first liquid medium at a temperature in the range of 115°C. to 170°C. to form a gaseous mixture containing methyl chloride, contacting the gaseous mixture with a second methanol portion and adding to a second liquid medium at a temperature in the range of 100°C. to 160°C., and recovering the methyl chloride.",DOW CORNING,CROW ROBERT DENNIS;;ROBERTS NEIL PHILIP,,https://lens.org/022-362-945-877-052,Search Report,yes,4,0,10,10,0,C07C17/16;;C07C17/16,C07C17/16;;C07C19/03,,0,0,,,,EXPIRED
87,US,A,US 4375928 A,078-801-620-827-640,1983-03-08,1983,US 17784980 A,1980-08-14,US 17784980 A,1980-08-14,Flexible concrete for soil erosion prevention,"This invention consists of a flexible type of concrete guard against the erosion of soil by flowing waters and wave action. It consists of rows of comparatively small, identical concrete blocks which form rectangular sections which are placed upon the ground surface which has previously been covered with a filter cloth. The said blocks are held together by a continuous wire cable which is embedded centrally in each block, and which passes through each row of blocks, forming a small loop as it leaves one of said rows to enter its next adjacent row, by means of which one section can be joined with the other, and pinned to the ground.",CROW ROBERT Q;;HANSEN DAVID H,CROW ROBERT Q;;HANSEN DAVID H,ARVAI LOUIS JR (1992-05-12);;CHASE CHARLES (1992-05-12);;CROW ROBERT (1983-06-24),https://lens.org/078-801-620-827-640,Granted Patent,yes,8,62,1,1,0,E02B3/123;;E02B3/123,E02B3/12,405/20;;405/17,0,0,,,,EXPIRED
88,US,A1,US 2007/0296970 A1,102-661-117-135-715,2007-12-27,2007,US 47281106 A,2006-06-21,US 47281106 A,2006-06-21,Methods and apparatus for locating and classifying optical radiation,"Disclosed are methods and systems for locating and classifying optical sources. In one aspect, a pair of imaging spectrometers is orthogonally oriented relative to an optical axis to accommodate simultaneous creation of two diffraction profiles for each imaged optical source. Such orientation increases the accuracy of detecting diffraction profiles of interest (“DPI”), as a DPI will not be declared unless it is sensed by both spectrometers. Furthermore, the spectrometers' orientation allows data such as a two-dimensional angle of incidence to be collected from an identified DPI without identification of either DPI's 0 th order ray segment, thereby increasing the accuracy of the collected data. Such increased accuracy in both data determinations allows optical sources to be more accurately located and classified as information such as wavelength, amplitude, etc. may be calculated from the detected DPI with a greater degree of accuracy. Furthermore, false DPI detections are minimized.",CROW ROBERT WALTER;;LOIZIDES CRAIG EMMANUEL,CROW ROBERT WALTER;;LOIZIDES CRAIG EMMANUEL,SENSING STRATEGIES INC (2006-09-20),https://lens.org/102-661-117-135-715,Patent Application,yes,4,5,2,2,0,G01J3/02;;G01J3/0294;;G01J3/2823;;G01J3/36;;G01S3/7835;;G01J3/2823;;G01S3/7835;;G01J3/02;;G01J3/0294;;G01J3/36,G01J3/28,356/328,0,0,,,,ACTIVE
89,US,A,US 5505263 A,119-856-116-472-303,1996-04-09,1996,US 13436093 A,1993-10-08,US 13436093 A,1993-10-08,Packer set safety valve for controlling dual fluid flows,"A packer set safety valve assembly for controlling annular and tubing flows within a subterranean wellbore is disclosed. The packer set safety valve assembly controls the annular and tubing flows through dual flow paths. The assembly includes a means, that is remotely actuatable, to secure the assembly within the wellbore, a means, also remotely actuatable, the allows selective control of fluid flow in the dual flow paths, and a means, remotely actuatable as well, to unsecure the assembly from within the wellbore. The packer set safety valve assembly is a ""fail closed"" design which prevents flows through the dual flow paths when the fluid flow control means is not actuated to allow flow.",WHITE; PAT M.;;CROW; ROBERT W.,WHITE PAT M;;CROW ROBERT W,HALLIBURTON COMPANY (1993-11-16),https://lens.org/119-856-116-472-303,Granted Patent,yes,12,19,4,4,0,E21B33/1295;;E21B34/10;;E21B34/10;;E21B33/1295,E21B33/1295;;E21B34/10,166/374;;166/122;;166/126;;166/129;;166/142;;166/319;;166/384,0,0,,,,EXPIRED
90,US,A,US 6111153 A,156-520-196-003-410,2000-08-29,2000,US 32341199 A,1999-06-01,US 32341199 A,1999-06-01,Process for manufacturing methyl chloride,"A process for manufacturing methyl chloride. The process consists essentially of contacting hydrogen chloride with at least a stoichiometric amount of methanol split into at least two portions with a first portion comprising about 60 to 95 percent of the methanol added to the process in the presence of a first liquid medium at a temperature in the range of about 115.degree. C. to 170.degree. C. to form a gaseous mixture containing methyl chloride, and contacting the gaseous mixture with a second methanol portion and adding to a second liquid medium at a temperature in the range of about 100.degree. C. to 160.degree. C., and recovering the methyl chloride.",DOW CORNING;;DOW CORNING,CROW ROBERT DENNIS;;ROBERTS NEIL PHILIP,DOW CORNING LIMITED (1999-06-23);;DOW SILICONES CORPORATION (1999-06-29),https://lens.org/156-520-196-003-410,Granted Patent,yes,2,45,10,10,0,C07C17/16;;C07C17/16,C07C17/16;;C07C19/03,570/258,0,0,,,,EXPIRED
91,US,A,US 5479989 A,181-806-147-389-740,1996-01-02,1996,US 27417594 A,1994-07-12,US 27417594 A,1994-07-12,Sleeve valve flow control device with locator shifter,"A sleeve valve assembly featuring a cylindrical housing within which a sleeve valve is axially slidable within a radially expanded section of the housing. The radially expanded section of the housing presents an inwardly extending stop shoulder at one point along its length and an annular expansion notch at another point. The sleeve valve includes a radially projecting chamfered boss about its circumference. A portion of the sleeve valve is longitudinally slotted so as to form collets. An outwardly biased C-ring is disposed about the sleeve valve within the radially expanded section. The C-ring is initially disposed to be free to travel axially along the radially expanded section between the boss and the stop shoulder. As the sleeve valve is moved toward an open position, the boss, C-ring and stop shoulder engage each other such that the sleeve valve is releasably snagged against further axial movement toward the open position. A significant axial force upon the sleeve valve is required to effect unsnagging. Upon application of increased axial force, the collets of the sliding sleeve are forced radially inward to permit the boss to slip past the C-ring. An exemplary stimulation tool incorporating the sleeve valve assembly is described which permits acid to be selectively communicated into the surrounding formation. A stimulation tool constructed in accordance with the present invention is particularly useful for acid stimulation applications in horizontal well conduits as the snagging feature of the sleeve valve assembly provides a positive indication that lateral acid flow ports within the shifter tool have been placed adjacent complimentary flow ports in the surrounding housing.",HALLIBURTON CO,SHY PERRY C;;CROW ROBERT W,HALLIBURTON COMPANY (1994-06-29),https://lens.org/181-806-147-389-740,Granted Patent,yes,20,74,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,166/332.4;;166/334.1,0,0,,,,EXPIRED
92,US,B2,US 7456940 B2,183-370-802-820-962,2008-11-25,2008,US 47281106 A,2006-06-21,US 47281106 A,2006-06-21,Methods and apparatus for locating and classifying optical radiation,"Disclosed are methods and systems for locating and classifying optical sources. In one aspect, a pair of imaging spectrometers is orthogonally oriented relative to an optical axis to accommodate simultaneous creation of two diffraction profiles for each imaged optical source. Such orientation increases the accuracy of detecting diffraction profiles of interest (“DPI”), as a DPI will not be declared unless it is sensed by both spectrometers. Furthermore, the spectrometers' orientation allows data such as a two-dimensional angle of incidence to be collected from an identified DPI without identification of either DPI's 0 th order ray segment, thereby increasing the accuracy of the collected data. Such increased accuracy in both data determinations allows optical sources to be more accurately located and classified as information such as wavelength, amplitude, etc. may be calculated from the detected DPI with a greater degree of accuracy. Furthermore, false DPI detections are minimized.",SENSING STRATEGIES INC,CROW ROBERT WALTER;;LOIZIDES CRAIG EMMANUEL,SENSING STRATEGIES INC (2006-09-20),https://lens.org/183-370-802-820-962,Granted Patent,yes,12,10,2,2,0,G01J3/02;;G01J3/0294;;G01J3/2823;;G01J3/36;;G01S3/7835;;G01J3/2823;;G01S3/7835;;G01J3/02;;G01J3/0294;;G01J3/36,G01J3/28,356/73;;356/328,0,0,,,,ACTIVE
93,EP,A3,EP 0692610 A3,011-838-012-468-865,1997-04-09,1997,EP 95304843 A,1995-07-11,US 27417594 A,1994-07-12,Downhole sleeve valve and stimulation tool,"A sleeve valve assembly for a downhole tool has a cylindrical housing (101) within which a sleeve valve member (114) is axially slidable within a radially expanded section (109) of the housing. The radially expanded section (109) of the housing presents an inwardly extending stop shoulder (110) at one point along its length and an annular expansion notch (112b) at another point. The sleeve valve member (114) includes a radially projecting chamfered boss (119) about its circumference. A portion of the sleeve valve is longitudinally slotted (117) so as to form collets (118). An outwardly biased C-ring (122) is disposed about the sleeve valve member (114) within the radially expanded section (109). The C-ring (122) is initially disposed to be free to travel axially along the radially expanded section between the boss (119) and the stop shoulder (110). As the sleeve valve is moved toward an open position, the boss (119), C-ring (122) and stop shoulder (110) engage each other such that the sleeve valve is releasably snagged against further axial movement toward the open position. A significant axial force upon the sleeve valve is required to effect unsnagging. Upon application of increased axial force, the collets (118) of the sliding sleeve member (114) are forced radially inward to permit the boss (119) to slip past the C-ring (122). A stimulation tool incorporating such a sleeve valve assembly is described which permits acid to be selectively communicated into the surrounding formation. A stimulation tool constructed in accordance with the present invention is particularly useful for acid stimulation applications in horizontal well conduits as the snagging feature of the sleeve valve assembly provides a positive indication that lateral acid flow ports within the shifter tool have been placed adjacent complementary flow ports in the surrounding housing.",HALLIBURTON CO,SHY PERRY C;;CROW ROBERT W,"HALLIBURTON ENERGY SERVICES, INC. (1999-06-16)",https://lens.org/011-838-012-468-865,Search Report,yes,1,0,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
94,DE,D1,DE 69513097 D1,015-784-731-011-428,1999-12-09,1999,DE 69513097 T,1995-07-11,US 27417594 A,1994-07-12,"Bohrlochwerkzeug, Bohrlochhülsenventil und Verfahren zur Stimulation einer unterirdischen Formation",,HALLIBURTON ENERGY SERV INC,SHY PERRY C;;CROW ROBERT W,,https://lens.org/015-784-731-011-428,Granted Patent,no,0,0,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
95,CA,A,CA 1129218 A,016-750-416-954-62X,1982-08-10,1982,CA 358218 A,1980-08-14,CA 358218 A,1980-08-14,FLEXIBLE CONCRETE FOR SOIL EROSION PREVENTION,"This invention consists of a flexible type of concrete guard against the erosion of soil by flowing waters and wave action. It consists of rows of comparatively small, identical concrete blocks which form rectangular sections which are placed upon the ground surface which has previously been covered with a filter cloth. The said blocks are held together by a continuous wire cable which is embedded centrally in each block, and which passes through each row of blocks, forming a small loop as it leaves one of said rows to enter its next adjacent row, by means of which one section can be joined with the other, and pinned to the ground.",CROW ROBERT Q;;HANSEN DAVID H,CROW ROBERT Q;;HANSEN DAVID H,,https://lens.org/016-750-416-954-62X,Granted Patent,no,0,5,1,1,0,E02B3/123,E02B3/12,61-29,0,0,,,,EXPIRED
96,US,A,US 2808469 A,066-983-037-299-507,1957-10-01,1957,US 34966653 A,1953-04-20,US 34966653 A,1953-04-20,Transistor circuit,,MOTOROLA INC,CROW ROBERT P;;DOREMUS JOHN A,,https://lens.org/066-983-037-299-507,Granted Patent,no,2,2,1,1,0,H03F3/26;;H03F3/26,H03F3/26,,0,0,,,,EXPIRED
97,MY,A,MY 117228 A,008-531-910-024-815,2004-05-31,2004,MY PI20002451 A,2000-05-31,US 32341199 A,1999-06-01,PROCESS FOR MANUFACTURING METHYL CHLORIDE.,"A PROCESS FOR MANUFACTURING METHYL CHLORIDE (22). THE PROCESS CONSISTS ESSENTIALLY OF CONTACTING HYDRIGEN CHLORIDE (2) WITH AT LEAST A STOICHIOMETRIC AMOUNT OF METHANOL SPLIT INTO AT LEAST TWO PORTIONS WITH A FIRST PORTION (8) COMPRISING ABOUT 60 TO 95 PERCENT OF THE METHANOL ADDED TO THE PROCESS IN THE PRESENCE OF A FIRST LIQUID MEDIUM AT A TEMPERATURE IN THE RANGE OF 115°C. TO 170°C. TO FORM A GASEOUS MIXTURE (12) CONTAINING METHYL CHLORIDE, CONTACTING THE GASEOUS MIXTURE (12) WITH A SECOND METHANOL PORTION (14) AND ADDING TO A SECOND LIQUID MEDIUM (16) AT A TEMPERATURE IN THE RANGE OF 100°C. TO 160°C. , AND RECOVERING THE METHYL CHLORIDE (22).",DOW CORNING,CROW ROBERT DENNIS;;ROBERTS NEIL PHILIP,,https://lens.org/008-531-910-024-815,Granted Patent,no,0,0,10,10,0,C07C17/16;;C07C17/16,C07C17/00;;C07C17/16;;C07C19/03,,0,0,,,,EXPIRED
98,US,A,US 3566970 A,039-366-246-245-959,1971-03-02,1971,US 3566970D A,1969-02-13,US 79899869 A,1969-02-13,METHOD OF INJECTING TREATING LIQUIDS INTO WELL TUBING,,DRESSER IND,CROW MORGAN L;;MCQUEEN ROBERT W,,https://lens.org/039-366-246-245-959,Granted Patent,no,8,14,2,2,0,E21B41/02;;E21B43/00;;Y10S166/902;;E21B43/00;;E21B41/02;;Y10S166/902,E21B41/02;;E21B43/00,166/310,1,0,,,"Muir, P.D. Organic Inhibitors In Oil & Gas J., Feb. 15, 1954, pp. 143 and 145 147. (Copy in 166-244C)",EXPIRED
99,CA,C,CA 2153643 C,049-372-023-749-176,1999-01-26,1999,CA 2153643 A,1995-07-11,US 27417594 A,1994-07-12,SLEEVE VALVE FLOW CONTROL DEVICE WITH LOCATOR SHIFTER,"A sleeve valve assembly featuring a cylindrical housing within which a sleeve valve is axially slidable within a radially expanded section of the housing. The radially expanded section of the housing presents an inwardly extending stop shoulder at one point along its length and an annular expansion notch at another point. The sleeve valve includes a radially projecting chamfered boss about its circumference. A portion of the sleeve valve is longitudinally slotted so as to form collets. An outwardly biased C-ring is disposed about the sleeve valve within the radially expanded section. The C-ring is initially disposed to be free to travel axially along the radially expanded section between the boss and the stop shoulder. As the sleeve valve is moved toward an open position, the boss, C-ring and stop shoulder engage each other such that the sleeve valve is releasably snagged against further axial movement toward the open position. A significant axial force upon the sleeve valve is required to effect unsnagging. Upon application of increased axial force, the collets of the sliding sleeve are forced radially inward to permit the boss to slip past the C-ring. An exemplary stimulation tool incorporating the sleeve valve assembly is described which permits acid to be selectively communicated into the surrounding formation. A stimulation tool constructed in accordance with the present invention is particularly useful for acid stimulation applications in horizontal well conduits as the snagging feature of the sleeve valve assembly provides a positive indication that lateral acid flow ports within the shifter tool have been placed adjacent complimentary flow ports in the surrounding housing.",,SHY PERRY C;;CROW ROBERT W,,https://lens.org/049-372-023-749-176,Granted Patent,no,0,0,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
100,NO,B1,NO 310158 B1,154-878-569-580-274,2001-05-28,2001,NO 952738 A,1995-07-10,US 27417594 A,1994-07-12,"Hylseventilenhet, strömstyreanordning samt fremgangsmåte for stimulering av en underjordisk formasjon",,HALLIBURTON CO,SHY PERRY C;;CROW ROBERT W,,https://lens.org/154-878-569-580-274,Granted Patent,no,0,0,11,11,0,E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/12;;E21B43/25;;E21B34/14;;E21B34/06;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
101,EP,B1,EP 1057802 B1,185-217-774-194-23X,2004-02-18,2004,EP 00110708 A,2000-05-19,US 32341199 A,1999-06-01,Process for manufacturing methyl chloride,,DOW CORNING,CROW ROBERT DENNIS;;ROBERTS NEIL PHILIP,,https://lens.org/185-217-774-194-23X,Granted Patent,yes,4,0,10,10,0,C07C17/16;;C07C17/16,C07C17/16;;C07C19/03,,0,0,,,,EXPIRED
102,EP,A3,EP 1049029 A3,179-193-635-348-023,2003-07-09,2003,EP 00303520 A,2000-04-26,US 30105799 A;;US 30117799 A,1999-04-28,File systems with versatile indirection,A memory storage device has a file storage operating system that uses inodes to access file segments. Each inode has a plurality of rows. A portion of the rows can store extents pointing directly to data blocks. Each extent either has a field to indicate whether the extent is an indirect extent or a direct extent or has a field to indicate an address for a target a logical volume.,EMC CORP,CROW PRESTON F;;MASON ROBERT S JR,,https://lens.org/179-193-635-348-023,Search Report,yes,7,0,4,9,0,G06F16/10,G06F12/00;;G06F17/30,,3,2,141-375-776-458-806;;003-913-456-669-948,10.1109/icde.1992.213180;;10.1109/hicss.1995.375407,"BILIRIS A: ""An efficient database storage structure for large dynamic objects"", DATA ENGINEERING, 1992. PROCEEDINGS. EIGHTH INTERNATIONAL CONFERENCE ON TEMPE, AZ, USA 2-3 FEB. 1992, LOS ALAMITOS, CA, USA,IEEE COMPUT. SOC, US, 2 February 1992 (1992-02-02), pages 301 - 308, XP010026793, ISBN: 0-8186-2545-7;;SWEENEY A ET AL: ""Scalability in the XFS file system"", PROCEEDINGS OF THE USENIX 1996 ANNUAL TECHNICAL CONFERENCE, PROCEEDINGS OF USENIX, SAN DIEGO, CA, USA, 22-26 JAN. 1996, 1996, Berkeley, CA, USA, USENIX Assoc, USA, pages 1 - 14, XP002231832;;PROTIC J ET AL: ""A survey of distributed shared memory systems"", SYSTEM SCIENCES. VOL. II., PROCEEDINGS OF THE TWENTY-EIGHTH HAWAII INTERNATIONAL CONFERENCE ON WAILEA, HI, USA 3-6 JAN. 1995, LOS ALAMITOS, CA, USA,IEEE COMPUT. SOC, 3 January 1995 (1995-01-03), pages 74 - 84, XP010128214, ISBN: 0-8186-6930-6",DISCONTINUED
103,CA,A,CA 594904 A,004-941-303-320-029,1960-03-22,1960,CA 594904D A,,CA 594904T A,,PAGING COMMUNICATION SYSTEM,,MOTOROLA INC,CROW ROBERT P;;YOST RUSSELL R JR,,https://lens.org/004-941-303-320-029,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
104,EP,A2,EP 1049029 A2,109-459-572-799-72X,2000-11-02,2000,EP 00303520 A,2000-04-26,US 30105799 A;;US 30117799 A,1999-04-28,File systems with versatile indirection,A memory storage device has a file storage operating system that uses inodes to access file segments. Each inode has a plurality of rows. A portion of the rows can store extents pointing directly to data blocks. Each extent either has a field to indicate whether the extent is an indirect extent or a direct extent or has a field to indicate an address for a target a logical volume.,EMC CORP,CROW PRESTON F;;MASON ROBERT S JR,,https://lens.org/109-459-572-799-72X,Patent Application,yes,0,8,4,9,0,G06F16/10,G06F12/00;;G06F17/30,,2,0,,,"OTTMANN T, WIDMAYER P: ""Algorithmen und Datenstrukturen"", 1990, BI WISSENSCHAFTSVERLAG, MANNHEIM;;HANDSSCHUH T: ""Solaris 2 Systemadministration. Grundlagen und Systemmanagement"", 1996, IWT VERLAG GMBH, BONN",DISCONTINUED
105,US,B2,US 6565093 B2,008-555-389-118-007,2003-05-20,2003,US 79750801 A,2001-03-01,US 79750801 A,2001-03-01,Seal structure for downhole tool,"
    A seal structure is provided for a downhole tool. In a described embodiment, a seal structure includes a seal support ring having at least one annular groove formed thereon and a longitudinal axis. At least one seal is included in the seal structure. The seal is disposed at least partially in the groove, and the seal is bonded to the ring. An annular recess is positioned longitudinally between opposing side walls of the groove. The recess may be formed in a body of the seal. 
",HALLIBURTON ENERGY SERV INC,CROW STEPHEN L;;HENDERSON WILLIAM D;;HARMS TIMOTHY E;;CROW ROBERT W;;JONES RALPH,HALLIBURTON ENERGY SERVICES INC (2001-04-25),https://lens.org/008-555-389-118-007,Granted Patent,yes,13,24,2,2,0,E21B33/1208;;E21B33/1208;;E21B33/10,E21B33/12,277/337;;277/338;;277/616;;277/626,2,0,,,Otis Engineering Corporation Drawing No. 91 M 849.;;Halliburton Energy Services Drawing No. 91 M 3479.,EXPIRED
106,US,A1,US 2002/0121743 A1,018-922-405-138-396,2002-09-05,2002,US 79750801 A,2001-03-01,US 79750801 A,2001-03-01,Seal structure for downhole tool,"
   A seal structure is provided for a downhole tool. In a described embodiment, a seal structure includes a seal support ring having at least one annular groove formed thereon and a longitudinal axis. At least one seal is included in the seal structure. The seal is disposed at least partially in the groove, and the seal is bonded to the ring. An annular recess is positioned longitudinally between opposing side walls of the groove. The recess may be formed in a body of the seal. 
",CROW STEPHEN L.;;HENDERSON WILLIAM D.;;HARMS TIMOTHY E.;;CROW ROBERT W.;;JONES RALPH,CROW STEPHEN L;;HENDERSON WILLIAM D;;HARMS TIMOTHY E;;CROW ROBERT W;;JONES RALPH,HALLIBURTON ENERGY SERVICES INC (2001-04-25),https://lens.org/018-922-405-138-396,Patent Application,yes,0,17,2,2,0,E21B33/1208;;E21B33/1208;;E21B33/10,E21B33/12,277/343,0,0,,,,EXPIRED
107,US,A1,US 2016/0374499 A1,089-246-005-453-033,2016-12-29,2016,US 201514753219 A,2015-06-29,US 201514753219 A,2015-06-29,STEAM GENERATION SYSTEM FOR USE IN COOKING APPLIANCE,"A steam generator system for a cooking appliance includes an in-line heating element coupled to a heating tube, wherein water from a water reservoir is gravitationally fed into the heating tube for heating by the in-line heating element to produce a hot water and steam mixture. A first supply line is coupled to the heating tube to carry the mixture to a separator without the need for moving or complex pump parts. The separator separates steam and hot water from the mixture of the two. A second supply line is coupled to the separator at a first end and opens into the cooking cavity of the cooking appliance at a second end. The second supply line is configured to supply steam separated at the separator to the cooking cavity via a steam outlet disposed in the cooking cavity.",WHIRLPOOL CO,DONARSKI ROBERT S;;CROW NICHOLAS E;;SCHNEEMANN JASON,WHIRLPOOL CORPORATION (2015-06-25),https://lens.org/089-246-005-453-033,Patent Application,yes,2,13,7,7,0,F24C15/327;;F24C15/327;;A47J27/04;;A47J2027/043;;F22B1/282;;F22B37/26,A47J27/04;;F22B1/28;;F22B37/26,,0,0,,,,ACTIVE
108,US,A,US 4866030 A,159-328-428-333-101,1989-09-12,1989,US 8354987 A,1987-08-06,US 8354987 A,1987-08-06,Method of producing high temperature superconductors by a molten hydroxide process,"The present invention is directed to a method of producing metal oxides which are useful as high temperature superconductors. The method comprises the steps of: (a) mixing generally stoichiometric amounts of metal compounds with an alkali metal metal hydroxide, thereby forming a mixture; (b) heating the mixture to drive off water; and (c) filtering the mixture to remove the alkali metal ions.",UNIV TEMPLE,SALOMON ROBERT E;;CROW JACK E;;KACZANOWICZ EDWARD,TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION BROAD ST. & MONTGOMERY ST. A PA. CORP (1987-08-10),https://lens.org/159-328-428-333-101,Granted Patent,yes,8,3,1,1,0,C01G3/006;;Y10S505/81;;Y10S505/815;;Y10S505/809;;H10N60/0268;;C01G3/006;;Y10S505/809;;Y10S505/81;;Y10S505/815;;H10N60/0268,C01G3/00;;H01L39/24,505/1;;423/263;;423/593;;423/604;;501/152;;501/126;;505/809;;505/810;;505/815,17,2,037-019-140-596-575;;023-382-113-873-408,10034925;;10.1103/physrevlett.58.405;;9941229;;10.1103/physrevb.35.8709,"Ceramic Processing Before Firing , Edited by Onoda and Hench (N.Y., NY, 1978), pp. 131 139.;;A Hydroxycarbonate Route to Superconducting Precursor Powders , Voight et al., MRS Symposium Proceedings, vol. 99, Dec. 1987, pp. 635 638.;;Manufacture and Testing of High Te Superconducting Materials , Yarar et al., Advanced Ceramic Materials, vol. 2, No. 3B Special Issue, Jul. 1987.;;Capone, et al., Upper Critical Fields and High Superconducting Transition Temperatures of La 1.85 Sr 0.15 CuO 4 and La 1.85 Ba 0.15 CuO 4 (U.S. Dept. of Energy sponsored work), submitted to Applied Physics Letters, 1/87.;;Liu, et al., Superconductivity and Structure of Single Crystal YBa 2 Cu 3 O 4 , submitted to Physics Letters A, 3/30/87, p. 2.;;Hinks, et al., Phase Diagram and Superconductivity in the Y Ba Cu O System, submitted to Appl. Phys. Lett., 3/18/87, p. 2.;;Beyers, et al., Annealing Treatment Effects on Structure and Superconductivity in Y 1 Ba 2 Cu 3 O 9 x submitted to Applied Phisics Letters, p. 2.;;Gallagher, et al., Identification and Preparation of Single Phase 90K Oxide Superconductor and Structural Determination by Lattice Imaging , submitted to Solid State Communications, 3/17/87, p. 3.;;Schirber, et al., Variation of the Pressure Dependence of the Superconducting Transition Temperature with x in La 1 x Sr x CuO 4 .;;Kwok, et al., Normal and Superconducting State Properties of La 1.85 Sr 0.15 CuO 4 , submitted to Phys. Rev. Lett., 1/87.;;Capone, et al., Upper Critical Fields and High Superconducting Transition Temperatures of La 1.85 Sr 0.15 CuO 4 and La 1.85 Ba 0.15 CuO 4 , p. 2.;;Jorgensen, et al., Lattice Instability and High Te Superconductivity in La 2 x Ba x CuO 4 , submitted to Physical Review Letters, 1/87, p. 3.;;Hawley, et al., Energy Gap in La 1.85 Sr 0.15 CuO 4 y From Point Contact Tunnelling , submitted to Phys. Rev. Lett., p. 2.;;Chu, et al., Evidence for Superconductivity above 40K in the La Ba Cu O Compound System , Physical Review Letters, vol. 58, No. 4, 1/26/87, pp. 405 407.;;Maranto, Superconductivity: Hype vs. Reality , Discover Magazine, 8/87, pp. 22 32.;;Fisher, Superconductor Frenzy , Popular Science Magazine , 7/87, pp. 54 58, 97.;;Schirber, et al., Pressure Dependence of the Superconducting Transition Temperature in the 94K Superconductor, YBa 2 Cu 3 O 7 , submitted to Phys. Rev.",EXPIRED
109,US,B2,US 10206532 B2,105-983-017-150-791,2019-02-19,2019,US 201715715307 A,2017-09-26,US 201715715307 A;;US 201514753219 A,2015-06-29,Steam generation system for use in cooking appliance,"A steam generator system for a cooking appliance includes an in-line heating element coupled to a heating tube, wherein water from a water reservoir is gravitationally fed into the heating tube for heating by the in-line heating element to produce a hot water and steam mixture. A first supply line is coupled to the heating tube to carry the mixture to a separator without the need for moving or complex pump parts. The separator separates steam and hot water from the mixture of the two. A second supply line is coupled to the separator at a first end and opens into the cooking cavity of the cooking appliance at a second end. The second supply line is configured to supply steam separated at the separator to the cooking cavity via a steam outlet disposed in the cooking cavity.",WHIRLPOOL CO,DONARSKI ROBERT S;;CROW NICHOLAS E;;SCHNEEMANN JASON,,https://lens.org/105-983-017-150-791,Granted Patent,yes,23,1,7,7,0,F24C15/327;;F24C15/327;;A47J27/04;;A47J2027/043;;F22B1/282;;F22B37/26,A47J27/04;;F22B1/28;;F22B37/26;;F24C15/32,,0,0,,,,ACTIVE
110,US,B2,US 10973359 B2,072-411-907-820-030,2021-04-13,2021,US 201816232485 A,2018-12-26,US 201816232485 A;;US 201715715307 A;;US 201514753219 A,2015-06-29,Steam generation system for use in cooking appliance,"A steam generator system for a cooking appliance includes an in-line heating element coupled to a heating tube, wherein water from a water reservoir is gravitationally fed into the heating tube for heating by the in-line heating element to produce a hot water and steam mixture. A first supply line is coupled to the heating tube to carry the mixture to a separator without the need for moving or complex pump parts. The separator separates steam and hot water from the mixture of the two. A second supply line is coupled to the separator at a first end and opens into the cooking cavity of the cooking appliance at a second end. The second supply line is configured to supply steam separated at the separator to the cooking cavity via a steam outlet disposed in the cooking cavity.",WHIRLPOOL CO,DONARSKI ROBERT S;;CROW NICHOLAS E;;SCHNEEMANN JASON,,https://lens.org/072-411-907-820-030,Granted Patent,yes,24,0,7,7,0,F24C15/327;;F24C15/327;;A47J27/04;;A47J2027/043;;F22B1/282;;F22B37/26,A47J27/04;;F22B1/28;;F22B37/26;;F24C15/32,,0,0,,,,ACTIVE
111,US,A,US 2811590 A,186-970-721-363-390,1957-10-29,1957,US 33983753 A,1953-03-02,US 33983753 A,1953-03-02,Series-energized cascade transistor amplifier,,MOTOROLA INC,DOREMUS JOHN A;;CROW ROBERT P;;HUGO KORN,,https://lens.org/186-970-721-363-390,Granted Patent,no,6,24,1,1,0,H03F3/42;;H03F3/42,H03F3/42,,0,0,,,,EXPIRED
112,US,B2,US 9788679 B2,089-863-773-484-127,2017-10-17,2017,US 201514753219 A,2015-06-29,US 201514753219 A,2015-06-29,Steam generation system for use in cooking appliance,"A steam generator system for a cooking appliance includes an in-line heating element coupled to a heating tube, wherein water from a water reservoir is gravitationally fed into the heating tube for heating by the in-line heating element to produce a hot water and steam mixture. A first supply line is coupled to the heating tube to carry the mixture to a separator without the need for moving or complex pump parts. The separator separates steam and hot water from the mixture of the two. A second supply line is coupled to the separator at a first end and opens into the cooking cavity of the cooking appliance at a second end. The second supply line is configured to supply steam separated at the separator to the cooking cavity via a steam outlet disposed in the cooking cavity.",WHIRLPOOL CO,DONARSKI ROBERT S;;CROW NICHOLAS E;;SCHNEEMANN JASON,WHIRLPOOL CORPORATION (2015-06-25),https://lens.org/089-863-773-484-127,Granted Patent,yes,23,0,7,7,0,F24C15/327;;F24C15/327;;A47J27/04;;A47J2027/043;;F22B1/282;;F22B37/26,A21B1/22;;A47J27/04;;F22B1/28;;F22B37/26;;F24C15/32,,0,0,,,,ACTIVE
113,CA,A,CA 554675 A,196-425-822-715-673,1958-03-18,1958,CA 554675D A,,CA 554675T A,,SERIES-ENERGIZED CASCADE TRANSISTOR AMPLIFIER,,MOTOROLA INC,DOREMUS JOHN A;;CROW ROBERT P;;KORN HUGO,,https://lens.org/196-425-822-715-673,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
114,EP,A1,EP 3112765 A1,161-942-216-340-045,2017-01-04,2017,EP 16168644 A,2016-05-06,US 201514753219 A,2015-06-29,STEAM GENERATION SYSTEM FOR USE IN A COOKING APPLIANCE,"A steam generator system (10) for a cooking appliance includes an in-line heating element (14) coupled to a heating tube (16), wherein water (W) from a water reservoir (12) is gravitationally fed into the heating tube (16) for heating by the in-line heating element (14) to produce a hot water and steam mixture (M). A first supply line (20, 22) is coupled to the heating tube (16) to carry the mixture (M) to a separator (18). The separator (18) separates steam (S) and hot water (HW) from the mixture (M). A second supply line (24) is coupled to the separator (18) at a first end and opens into the cooking cavity (30) of the cooking appliance at a second end. The second supply line (24) is configured to supply steam via a steam outlet (32) to the cooking cavity (30).",WHIRLPOOL CO,DONARSKI ROBERT S;;CROW NICHOLAS E;;SCHNEEMANN JASON,,https://lens.org/161-942-216-340-045,Patent Application,yes,4,3,7,7,0,F24C15/327;;F24C15/327;;A47J27/04;;A47J2027/043;;F22B1/282;;F22B37/26,F24C15/32,,0,0,,,,DISCONTINUED
115,US,A1,US 2018/0014684 A1,018-740-198-962-878,2018-01-18,2018,US 201715715307 A,2017-09-26,US 201715715307 A;;US 201514753219 A,2015-06-29,STEAM GENERATION SYSTEM FOR USE IN COOKING APPLIANCE,"A steam generator system for a cooking appliance includes an in-line heating element coupled to a heating tube, wherein water from a water reservoir is gravitationally fed into the heating tube for heating by the in-line heating element to produce a hot water and steam mixture. A first supply line is coupled to the heating tube to carry the mixture to a separator without the need for moving or complex pump parts. The separator separates steam and hot water from the mixture of the two. A second supply line is coupled to the separator at a first end and opens into the cooking cavity of the cooking appliance at a second end. The second supply line is configured to supply steam separated at the separator to the cooking cavity via a steam outlet disposed in the cooking cavity.",WHIRLPOOL CO,DONARSKI ROBERT S;;CROW NICHOLAS E;;SCHNEEMANN JASON,,https://lens.org/018-740-198-962-878,Patent Application,yes,0,2,7,7,0,F24C15/327;;F24C15/327;;A47J27/04;;A47J2027/043;;F22B1/282;;F22B37/26,A47J27/04;;F22B1/28;;F22B37/26;;F24C15/32,,0,0,,,,ACTIVE
116,US,A1,US 2019/0125121 A1,043-193-763-857-904,2019-05-02,2019,US 201816232485 A,2018-12-26,US 201816232485 A;;US 201715715307 A;;US 201514753219 A,2015-06-29,STEAM GENERATION SYSTEM FOR USE IN COOKING APPLIANCE,"A steam generator system for a cooking appliance includes an in-line heating element coupled to a heating tube, wherein water from a water reservoir is gravitationally fed into the heating tube for heating by the in-line heating element to produce a hot water and steam mixture. A first supply line is coupled to the heating tube to carry the mixture to a separator without the need for moving or complex pump parts. The separator separates steam and hot water from the mixture of the two. A second supply line is coupled to the separator at a first end and opens into the cooking cavity of the cooking appliance at a second end. The second supply line is configured to supply steam separated at the separator to the cooking cavity via a steam outlet disposed in the cooking cavity.",WHIRLPOOL CO,DONARSKI ROBERT S;;CROW NICHOLAS E;;SCHNEEMANN JASON,,https://lens.org/043-193-763-857-904,Patent Application,yes,0,6,7,7,0,F24C15/327;;F24C15/327;;A47J27/04;;A47J2027/043;;F22B1/282;;F22B37/26,A47J27/04;;F22B1/28;;F22B37/26;;F24C15/32,,0,0,,,,ACTIVE
117,GB,B,GB 2111567 B,194-728-981-263-921,1985-07-24,1985,GB 8236019 A,1982-12-17,US 33164181 A,1981-12-17,WELL SAFETY SYSTEM,,OTIS ENG CO,CROW ROBERT W;;VINZANT MICHAEL B;;SCHWENDEMANN KENNETH L,,https://lens.org/194-728-981-263-921,Granted Patent,no,0,0,4,4,0,E21B34/106;;E21B34/106,E21B34/10,E1F301;;E1F302;;E1FLH,0,0,,,,EXPIRED
118,US,A,US 3416608 A,056-417-824-179-927,1968-12-17,1968,US 56075666 A,1966-06-27,US 56075666 A,1966-06-27,Retrievable well packer,,DRESSER IND,CROW MORGAN L;;KILGORE MARION D;;PUMPELLY ROBERT C,,https://lens.org/056-417-824-179-927,Granted Patent,no,10,19,3,3,0,E21B33/1294;;E21B33/1294;;E21B33/1292;;E21B33/1292,E21B33/129,166/129,0,0,,,,EXPIRED
119,US,A,US 4469179 A,190-225-276-418-342,1984-09-04,1984,US 33164181 A,1981-12-17,US 33164181 A,1981-12-17,Safety system,A well controlled by two hydraulically operated subsurface safety valves made up in the tubing string. A first valve is mechanically locked in open position and the second valve is utilized to control flow through the string. Upon malfunction of the second valve it is locked in open position and the first valve is released from its locked open position and is utilized to control flow through the string.,OTIS ENG CO,CROW ROBERT W;;VINZANT MICHAEL B;;SCHWENDEMANN KENNETH L,OTIS ENGINEERING CORPORATION A CORP. OF DE (1982-06-14);;HALLIBURTON COMPANY (1993-06-24),https://lens.org/190-225-276-418-342,Granted Patent,yes,7,20,4,4,0,E21B34/106;;E21B34/106,E21B34/10,166/319;;166/375;;166/323,0,0,,,,EXPIRED
120,US,A,US 4921048 A,004-317-658-381-489,1990-05-01,1990,US 24776088 A,1988-09-22,US 24776088 A,1988-09-22,Well production optimizing system,"A programmable system for controlling the operation of a plunger completion oil or gas production well to optimize production from the well. The controller operates one or more motor valves controlling the well in accordance with programmable values of off-time, on-time and exhaust-time. The controller monitors whether or not a plunger arrival signal is received on each cycle of intermitting the well and changes either the off-time or the exhaust-time for the next cycle in response thereto. In oil well mode, the off-time is decreased slightly for each cycle following a cycle in which plunger arrival occurred and increased slightly for each cycle following one in which it did not. In gas well mode, the exhaust-time is increased slightly for each cycle following a cycle in which plunger arrival occurred before on-time expired and decreased slightly for each cycle following one in which it did not.",OTIS ENG CO,CROW ROBERT W;;HOLLOMAN RICKY M;;PRUDEN JAMES B,OTIS ENGINEERING CORPORATION DALLAS TEXAS A CORP. OF DE (1988-12-08);;MEGA SYSTEMS LLC (1999-09-14);;HALLIBURTON COMPANY (1993-06-24);;MEGA LIFT SYSTEMS LLC (2002-02-01);;CAMCO INTERNATIONAL INC (1997-10-09),https://lens.org/004-317-658-381-489,Granted Patent,yes,8,85,7,7,0,Y10T137/86461;;E21B43/13;;Y10T137/86461;;E21B43/13,E21B43/12,166/372;;137/624.2;;166/53;;166/64;;166/66,1,0,,,"Differential Control System Operating Manual , dated Aug. 27, 1982 by Plunger Lift Systems, Inc.",EXPIRED
121,GB,A,GB 2603921 A,101-622-509-171-32X,2022-08-24,2022,GB 202102300 A,2021-02-18,GB 202102300 A,2021-02-18,3D knitted structure and a method of providing a 3D knitted struture,"A cover 212, such as for a vehicle seat or trim component, comprising a 3D knitted structure formed from heat activated and non-heat activated yarns knitted together. The structure has integral channels 216Fa-c formed of continuous loops of knitted material; and a vehicle component, such as a cable or wire, can be inserted into ends of the channels 216Fa-c and held within the channels 216Fa-c. A method (500, Fig. 9) of fabricating a cover that can be used for an interior or exterior trim component of a vehicle comprises forming (510, Fig. 9) a 3D knitted structure by knitting together heat-activated and non-heat activated yarns. The 3D knitted structure comprises a integrally formed channels, comprising a loop of knitted material, with an end through which a vehicle component, such as a cable or wire, can be inserted and subsequently retained in the channel.",JAGUAR LAND ROVER LTD,BELINDA MASON;;SARAH-KATE FRASER;;CLAIRE XU;;ROBERT CROW,,https://lens.org/101-622-509-171-32X,Patent Application,no,4,0,8,8,0,B60N2/5891;;B60N2/58;;D04B1/22;;D04B1/108;;D10B2401/041;;D10B2505/12;;D10B2403/0332;;D10B2403/0113;;D10B2505/08;;B60N2/5891;;D04B1/16;;D04B21/14;;B32B2262/152;;D10B2401/04;;D10B2505/12,B60N2/58;;D04B1/16;;D04B21/14,,0,0,,,,ACTIVE
122,WO,A1,WO 2022/175415 A1,131-098-442-504-862,2022-08-25,2022,EP 2022054012 W,2022-02-17,GB 202102300 A,2021-02-18,3D KNITTED STRUCTURE AND A METHOD OF PROVIDING A 3D KNITTED STRUCTURE,"Aspects of the present invention relate to a method (500) of fabricating a cover for an interior trim component or an exterior trim component for a vehicle. The method comprising forming a 3D knitted structure (510) by knitting together at least one heat activated yarn and at least one non-heat activated yarn. The structure may be arranged whereby, during a subsequent heat treatment process (520) in which the cover is heated to a temperature at or above an activation temperature, the heat-activated yarn is activated thereby to form an automotive cover having a knitted structure of increased stiffness once cooled.",JAGUAR LAND ROVER LTD,MASON BELINDA;;FRASER SARAH-KATE;;XU CLAIRE;;CROW ROBERT,,https://lens.org/131-098-442-504-862,Patent Application,yes,6,0,8,8,0,B60N2/5891;;B60N2/58;;D04B1/22;;D04B1/108;;D10B2401/041;;D10B2505/12;;D10B2403/0332;;D10B2403/0113;;D10B2505/08;;B60N2/5891;;D04B1/16;;D04B21/14;;B32B2262/152;;D10B2401/04;;D10B2505/12,B60N2/58;;D04B1/10;;D04B1/22,,0,0,,,,PENDING
123,CA,C,CA 1338022 C,089-256-957-220-56X,1996-01-30,1996,CA 609051 A,1989-08-22,US 24776088 A,1988-09-22,WELL PRODUCTION OPTIMIZING SYSTEM,"A programmable system for controlling the operation of a plunger completion oil or gas production well to optimize production from the well. The controller operates one or more motor valves controlling the well in accordance with programmable values of off-time, on-time and exhaust-time. The controller monitors whether or not a plunger arrival signal is received on each cycle of intermitting the well and changes either the offtime or the exhaust-time for the next cycle in response thereto. In oil well mode, the off-time is decreased slightly for each cycle following a cycle in which plunger arrival occurred and increased slightly for each cycle following one in which it did not. In gas well mode, the exhaust-time is increased slightly for each cycle following a cycle in which plunger arrival occurred before on-time expired and decreased slightly for each cycle following one in which it did not.",HALLIBURTON CO,CROW ROBERT W;;HOLLOMAN RICKY M;;PRUDEN JAMES B,,https://lens.org/089-256-957-220-56X,Granted Patent,no,0,1,7,7,0,Y10T137/86461;;E21B43/13;;Y10T137/86461;;E21B43/13,E21B43/12,D434200221   M;;3420031    S,0,0,,,,EXPIRED
124,CA,A,CA 1196856 A,004-529-905-377-992,1985-11-19,1985,CA 417847 A,1982-12-16,US 33164181 A,1981-12-17,SAFETY SYSTEM,A well controlled by two hydraulically operated subsurface safety valves made up in the tubing string. A first valve is mechanically locked in open position and the second valve is utilized to control flow through the string. Upon malfunction of the second valve it is locked in open position and the first valve is released from its locked open position and is utilized to control flow through the string.,OTIS ENG CO,CROW ROBERT W;;VINZANT MICHAEL B;;SCHWENDEMANN KENNETH L,,https://lens.org/004-529-905-377-992,Granted Patent,no,0,0,4,4,0,E21B34/106;;E21B34/106,E21B34/10,166-41,0,0,,,,EXPIRED
125,CA,A,CA 651254 A,069-294-513-506-390,1962-10-30,1962,CA 651254D A,,CA 651254T A,,MOBILE DOOR CONTROL,,MOTOROLA INC,ROSE SAMUEL W;;KELLEY WALTER A;;CROW ROBERT P,,https://lens.org/069-294-513-506-390,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
126,CA,A,CA 948298 A,082-645-571-846-185,1974-05-28,1974,CA 114790 A,1971-06-04,US 6902370 A,1970-09-02,AUTOMATIC HEADWAY CONTROL SYSTEM,,FORD MOTOR CANADA,CHERRY JAMES R;;CROW JOSEPH W;;PARKER ROBERT H,,https://lens.org/082-645-571-846-185,Granted Patent,no,0,0,2,2,0,B60K31/0008;;B60W2720/106;;G01S13/931;;G01S2013/9321;;G01S2013/9325;;G01S2013/9319;;G01S2013/93185;;G01S2013/932;;G01S2013/93271;;G01S13/931;;B60W2720/106;;B60K31/0008;;G01S2013/9325;;G01S2013/9321;;G01S2013/932;;G01S2013/9319;;G01S2013/93185;;G01S2013/93271,G01S13/931;;B60K31/00,343-7,0,0,,,,EXPIRED
127,US,A,US 3041507 A,060-120-199-713-887,1962-06-26,1962,US 75132758 A,1958-07-28,US 75132758 A,1958-07-28,Mobile door control,,MOTOROLA INC,ROSE SAMUEL W;;CROW ROBERT P;;KELLEY WALTER A,,https://lens.org/060-120-199-713-887,Granted Patent,no,6,10,1,1,0,E05F15/77;;E05F15/77,E05F15/20,,0,0,,,,EXPIRED
128,US,A,US 6116183 A,101-522-613-041-156,2000-09-12,2000,US 16469698 A,1998-10-01,US 16469698 A,1998-10-01,Positively locking boat seat and method for making the same,"A pedestal seat assembly for supporting a boat seat thereon includes first and second self-biasing locking mechanisms for restricting rotational and longitudinal movement of the boat seat. A base is configured for mounting to a supporting surface and includes a mounting socket therein. A pedestal or extension has its lower end mounted within the socket of the base. The first self-biasing locking mechanism is mounted within the extension and releasably interconnects the extension and the base, such that the extension is restricted from rotational and longitudinal movement within the base. A seat mount has an upper portion configured to fixedly attach a seat thereto, and a lower portion configured to rotatably mount within the upper end of the extension. The lower end of the seat mount can alternatively be mounted within the socket of the base. The second self-biasing locking mechanism is mounted within the lower portion of the seat mount and releasably interconnects the extension or base such that the seat mount is restricted from rotational and longitudinal movement.",ATTWOOD CORP,CROW ROBERT S;;HOLTFORTH JOHN A;;RATZA CLIFTON J,ATTWOOD CORPORATION (1999-01-14);;BRUNSWICK OUTLET CORPORATION (2003-08-29);;STEELCASE DEVELOPMENT CORPORATION (2001-08-06),https://lens.org/101-522-613-041-156,Granted Patent,yes,41,62,1,1,0,A47C15/004;;A47C15/004;;B63B29/06;;B63B29/06;;B63B2029/043;;B63B2029/043,A47C9/10;;B63B29/06,114/363;;297/344.22;;297/451.5,1,0,,,"Springfield Marine Co.; 1993 Marine Products Catalog; pp. 18 23; Spring Lock , Taper Lock , and Kingpin pedestal systems.",EXPIRED
129,EP,A1,EP 4294672 A1,189-126-298-464-498,2023-12-27,2023,EP 22707083 A,2022-02-17,GB 202102300 A;;EP 2022054012 W,2021-02-18,3D KNITTED STRUCTURE AND A METHOD OF PROVIDING A 3D KNITTED STRUCTURE,,JAGUAR LAND ROVER LTD,MASON BELINDA;;FRASER SARAH-KATE;;XU GEGE;;CROW ROBERT,,https://lens.org/189-126-298-464-498,Patent Application,yes,0,0,8,8,0,B60N2/5891;;B60N2/58;;D04B1/22;;D04B1/108;;D10B2401/041;;D10B2505/12;;D10B2403/0332;;D10B2403/0113;;D10B2505/08;;B60N2/5891;;D04B1/16;;D04B21/14;;B32B2262/152;;D10B2401/04;;D10B2505/12,B60N2/58;;D04B1/10;;D04B1/22,,0,0,,,,PENDING
130,GB,B8,GB 2603921 B8,100-836-373-593-650,2023-08-16,2023,GB 202102300 A,2021-02-18,GB 202102300 A,2021-02-18,3D knitted structure and a method of providing a 3D knitted struture,,JAGUAR LAND ROVER LTD,BELINDA MASON;;SARAH-KATE FRASER;;GEGE XU;;ROBERT CROW,,https://lens.org/100-836-373-593-650,Amended Patent,no,0,0,8,8,0,B60N2/5891;;B60N2/58;;D04B1/22;;D04B1/108;;D10B2401/041;;D10B2505/12;;D10B2403/0332;;D10B2403/0113;;D10B2505/08;;B60N2/5891;;D04B1/16;;D04B21/14;;B32B2262/152;;D10B2401/04;;D10B2505/12,B60N2/58;;D04B1/16;;D04B21/14,,0,0,,,,ACTIVE
131,MX,B,MX 164164 B,000-797-198-199-722,1992-07-21,1992,MX 1754589 A,1989-09-13,US 24776088 A,1988-09-22,SISTEMA PARA OPTIMIZACION DE PRODUCCION DE POZOS,,OTIS ENG CO,CROW ROBERT W;;HOLLOMAN RICHY M;;PRUDEN JAMES B,,https://lens.org/000-797-198-199-722,Granted Patent,no,0,0,7,7,0,Y10T137/86461;;E21B43/13;;Y10T137/86461;;E21B43/13,E21B43/12,,0,0,,,,EXPIRED
132,CA,A,CA 826475 A,105-970-154-727-259,1969-11-04,1969,CA 826475D A,,CA 826475T A,,RETRIEVABLE WELL PACKER,,DRESSER IND,CROW MORGAN L;;PUMPELLY ROBERT C;;KILGORE MARION D,,https://lens.org/105-970-154-727-259,Granted Patent,no,0,2,1,1,0,,,,0,0,,,,EXPIRED
133,GB,A,GB 2111567 A,127-692-276-806-538,1983-07-06,1983,GB 8236019 A,1982-12-17,US 33164181 A,1981-12-17,WELL SAFETY SYSTEM,,OTIS ENG CO,CROW ROBERT W;;VINZANT MICHAEL B;;SCHWENDEMANN KENNETH L,,https://lens.org/127-692-276-806-538,Patent Application,no,0,1,4,4,0,E21B34/106;;E21B34/106,E21B34/10,E1F FLH           FLH;;E1F F301          FLH;;E1F F302          FLH,0,0,,,,EXPIRED
134,GB,A,GB 2224864 A,131-970-714-017-611,1990-05-16,1990,GB 8919724 A,1989-08-31,US 24776088 A,1988-09-22,CONTROLLING OIL PRODUCTION FROM WELL,,OTIS ENG CO,CROW ROBERT W;;HOLLOMAN RICHY M;;PRUDEN JAMES B,,https://lens.org/131-970-714-017-611,Patent Application,no,0,0,7,7,0,Y10T137/86461;;E21B43/13;;Y10T137/86461;;E21B43/13,E21B43/12,G3N NGBB3         GBB3;;G3N N265B         GBB3;;G3N N287          GBB3;;G3N N373          GBB3;;G3N N374          GBB3;;G3N N404          GBB3;;U1S S1269;;U1S S1748,0,0,,,,EXPIRED
135,GB,A8,GB 2603921 A8,084-918-328-962-841,2023-08-16,2023,GB 202102300 A,2021-02-18,GB 202102300 A,2021-02-18,3D knitted structure and a method of providing a 3D knitted struture,"A cover 212, such as for a vehicle seat or trim component, comprising a 3D knitted structure formed from heat activated and non-heat activated yarns knitted together. The structure has integral channels 216Fa-c formed of continuous loops of knitted material; and a vehicle component, such as a cable or wire, can be inserted into ends of the channels 216Fa-c and held within the channels 216Fa-c. A method (500, Fig. 9) of fabricating a cover that can be used for an interior or exterior trim component of a vehicle comprises forming (510, Fig. 9) a 3D knitted structure by knitting together heat-activated and non-heat activated yarns. The 3D knitted structure comprises a integrally formed channels, comprising a loop of knitted material, with an end through which a vehicle component, such as a cable or wire, can be inserted and subsequently retained in the channel.",JAGUAR LAND ROVER LTD,BELINDA MASON;;SARAH-KATE FRASER;;GEGE XU;;ROBERT CROW,,https://lens.org/084-918-328-962-841,Patent Application,no,0,0,8,8,0,B60N2/5891;;B60N2/58;;D04B1/22;;D04B1/108;;D10B2401/041;;D10B2505/12;;D10B2403/0332;;D10B2403/0113;;D10B2505/08;;B60N2/5891;;D04B1/16;;D04B21/14;;B32B2262/152;;D10B2401/04;;D10B2505/12,B60N2/58;;D04B1/16;;D04B21/14,,0,0,,,,ACTIVE
136,US,A,US 5766565 A,130-498-403-399-170,1998-06-16,1998,US 641193 A,1993-01-21,US 641193 A,1993-01-21,Purification of hydrochloric acid,A process is described by which numerous waste or by-product aqueous hydrochloric acid streams can be purified by contacting the aqueous hydrochloric acid with activated carbon to remove silicon containing impurities and thereby allowing the hydrochloric acid to be re-used for various applications.,DOW CORNING,CRONIN KIRK ANDREW;;CROW ROBERT DENNIS;;EVANKO WILLIAM ANDREW,DOW CORNING CORPORATION (1992-12-07),https://lens.org/130-498-403-399-170,Granted Patent,yes,8,16,1,1,0,C01B7/0725;;C01B7/0725;;C01B32/36;;C01B32/36,C01B7/07;;C01B31/08,423/488;;210/670,1,0,,,"Encyclopedia of Chemical Technology, Third Edition, vol. 4, p. 561: by: Kirk Othmer, 1980 (no month).",EXPIRED
137,BR,A,BR 8904452 A,054-591-861-371-732,1990-04-17,1990,BR 8904452 A,1989-09-04,US 24776088 A,1988-09-22,PROCESSO PARA CONTROLAR O FUNCIONAMENTO CICLICO DE UM POCO PRODUTOR DE PETROLEO;SISTEMA PARA CONTROLAR O FUNCIONAMENTO CICLICO DE UM POCO PRODUTOR DE GAS;PROCESSO E SISTEMA PARA A OTIMIZACAO DA PRODUCAO DE UM POCO PRODUTOR DE PETROLEO E PROCESSO PARA A OTIMIZACAO DA PRODUCAO DE UM POCO PRODUTOR DE GAS,,OTIS ENG CO,CROW ROBERT W;;HOLLOMAN RICKY M;;PRUDEN JAMES B,,https://lens.org/054-591-861-371-732,Patent Application,no,0,0,7,7,0,Y10T137/86461;;E21B43/13;;Y10T137/86461;;E21B43/13,E21B43/12,,0,0,,,,DISCONTINUED
138,GB,B,GB 2603921 B,106-509-829-899-499,2023-06-14,2023,GB 202102300 A,2021-02-18,GB 202102300 A,2021-02-18,3D knitted structure and a method of providing a 3D knitted struture,,JAGUAR LAND ROVER LTD,BELINDA MASON;;SARAH-KATE FRASER;;CLAIRE XU;;ROBERT CROW,,https://lens.org/106-509-829-899-499,Granted Patent,no,4,0,8,8,0,B60N2/5891;;B60N2/58;;D04B1/22;;D04B1/108;;D10B2401/041;;D10B2505/12;;D10B2403/0332;;D10B2403/0113;;D10B2505/08;;B60N2/5891;;D04B1/16;;D04B21/14;;B32B2262/152;;D10B2401/04;;D10B2505/12,B60N2/58;;D04B1/16;;D04B21/14,,0,0,,,,ACTIVE
139,GB,B,GB 2224864 B,167-713-681-503-638,1993-02-17,1993,GB 8919724 A,1989-08-31,US 24776088 A,1988-09-22,WELL PRODUCTION OPTIMIZING SYSTEM,,OTIS ENG CO,CROW ROBERT W;;HOLLOMAN RICHY M;;PRUDEN JAMES B,,https://lens.org/167-713-681-503-638,Granted Patent,no,0,0,7,7,0,Y10T137/86461;;E21B43/13;;Y10T137/86461;;E21B43/13,E21B43/12,G3N NGBB3         GBB3;;G3N N265B         GBB3;;G3N N287          GBB3;;G3N N373          GBB3;;G3N N374          GBB3;;G3N N404          GBB3;;U1S S1269;;U1S S1748,0,0,,,,EXPIRED
140,CN,A,CN 115768790 A,037-580-622-473-061,2023-03-07,2023,CN 202180023056 A,2021-03-25,US 202063000299 P;;US 202063002896 P;;US 202063003716 P;;US 202063023545 P;;US 202063024204 P;;US 202063024248 P;;US 202063027173 P;;US 202063037984 P;;US 202063040224 P;;US 202063040246 P;;US 202163142196 P;;US 202163161890 P;;US 2021/0024215 W,2020-03-26,Human monoclonal antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),"The present disclosure relates to antibodies that bind to and neutralize coronavirus, referred to as SARS-CoV-2, and methods of using the same.",UNIV VANDERBILT,CROW JR JAMES EDWARD;;ZOST STEFAN;;CARNAHAN ROBERT;;JILCHUK PIOTR,,https://lens.org/037-580-622-473-061,Patent Application,no,0,0,25,31,0,C07K2317/56;;C07K2317/35;;C07K2317/565;;C07K2317/76;;A61K2039/505;;G01N33/56983;;G01N2333/165;;G01N2469/10;;C07K16/1003;;C07K16/10;;A61K2039/505;;C07K2317/565;;A61K2039/507;;A61P31/14;;G01N33/56983;;C07K2317/56;;C07K2317/55;;C07K2317/35;;C07K2317/76;;C07K2317/52;;G01N2469/10;;C07K2317/94;;G01N2333/165;;C07K16/10;;A61P31/14;;G01N33/56983;;C07K2317/76;;C07K2317/92;;C07K2317/35;;A61K2039/505;;G01N2333/165;;A61P31/14;;A61K2039/505;;A61K2039/507;;C07K16/10;;C07K2317/52;;C07K2317/55;;C07K2317/565;;C07K2317/76;;C07K2317/94;;G01N33/56983,C07K16/10;;A61K39/00;;G01N33/569;;G01N33/577,,0,0,,,,PENDING
141,WO,A3,WO 2012/166527 A3,058-084-372-691-929,2013-03-07,2013,US 2012/0039385 W,2012-05-24,US 201161492567 P,2011-06-02,NEEDLE-PROTECTION DEVICE FOR A SYRINGE,"A needle-protection device (2) for a syringe (1) includes a protector support (120) having at least one recess (126 A) that extends therethrough and at least one rib (170) that extends across at least a portion of the recess. The rib is generally centrally positioned within the recess. A needle protector (22) has an inner diameter that is at least slightly greater than an outer diameter of the protector support, such that at least a portion of the protector support can be inserted within at least a portion of the needle protector. At least one hook (56) extends radially inwardly from the needle protector. The needle protector is rotatable with respect to the protector support such that the at least one hook snaps over the at least one rib and locks the rotational position of the protector support with respect to the needle protector.",WEST PHARM SERV INC;;BOYD ROBERT R;;DAVIS TOMMY;;CROW DOUG OWEN;;GILLESPIE RICHARD DAVID,BOYD ROBERT R;;DAVIS TOMMY;;CROW DOUG OWEN;;GILLESPIE RICHARD DAVID,,https://lens.org/058-084-372-691-929,Search Report,yes,4,0,5,5,0,A61M5/3257;;A61M5/3271;;A61M5/326;;A61M2005/3247;;A61M5/3271;;A61M5/3257;;A61M5/326;;A61M2005/3247;;A61M5/3213;;A61M5/5086,A61M5/32,,0,0,,,,PENDING
142,EP,A2,EP 2714156 A2,199-224-198-756-700,2014-04-09,2014,EP 12751148 A,2012-05-24,US 201161492567 P;;US 2012/0039385 W,2011-06-02,NEEDLE-PROTECTION DEVICE FOR A SYRINGE,,WEST PHARM SERV INC,BOYD ROBERT R;;DAVIS TOMMY;;CROW DOUG OWEN;;GILLESPIE RICHARD DAVID,,https://lens.org/199-224-198-756-700,Patent Application,yes,0,0,5,5,0,A61M5/3257;;A61M5/3271;;A61M5/326;;A61M2005/3247;;A61M5/3271;;A61M5/3257;;A61M5/326;;A61M2005/3247;;A61M5/3213;;A61M5/5086,A61M5/32,,0,0,,,,ACTIVE
143,WO,A1,WO 2003/102363 A1,056-971-378-389-366,2003-12-11,2003,US 0301852 W,2003-01-22,US 16021602 A,2002-05-31,APPARATUS AND METHOD FOR GRAVEL PACKING AN INTERVAL OF A WELLBORE,"An apparatus and method for gravel packing an interval of a wellbore comprises an outer tubular ࿈112&rpar;, which forms a first annulus with the wellbore, and an sand control screen ࿈118&rpar; disposed within the outer tubular ࿈112&rpar; forming a second annulus therebetween&period; Within the second annulus is an axially extending production pathway ࿈146&rpar; and an axially extending slurry passageway ࿈144&rpar;, which is defined between a sheet member ࿈140&rpar; positioned on the sand control screen ࿈118&rpar; and a channel ࿈132&rpar;&period; The outer tubular ࿈112&rpar; has outlets ࿈116&rpar; that are substantially aligned with outlets ࿈142&rpar; of the channel ࿈132&rpar;&period; When a fluid slurry containing gravel is injected through the slurry passageway ࿈144&rpar;, the fluid slurry exits through the outlets ࿈116, 142&rpar; leaving gravel in the first annulus, thereby gravel packing the interval&period;",HALLIBURTON ENERGY SERV INC,MCGREGOR RONALD W;;CROW ROBERT;;HEJL DAVID A;;GIBSON RONALD A,,https://lens.org/056-971-378-389-366,Patent Application,yes,5,0,6,6,0,E21B43/088;;E21B43/088;;E21B43/045;;E21B43/045;;E21B43/086;;E21B43/086,E21B43/04;;E21B43/08,,0,0,,,,PENDING
144,US,A1,US 2003/0221828 A1,088-479-800-829-395,2003-12-04,2003,US 16021602 A,2002-05-31,US 16021602 A,2002-05-31,Apparatus and method for gravel packing an interval of a wellbore,"
    An apparatus and method for gravel packing an interval of a wellbore comprises an outer tubular ( 112 ), which forms a first annulus with the wellbore, and an sand control screen ( 118 ) disposed within the outer tubular ( 112 ) forming a second annulus therebetween. Within the second annulus is an axially extending production pathway ( 146 ) and an axially extending slurry passageway ( 144 ), which is defined between a sheet member ( 140 ) positioned on the sand control screen ( 118 ) and a channel ( 132 ). The outer tubular ( 112 ) has outlets ( 116 ) that are substantially aligned with outlets ( 142 ) of the channel ( 132 ). When a fluid slurry containing gravel is injected through the slurry passageway ( 144 ), the fluid slurry exits through the outlets ( 116, 142 ) leaving gravel in the first annulus, thereby gravel packing the interval. 
",MCGREGOR RONALD W.;;CROW ROBERT;;HEJL DAVID A.;;GIBSON RONALD A.,MCGREGOR RONALD W;;CROW ROBERT;;HEJL DAVID A;;GIBSON RONALD A,HALLIBURTON ENERGY SERVICES INC (2002-07-15),https://lens.org/088-479-800-829-395,Patent Application,yes,0,11,6,6,0,E21B43/088;;E21B43/088;;E21B43/045;;E21B43/045;;E21B43/086;;E21B43/086,E21B43/04;;E21B43/08,166/278;;166/51,0,0,,,,EXPIRED
145,US,A1,US 2010/0130460 A1,020-269-426-862-677,2010-05-27,2010,US 9675306 A,2006-12-08,US 9675306 A;;US 74933305 P;;US 2006/0047027 W,2005-12-09,TOPICAL GLUCOCORTICOSTEROID FORMULATIONS,"Disclosed are topical formulations comprising an androstane steroid, propylene glycol, and benzyl alcohol in an amount effective to dissolve the androstane steroid compound, wherein the amount of benzyl alcohol is not effective to act as a penetration enhancer. The formulations are useful for the treatment of inflammatory and/or pruritic manifestations of corticosteroid-responsive dermatoses.",NYCOMED US INC,ALBANO BRIAN;;ANDERSON ROBERT J;;CHECK III JOSEPH A;;CROW WELDON,FOUGERA PHARMACEUTICALS INC (2009-12-02),https://lens.org/020-269-426-862-677,Patent Application,yes,9,3,7,7,0,A61K9/0014;;A61K9/06;;A61K31/573;;A61K47/10;;A61P17/00;;A61P17/04;;A61K31/573;;A61K47/10;;A61K9/06;;A61K9/0014,A61K31/569;;A61P17/04,514/180;;514/179,0,0,,,,DISCONTINUED
146,MX,A,MX 2008007439 A,063-290-137-084-043,2009-01-22,2009,MX 2008007439 A,2006-12-08,US 74933305 P;;US 2006/0047027 W,2005-12-09,TOPICAL GLUCOCORTICOSTEROID FORMULATIONS.,"Disclosed are topical formulations comprising an androstane steroid, propylene glycol, and benzyl alcohol in an amount effective to dissolve the androstane steroid compound, wherein the amount of benzyl alcohol is not effective to act as a penetration enhancer. The formulations are useful for the treatment of inflammatory and/or pruritic manifestations of corticosteroid-responsive dermatoses.",NYCOMED US INC,ANDERSON ROBERT J;;ALBANO BRIAN;;CHECK JOSEPH A III;;CROW WELDON,,https://lens.org/063-290-137-084-043,Patent Application,no,0,0,7,7,0,A61K9/0014;;A61K9/06;;A61K31/573;;A61K47/10;;A61P17/00;;A61P17/04;;A61K31/573;;A61K47/10;;A61K9/06;;A61K9/0014,A61K31/585;;A61K31/56;;A61K31/58,,0,0,,,,DISCONTINUED
147,EP,A4,EP 1957080 A4,077-107-438-281-593,2013-10-09,2013,EP 06839256 A,2006-12-08,US 2006/0047027 W;;US 74933305 P,2005-12-09,TOPICAL GLUCOCORTICOSTEROID FORMULATIONS,,FOUGERA PHARMACEUTICALS INC;;ALBANO BRIAN;;ANDERSON ROBERT;;CHECK III JOSEPH A;;CROW WELDON,ALBANO BRIAN;;ANDERSON ROBERT J;;CHECK III JOSEPH A;;CROW WELDON,"CHECK, III JOSEPH A. (2012-02-08);;ALBANO, BRIAN (2012-02-08);;CROW, WELDON (2012-02-08);;FOUGERA PHARMACEUTICALS INC. (2012-02-08);;ANDERSON, ROBERT (2012-02-08)",https://lens.org/077-107-438-281-593,Search Report,no,3,0,7,7,0,A61K9/0014;;A61K9/06;;A61K31/573;;A61K47/10;;A61P17/00;;A61P17/04;;A61K31/573;;A61K47/10;;A61K9/06;;A61K9/0014,A61K31/56;;A61K9/06;;A61K31/573;;A61K47/10;;A61P17/00;;A61P17/04,,0,0,,,,DISCONTINUED
148,WO,A2,WO 2012/166527 A2,084-741-509-539-830,2012-12-06,2012,US 2012/0039385 W,2012-05-24,US 201161492567 P,2011-06-02,NEEDLE-PROTECTION DEVICE FOR A SYRINGE,"A needle-protection device (2) for a syringe (1) includes a protector support (120) having at least one recess (126 A) that extends therethrough and at least one rib (170) that extends across at least a portion of the recess. The rib is generally centrally positioned within the recess. A needle protector (22) has an inner diameter that is at least slightly greater than an outer diameter of the protector support, such that at least a portion of the protector support can be inserted within at least a portion of the needle protector. At least one hook (56) extends radially inwardly from the needle protector. The needle protector is rotatable with respect to the protector support such that the at least one hook snaps over the at least one rib and locks the rotational position of the protector support with respect to the needle protector.",WEST PHARM SERV INC;;BOYD ROBERT R;;DAVIS TOMMY;;CROW DOUG OWEN;;GILLESPIE RICHARD DAVID,BOYD ROBERT R;;DAVIS TOMMY;;CROW DOUG OWEN;;GILLESPIE RICHARD DAVID,,https://lens.org/084-741-509-539-830,Patent Application,yes,2,5,5,5,0,A61M5/3257;;A61M5/3271;;A61M5/326;;A61M2005/3247;;A61M5/3271;;A61M5/3257;;A61M5/326;;A61M2005/3247;;A61M5/3213;;A61M5/5086,A61M5/32,,0,0,,,,PENDING
149,EP,B1,EP 2714156 B1,003-046-853-864-170,2018-07-11,2018,EP 12751148 A,2012-05-24,US 201161492567 P;;US 2012/0039385 W,2011-06-02,NEEDLE-PROTECTION DEVICE FOR A SYRINGE,,WEST PHARMACEUTICAL SERVICES INC,BOYD ROBERT R;;DAVIS TOMMY;;CROW DOUG OWEN;;GILLESPIE RICHARD DAVID,,https://lens.org/003-046-853-864-170,Granted Patent,yes,1,0,5,5,0,A61M5/3257;;A61M5/3271;;A61M5/326;;A61M2005/3247;;A61M5/3271;;A61M5/3257;;A61M5/326;;A61M2005/3247;;A61M5/3213;;A61M5/5086,A61M5/32,,0,0,,,,ACTIVE
150,WO,A2,WO 2007/070423 A2,098-104-778-043-936,2007-06-21,2007,US 2006/0047027 W,2006-12-08,US 74933305 P,2005-12-09,TOPICAL GLUCOCORTICOSTEROID FORMULATIONS,"Disclosed are topical formulations comprising an androstane steroid, propylene glycol, and benzyl alcohol in an amount effective to dissolve the androstane steroid compound, wherein the amount of benzyl alcohol is not effective to act as a penetration enhancer. The formulations are useful for the treatment of inflammatory and/or pruritic manifestations of corticosteroid-responsive dermatoses.",ALTANA INC;;ALBANO BRIAN;;ANDERSON ROBERT J;;CHECK III JOSEPH A;;CROW WELDON,ALBANO BRIAN;;ANDERSON ROBERT J;;CHECK III JOSEPH A;;CROW WELDON,,https://lens.org/098-104-778-043-936,Patent Application,yes,0,3,7,7,0,A61K9/0014;;A61K9/06;;A61K31/573;;A61K47/10;;A61P17/00;;A61P17/04;;A61K31/573;;A61K47/10;;A61K9/06;;A61K9/0014,A61K31/573,,0,0,,,,PENDING
151,EP,A2,EP 1957080 A2,058-848-759-467-259,2008-08-20,2008,EP 06839256 A,2006-12-08,US 2006/0047027 W;;US 74933305 P,2005-12-09,TOPICAL GLUCOCORTICOSTEROID FORMULATIONS,,NYCOMED US INC;;ALBANO BRIAN;;ANDERSON ROBERT;;CHECK III JOSEPH A;;CROW WELDON,ALBANO BRIAN;;ANDERSON ROBERT J;;CHECK JOSEPH A III;;CROW WELDON,"CHECK, III JOSEPH A. (2012-02-08);;ALBANO, BRIAN (2012-02-08);;CROW, WELDON (2012-02-08);;FOUGERA PHARMACEUTICALS INC. (2012-02-08);;ANDERSON, ROBERT (2012-02-08)",https://lens.org/058-848-759-467-259,Patent Application,yes,0,0,7,7,0,A61K9/0014;;A61K9/06;;A61K31/573;;A61K47/10;;A61P17/00;;A61P17/04;;A61K31/573;;A61K47/10;;A61K9/06;;A61K9/0014,A61K31/56;;A61K9/06;;A61K31/573;;A61K47/10;;A61P17/00;;A61P17/04,,0,0,,,,DISCONTINUED
152,CA,A1,CA 2632616 A1,134-445-209-775-845,2007-06-21,2007,CA 2632616 A,2006-12-08,US 74933305 P;;US 2006/0047027 W,2005-12-09,TOPICAL GLUCOCORTICOSTEROID FORMULATIONS,,NYCOMED US INC,CHECK JOSEPH A III;;CROW WELDON;;ANDERSON ROBERT J;;ALBANO BRIAN,,https://lens.org/134-445-209-775-845,Patent Application,no,0,0,7,7,0,A61K9/0014;;A61K9/06;;A61K31/573;;A61K47/10;;A61P17/00;;A61P17/04;;A61K31/573;;A61K47/10;;A61K9/06;;A61K9/0014,A61K31/585;;A61K31/56;;A61K31/58,,0,0,,,,DISCONTINUED
153,AU,A1,AU 2003/210603 A1,022-935-338-898-033,2003-12-19,2003,AU 2003/210603 A,2003-01-22,US 16021602 A;;US 0301852 W,2002-05-31,APPARATUS AND METHOD FOR GRAVEL PACKING AN INTERVAL OF A WELLBORE,,HALLIBURTON ENERGY SERV INC,GIBSON RONALD A;;MCGREGOR RONALD W;;CROW ROBERT;;HEJL DAVID A,,https://lens.org/022-935-338-898-033,Patent Application,no,0,0,6,6,0,E21B43/088;;E21B43/088;;E21B43/045;;E21B43/045;;E21B43/086;;E21B43/086,E21B43/04;;E21B43/08,,0,0,,,,DISCONTINUED
154,WO,A3,WO 2007/070423 A3,151-449-512-029-241,2008-01-24,2008,US 2006/0047027 W,2006-12-08,US 74933305 P,2005-12-09,TOPICAL GLUCOCORTICOSTEROID FORMULATIONS,"Disclosed are topical formulations comprising an androstane steroid, propylene glycol, and benzyl alcohol in an amount effective to dissolve the androstane steroid compound, wherein the amount of benzyl alcohol is not effective to act as a penetration enhancer. The formulations are useful for the treatment of inflammatory and/or pruritic manifestations of corticosteroid-responsive dermatoses.",ALTANA INC;;ALBANO BRIAN;;ANDERSON ROBERT J;;CHECK III JOSEPH A;;CROW WELDON,ALBANO BRIAN;;ANDERSON ROBERT J;;CHECK III JOSEPH A;;CROW WELDON,,https://lens.org/151-449-512-029-241,Search Report,yes,2,0,7,7,0,A61K9/0014;;A61K9/06;;A61K31/573;;A61K47/10;;A61P17/00;;A61P17/04;;A61K31/573;;A61K47/10;;A61K9/06;;A61K9/0014,A61K31/56;;A61K31/585;;A61K31/58,,0,0,,,,PENDING
155,EP,A1,EP 1708104 A1,084-812-439-274-35X,2006-10-04,2006,EP 06111548 A,2006-03-22,US 9642905 A,2005-03-29,Crawling databases for information,"A system facilitates the search engine to search for pieces of information in various databases and application documents without the need to know the specific protocols to communicate with the various databases and application documents, such as Microsoft Excel documents. Despite the multitude of possible protocols which a crawler would have to use to connect to the databases, the system includes a unifying application programming interface to unify the way to access pieces of information in the databases and application documents.
",MICROSOFT CORP,KAPADIA ARSHISH C;;CROW HOWARD M;;BURKE JONAH S;;PARKE ROBERT D,,https://lens.org/084-812-439-274-35X,Patent Application,yes,0,0,8,8,0,G06F16/951;;G06F17/40;;G06F16/951,G06F17/30,,4,2,052-419-549-536-806;;094-851-156-410-176,10.1109/coopis.1996.555006;;10.1016/0306-4379(89)90005-7,"LIU L ET AL: ""An adaptive approach to query mediation across heterogeneous information sources"", COOPERATIVE INFORMATION SYSTEMS, 1996. PROCEEDINGS., FIRST IFCIS INTERNATIONAL CONFERENCE ON BRUSSELS, BELGIUM 19-21 JUNE 1996, LOS ALAMITOS, CA, USA,IEEE COMPUT. SOC P, US, 19 June 1996 (1996-06-19), pages 144 - 156, XP010200757, ISBN: 0-8186-7505-5;;ANONYMOUS: ""JDBC Guide: Getting Started"", INTERNET, 6 March 1997 (1997-03-06), XP002069529;;SHUPING RAN ET AL: ""The rigorous evaluation of enterprise java bean technology"", INFORMATION NETWORKING, 2001. PROCEEDINGS. 15TH INTERNATIONAL CONFERENCE ON 31 JANUARY - 2 FEBRUARY 2, PISCATAWAY, NJ, USA,IEEE, 2001, pages 93 - 100, XP010534260, ISBN: 0-7695-0951-7;;BERTIN E ET AL: ""Integration of Heterogenous Database Applications Through an Object-Oriented Interface"", INFORMATION SYSTEMS, PERGAMON PRESS, OXFORD, GB, vol. 14, no. 5, 1989, pages 407 - 420, XP002094517, ISSN: 0306-4379",DISCONTINUED
156,US,B1,US 6302210 B1,082-307-431-540-115,2001-10-16,2001,US 96655497 A,1997-11-10,US 96655497 A,1997-11-10,Safety valve utilizing an isolation valve and method of using the same,"A subsurface safety valve has a tubular valve housing, a valve closure member movable between an open and a closed position, an axially shiftable flow tube for opening the valve closure member. Hydraulic pressure from the control line is used to move a piston, which in turn moves an axially shiftable opening prong through the closure member. A balance line, or second hydraulic line is also used to make the valve well insensitive. An isolation valve is placed in the flow path of the second hydraulic line. The isolation valve prevents gas migration into the balance line. It also provides volume control for the fluid displaced when the piston is moved by pressure from the control line. Further, the valve can be closed by the application of sufficient pressure through the second hydraulic line.",HALLIBURTON ENERGY SERV INC,CROW ROBERT WESLEY;;VINZANT MICHAEL BURL;;MEADERS MICHAEL WADE;;LEBOEUF GERALD L,,https://lens.org/082-307-431-540-115,Granted Patent,yes,13,49,6,6,0,E21B34/10;;E21B34/10;;E21B2200/05;;E21B2200/05,E21B34/00;;E21B34/10,166/324;;166/321,0,0,,,,EXPIRED
157,EP,A1,EP 2840884 A1,099-944-757-894-035,2015-03-04,2015,EP 14719908 A,2014-03-11,US 201313859081 A;;US 2014/0023446 W,2013-04-09,ROW DIVIDER FOR A CORN HEAD ASSEMBLY HAVING A HOOD WITH A STRUCTURED SURFACE,,CNH IND AMERICA LLC,WALKER ERIC L;;CROW BRIAN PATRICK;;GESSEL JAMES MICHAEL;;HUBACH FREDERICK ROBERT,CNH INDUSTRIAL BELGIUM NV (2015-03-25),https://lens.org/099-944-757-894-035,Patent Application,yes,0,0,9,9,0,A01D45/021;;A01D45/021,A01D45/02,,1,0,,,See references of WO 2014168706A1,ACTIVE
158,US,A1,US 2010/0056021 A1,046-303-229-671-847,2010-03-04,2010,US 26972408 A,2008-11-12,US 26972408 A;;US 83386807 A;;US 82168806 P,2006-08-07,ORNAMENT WITH MODULAR DESIGN MOTION SYSTEM,"A motion device capable of incorporation into an ornament has a module drive mechanism and one or more visual elements capable of being set in motion by a user's interaction with the drive mechanism. The module drive mechanism includes a plurality of motion components, such as gears. The motion components are activated via manual rotation of a crank arm.",HALLMARK CARDS,CARLSON RONALD L;;CROW KENNETH DEAN;;FERRON ROBERT W;;KRIVANEK DOUG L,HALLMARK CARDS INCORPORATED (2008-11-13),https://lens.org/046-303-229-671-847,Patent Application,yes,22,9,1,5,0,G09F19/08;;G09F19/08,A63H33/00,446/487,0,0,,,,DISCONTINUED
159,US,A1,US 2014/0298769 A1,096-900-771-551-959,2014-10-09,2014,US 201313859081 A,2013-04-09,US 201313859081 A,2013-04-09,ROW DIVIDER FOR A CORN HEAD ASSEMBLY HAVING A HOOD WITH A STRUCTURED SURFACE,"A corn head assembly for a combine harvester capable of reducing grain loss. The corn head assembly includes a frame, a plurality of row units and a hood. The frame is mounted to a forward end of the combine harvester. The plurality of row units extends forward from the frame. The hood extends between an adjacent pair of row units. The hood includes a first end proximal to the frame, a second end distal to the frame and opposite the first end, and an outer surface extending between the first and second ends. The outer surface has a plurality of structures configured to inhibit a flow of grain in a forward direction along the outer surface.",CNH AMERICA LLC,WALKER ERIC L;;CROW BRIAN PATRICK;;GESSEL JAMES MICHAEL;;HUBACH FREDERICK ROBERT,CNH INDUSTRIAL AMERICA LLC (2014-03-01);;BLUE LEAF I.P. INC (2017-07-14),https://lens.org/096-900-771-551-959,Patent Application,yes,18,7,9,9,0,A01D45/021;;A01D45/021,A01D63/00,56/119,0,0,,,,ACTIVE
160,BR,B1,BR 112015025360 B1,167-427-533-965-948,2019-11-19,2019,BR 112015025360 A,2014-03-11,US 2014/0023446 W;;US 201313859081 A,2013-04-09,conjunto de plataforma de milho e divisor de linha,"resumo “conjunto de plataforma de milho e divisor de linha” trata-se de um conjunto de plataforma de milho para uma colheitadeira-debulhadora que tem a capacidade de reduzir a perda de grão. o conjunto de plataforma de milho inclui uma armação, uma pluralidade de unidades de linha e um capô. a armação é montada em uma extremidade frontal da colheitadeira-debulhadora. a pluralidade de unidades de linha se estende para frente a partir da armação. o capô se estende entre um par adjacente de unidades de linha. o capô inclui uma primeira extremidade proximal à armação, uma segunda extremidade distal à armação e oposta à primeira extremidade e uma superfície externa que se estende entre a primeira e a segunda extremidades. a superfície externa tem uma pluralidade de estruturas configuradas para inibir um fluxo de grão em uma direção para frente ao longo da superfície externa. 1/1",CNH IND AMERICA LLC,BRIAN PATRICK CROW;;ERIC L WALKER;;FREDERICK ROBERT HUBACH;;JAMES MICHAEL GESSEL,,https://lens.org/167-427-533-965-948,Granted Patent,no,0,0,9,9,0,A01D45/021;;A01D45/021,A01D45/02,,0,0,,,,ACTIVE
161,WO,A1,WO 2008/157135 A1,132-081-939-266-148,2008-12-24,2008,US 2008/0066435 W,2008-06-10,US 76438707 A,2007-06-18,WELL COMPLETION SELF ORIENTING CONNECTOR SYSTEM,"A well completion system, including a packer and a lower signal line connector carried on tubing below the packer. An upper signal line connector is carried on an upper tubing section. The upper tubing is adapted for lowering through the packer into sealing contact with the lower tubing and for operatively connecting the upper signal line connector to the lower signal line connector. A lug on the upper tubing and a profile in the lower tubing interact to rotate the upper connector into alignment with the lower connector. An upper signal line extends from a surface location down the upper tubing to the upper connector. A lower signal line extends from the lower connector down the lower tubing to downhole sensors and/or actuators.",HALLIBURTON ENERGY SERV INC;;COX MORRIS W;;CROW ROBERT W;;GREEN BRENT M;;MCGREGOR RONALD W,COX MORRIS W;;CROW ROBERT W;;GREEN BRENT M;;MCGREGOR RONALD W,,https://lens.org/132-081-939-266-148,Patent Application,yes,7,2,2,2,0,E21B17/023;;E21B33/12;;E21B47/12;;E21B47/12;;E21B17/023;;E21B33/12,E21B47/12,,0,0,,,,PENDING
162,CN,A,CN 105357954 A,021-517-768-860-651,2016-02-24,2016,CN 201480020318 A,2014-03-11,US 2014/0023446 W;;US 201313859081 A,2013-04-09,Row divider for a corn head assembly having a hood with a structured surface,"A corn head assembly (10) for a combine harvester (1) capable of reducing grain loss. The corn head assembly includes a frame (12), a plurality of row units (14) and a hood (16). The frame is mounted to a forward end of the combine harvester. The plurality of row units extends forward from the frame. The hood extends between an adjacent pair of row units. The hood includes a first end (16a) proximal to the frame, a second end (16b) distal to the frame and opposite the first end, and an outer surface (28) extending between the first and second ends. The outer surface has a plurality of structures (30) configured to inhibit a flow of grain in a forward direction along the outer surface.",CNH IND AMERICA LLC,WLAKER ERIC L;;CROW BRIAN PATRICK;;GESSEL JAMES MICHAEL;;HUBACH FREDERICK ROBERT,,https://lens.org/021-517-768-860-651,Patent Application,no,7,1,9,9,0,A01D45/021;;A01D45/021,A01D45/02,,0,0,,,,ACTIVE
163,DE,T2,DE 69825013 T2,083-382-980-400-568,2004-11-11,2004,DE 69825013 T,1998-11-09,US 96655497 A,1997-11-10,Sicherheitsventil unter Verwendung eines Abschlussventils,,HALLIBURTON ENERGY SERV INC,CROW ROBERT W;;VINZANT MICHAEL B;;MEADERS MICHAEL W;;LEBOEUF GERALD L,,https://lens.org/083-382-980-400-568,Granted Patent,no,0,0,6,6,0,E21B34/10;;E21B34/10;;E21B2200/05;;E21B2200/05,E21B34/00;;E21B34/10,,0,0,,,,EXPIRED
164,US,A1,US 2008/0311776 A1,150-961-235-567-610,2008-12-18,2008,US 76438707 A,2007-06-18,US 76438707 A,2007-06-18,Well Completion Self Orienting Connector system,"A well completion system, including a packer and a lower signal line connector carried on tubing below the packer. An upper signal line connector is carried on an upper tubing section. The upper tubing is adapted for lowering through the packer into sealing contact with the lower tubing and for operatively connecting the upper signal line connector to the lower signal line connector. A lug on the upper tubing and a profile in the lower tubing interact to rotate the upper connector into alignment with the lower connector. An upper signal line extends from a surface location down the upper tubing to the upper connector. A lower signal line extends from the lower connector down the lower tubing to downhole sensors and/or actuators.",HALLIBURTON ENERGY SERV INC,COX MORRIS W;;CROW ROBERT W;;GREEN BRENT M;;MCGREGOR RONALD W,HALLIBURTON ENERGY SERVICES INC (2007-09-19),https://lens.org/150-961-235-567-610,Patent Application,yes,10,29,2,2,0,E21B17/023;;E21B33/12;;E21B47/12;;E21B47/12;;E21B17/023;;E21B33/12,E21B43/00;;H01R4/60,439/192;;166/313,0,0,,,,DISCONTINUED
165,EP,A2,EP 0915230 A2,046-157-739-163-073,1999-05-12,1999,EP 98309146 A,1998-11-09,US 96655497 A,1997-11-10,Safety valve utilizing an isolation valve,"A safety valve (100) for use in a well bore having an annulus. The valve (100) comprises a tubular valve housing having a valve closure member (132) captured therein and movable between an open and a closed position. An axially shiftable opening prong (130) is also captured in said housing for opening the valve closure member (132). A control line (104) is provided for supplying a hydraulic pressure to move the opening prong (130) against the closure member (132). A balance line (106) coupled to said tubular housing, and an isolation valve (108) coupled to said balance line (106).",HALLIBURTON ENERGY SERV INC,CROW ROBERT W;;VINZANT MICHAEL B;;MEADERS MICHAEL W;;LEBOEUF GERALD L,,https://lens.org/046-157-739-163-073,Patent Application,yes,0,17,6,6,0,E21B34/10;;E21B34/10;;E21B2200/05;;E21B2200/05,E21B34/00;;E21B34/10,,0,0,,,,EXPIRED
166,US,S,US D0739881 S,054-465-966-751-136,2015-09-29,2015,US 201329475490 F,2013-12-03,US 201329475490 F;;US 201329451804 F,2013-04-09,Row divider hood having a structured surface for a corn head assembly,,CNH AMERICA LLC;;CNH IND AMERICA LLC,WALKER ERIC L;;CROW BRIAN PATRICK;;GESSEL JAMES MICHAEL;;HUBACH FREDERICK ROBERT,CNH INDUSTRIAL AMERICA LLC (2014-03-01);;BLUE LEAF I.P. INC (2015-11-05),https://lens.org/054-465-966-751-136,Design Right,no,0,10,2,2,0,,,1503;;D15/28,0,0,,,,ACTIVE
167,DE,D1,DE 69825013 D1,130-327-207-019-47X,2004-08-19,2004,DE 69825013 T,1998-11-09,US 96655497 A,1997-11-10,Sicherheitsventil unter Verwendung eines Abschlussventils,,HALLIBURTON ENERGY SERV INC,CROW ROBERT W;;VINZANT MICHAEL B;;MEADERS MICHAEL W;;LEBOEUF GERALD L,,https://lens.org/130-327-207-019-47X,Granted Patent,no,0,0,6,6,0,E21B34/10;;E21B34/10;;E21B2200/05;;E21B2200/05,E21B34/00;;E21B34/10,,0,0,,,,EXPIRED
168,KR,A,KR 20060105438 A,064-972-364-640-278,2006-10-11,2006,KR 20060012550 A,2006-02-09,US 9642905 A,2005-03-29,GRAWLING DATABASE FOR INFOMATION,,MICROSOFT CORP,KAPADIA ARSHISH C;;CROW HOWARD M;;BURKE JONAH S;;PARKE ROBERT D,,https://lens.org/064-972-364-640-278,Patent Application,no,0,1,8,8,0,G06F16/951;;G06F17/40;;G06F16/951,G06F17/40,,0,0,,,,INACTIVE
169,US,B2,US 9675006 B2,190-056-348-989-490,2017-06-13,2017,US 201313859081 A,2013-04-09,US 201313859081 A,2013-04-09,Row divider for a corn head assembly having a hood with a structured surface,"A corn head assembly for a combine harvester capable of reducing grain loss. The corn head assembly includes a frame, a plurality of row units and a hood. The frame is mounted to a forward end of the combine harvester. The plurality of row units extends forward from the frame. The hood extends between an adjacent pair of row units. The hood includes a first end proximal to the frame, a second end distal to the frame and opposite the first end, and an outer surface extending between the first and second ends. The outer surface has a plurality of structures configured to inhibit a flow of grain in a forward direction along the outer surface.",CNH AMERICA LLC;;CNH IND AMERICA LLC,WALKER ERIC L;;CROW BRIAN PATRICK;;GESSEL JAMES MICHAEL;;HUBACH FREDERICK ROBERT,CNH INDUSTRIAL AMERICA LLC (2014-03-01);;BLUE LEAF I.P. INC (2017-07-14),https://lens.org/190-056-348-989-490,Granted Patent,yes,41,1,9,9,0,A01D45/021;;A01D45/021,A01D45/02,,2,0,,,"PCT/US2014/023446, International Search Report, mailed Jun. 5, 2014, 4 pages.;;PCT/US2014/023446, Written Opinion, mailed Jun. 5, 2014, 6 pages.",ACTIVE
170,EP,A3,EP 0915230 A3,167-819-382-114-777,2001-02-14,2001,EP 98309146 A,1998-11-09,US 96655497 A,1997-11-10,Safety valve utilizing an isolation valve,"A safety valve (100) for use in a well bore having an annulus. The valve (100) comprises a tubular valve housing having a valve closure member (132) captured therein and movable between an open and a closed position. An axially shiftable opening prong (130) is also captured in said housing for opening the valve closure member (132). A control line (104) is provided for supplying a hydraulic pressure to move the opening prong (130) against the closure member (132). A balance line (106) coupled to said tubular housing, and an isolation valve (108) coupled to said balance line (106).",HALLIBURTON ENERGY SERV INC,CROW ROBERT W;;VINZANT MICHAEL B;;MEADERS MICHAEL W;;LEBOEUF GERALD L,,https://lens.org/167-819-382-114-777,Search Report,yes,4,0,6,6,0,E21B34/10;;E21B34/10;;E21B2200/05;;E21B2200/05,E21B34/00;;E21B34/10,,0,0,,,,EXPIRED
171,BR,A2,BR 112015025360 A2,027-878-970-193-700,2017-07-18,2017,BR 112015025360 A,2014-03-11,US 2014/0023446 W;;US 201313859081 A,2013-04-09,conjunto de plataforma de milho e divisor de linha,"resumo “conjunto de plataforma de milho e divisor de linha” trata-se de um conjunto de plataforma de milho para uma colheitadeira-debulhadora que tem a capacidade de reduzir a perda de grão. o conjunto de plataforma de milho inclui uma armação, uma pluralidade de unidades de linha e um capô. a armação é montada em uma extremidade frontal da colheitadeira-debulhadora. a pluralidade de unidades de linha se estende para frente a partir da armação. o capô se estende entre um par adjacente de unidades de linha. o capô inclui uma primeira extremidade proximal à armação, uma segunda extremidade distal à armação e oposta à primeira extremidade e uma superfície externa que se estende entre a primeira e a segunda extremidades. a superfície externa tem uma pluralidade de estruturas configuradas para inibir um fluxo de grão em uma direção para frente ao longo da superfície externa. 1/1",CNH IND AMERICA LLC,BRIAN PATRICK CROW;;ERIC L WALKER;;FREDERICK ROBERT HUBACH;;JAMES MICHAEL GESSEL,,https://lens.org/027-878-970-193-700,Patent Application,no,0,0,9,9,0,A01D45/021;;A01D45/021,A01D45/02,,0,0,,,,ACTIVE
172,EP,B1,EP 0915230 B1,018-491-237-852-555,2004-07-14,2004,EP 98309146 A,1998-11-09,US 96655497 A,1997-11-10,Safety valve utilizing an isolation valve,,HALLIBURTON ENERGY SERV INC,CROW ROBERT W;;VINZANT MICHAEL B;;MEADERS MICHAEL W;;LEBOEUF GERALD L,,https://lens.org/018-491-237-852-555,Granted Patent,yes,4,3,6,6,0,E21B34/10;;E21B34/10;;E21B2200/05;;E21B2200/05,E21B34/00;;E21B34/10,,0,0,,,,EXPIRED
173,WO,A1,WO 2014/168706 A1,147-674-661-921-977,2014-10-16,2014,US 2014/0023446 W,2014-03-11,US 201313859081 A,2013-04-09,ROW DIVIDER FOR A CORN HEAD ASSEMBLY HAVING A HOOD WITH A STRUCTURED SURFACE,"A corn head assembly (10) for a combine harvester (1) capable of reducing grain loss. The corn head assembly includes a frame (12), a plurality of row units (14) and a hood (16). The frame is mounted to a forward end of the combine harvester. The plurality of row units extends forward from the frame. The hood extends between an adjacent pair of row units. The hood includes a first end (16a) proximal to the frame, a second end (16b) distal to the frame and opposite the first end, and an outer surface (28) extending between the first and second ends. The outer surface has a plurality of structures (30) configured to inhibit a flow of grain in a forward direction along the outer surface.",CNH IND AMERICA LLC,WLAKER ERIC L;;CROW BRIAN PATRICK;;GESSEL JAMES MICHAEL;;HUBACH FREDERICK ROBERT,,https://lens.org/147-674-661-921-977,Patent Application,yes,3,2,9,9,0,A01D45/021;;A01D45/021,A01D45/02,,0,0,,,,PENDING
174,EP,B1,EP 2840884 B1,111-891-780-303-535,2016-05-18,2016,EP 14719908 A,2014-03-11,US 201313859081 A;;US 2014/0023446 W,2013-04-09,ROW DIVIDER FOR A CORN HEAD ASSEMBLY HAVING A HOOD WITH A STRUCTURED SURFACE,,CNH IND BELGIUM NV,WALKER ERIC L;;CROW BRIAN PATRICK;;GESSEL JAMES MICHAEL;;HUBACH FREDERICK ROBERT,CNH INDUSTRIAL BELGIUM NV (2015-03-25),https://lens.org/111-891-780-303-535,Granted Patent,yes,3,0,9,9,0,A01D45/021;;A01D45/021,A01D45/02,,0,0,,,,ACTIVE
175,US,S,US D0697944 S,173-076-028-386-991,2014-01-21,2014,US 201329451804 F,2013-04-09,US 201329451804 F,2013-04-09,Row divider hood having a structured surface for a corn head assembly,,CNH AMERICA LLC,WALKER ERIC L;;CROW BRIAN PATRICK;;GESSEL JAMES MICHAEL;;HUBACH FREDERICK ROBERT,CNH AMERICA LLC (2013-03-20);;BLUE LEAF I.P. INC. (2014-08-05),https://lens.org/173-076-028-386-991,Design Right,no,0,13,2,2,0,,,1503;;D15/28,0,0,,,,ACTIVE
176,US,A1,US 2014/0107577 A1,163-237-959-021-087,2014-04-17,2014,US 201214118815 A,2012-05-24,US 201214118815 A;;US 201161492567 P;;US 2012/0039385 W,2011-06-02,NEEDLE-PROTECTION DEVICE FOR A SYRINGE,"A needle-protection device ( 2 ) for a syringe ( 1 ) includes a protector support ( 120 ) having at least one recess ( 126 A) that extends therethrough and at least one rib ( 170 ) that extends across at least a portion of the recess. The rib is generally centrally positioned within the recess. A needle protector ( 22 ) has an inner diameter that is at least slightly greater than an outer diameter of the protector support, such that at least a portion of the protector support can be inserted within at least a portion of the needle protector. At least one hook ( 56 ) extends radially inwardly from the needle protector. The needle protector is rotatable with respect to the protector support such that the at least one hook snaps over the at least one rib and locks the rotational position of the protector support with respect to the needle protector.",BOYD ROBERT R;;DAVIS TOMMY;;CROW DOUG OWEN;;GILLESPIE III RICHARD DAVID;;WEST PHARM SERV INC,BOYD ROBERT R;;DAVIS TOMMY;;CROW DOUG OWEN;;GILLESPIE III RICHARD DAVID,WEST PHARMACEUTICAL SERVICES INC (2013-11-04),https://lens.org/163-237-959-021-087,Patent Application,yes,4,16,5,5,0,A61M5/3257;;A61M5/3271;;A61M5/326;;A61M2005/3247;;A61M5/3271;;A61M5/3257;;A61M5/326;;A61M2005/3247;;A61M5/3213;;A61M5/5086,A61M5/32;;A61M5/50,604/111;;604/192,0,0,,,,DISCONTINUED
177,US,B2,US 6789624 B2,128-137-918-309-888,2004-09-14,2004,US 16021602 A,2002-05-31,US 16021602 A,2002-05-31,Apparatus and method for gravel packing an interval of a wellbore,"
    An apparatus and method for gravel packing an interval of a wellbore comprises an outer tubular (  112  ), which forms a first annulus with the wellbore, and an sand control screen (  118  ) disposed within the outer tubular (  112  ) forming a second annulus therebetween. Within the second annulus is an axially extending production pathway (  146  ) and an axially extending slurry passageway (  144  ), which is defined between a sheet member (  140  ) positioned on the sand control screen (  118  ) and a channel (  132  ). The outer tubular (  112  ) has outlets (  116  ) that are substantially aligned with outlets (  142  ) of the channel (  132  ). When a fluid slurry containing gravel is injected through the slurry passageway (  144  ), the fluid slurry exits through the outlets (  116, 142  ) leaving gravel in the first annulus, thereby gravel packing the interval. 
",HALLIBURTON ENERGY SERV INC,MCGREGOR RONALD W;;CROW ROBERT W;;HEJL DAVID A;;GIBSON RONALD A,HALLIBURTON ENERGY SERVICES INC (2002-07-15),https://lens.org/128-137-918-309-888,Granted Patent,yes,67,43,6,6,0,E21B43/088;;E21B43/088;;E21B43/045;;E21B43/045;;E21B43/086;;E21B43/086,E21B43/04;;E21B43/08,166/278;;166/51;;166/228,8,3,068-598-658-441-918;;159-802-522-515-353;;130-528-674-159-261,10.2118/23741-ms;;10.2118/58775-ms;;10.2118/68205-ms,"""Mechanical Fluid-Loss Control Systems Used During Sand Control Operations,"" H.L. Restarick of Otis Engineering Corp., 1992.;;""Sand Control Screens,"" Halliburton Energy Services, 1994.;;""Frac Pack Technology Still Evolving,"" Charles D. Ebinger of Ely & Associates Inc.; Oil & Gas Journal, Oct. 23, 1995.;;""Screenless Single Trip Multizone Sand Control Tool System Saves Rig Time,"" Travis Hailey and Morris Cox of Haliburton Energy Services, Inc.; and Kirk Johnson of BP Exploration (Alaska), Inc. Society of Petroleum Engineers Inc., Feb., 2000.;;""Caps<SM> Sand Control Service for Horizontal Completions Improves Gravel Pack Reliability and Increases Production Potential from Horizontal Completions,"" Halliburton Energy Services, Inc., Aug., 2000.;;""CAPS<SM> Concentric Annular Packing Service for Sand Control,"" Halliburton Energy Services, Inc., Aug., 2000.;;""Simultaneous Gravel Packing and Filter Cake Removal in Horizontal Wells Applying Shunt Tubes and Novel Carrier and Breaker Fluid,"" Pedro M. Saldungaray of Schlumberger; Juan C. Troncoso of Repson-YPF; Bambang T. Santoso of Repsol-YPF. Society of Petroleum Engineers, Inc., Mar., 2001.;;""The Only Way to Seal it Shut is to Pneuma-Seal it,"" DESIGNFAX, Jan. 2002.",EXPIRED
178,US,B2,US 11885289 B2,017-636-092-404-556,2024-01-30,2024,US 202117246146 A,2021-04-30,US 202117246146 A,2021-04-30,Components formed with high strength steel,"An example component of a machine includes a core layer and an outer layer encasing the core layer. The outer layer has a greater carbon concentration and hardness than the core layer. The outer layer may also be compressively stressed, while the core layer may have tensile stress. The stress and/or hardness profile of the component may enhance its resistance to cracking, particularly in applications where the component is impacted by other object and/or operates at elevated temperatures. The component, such as parts of a fuel injector, may be formed by rough forming the component, carburizing the component, quenching the component, subzero processing the component, and then performing a tempering process. The components may have relatively sharp transition from the high carbon outer layer to the lower carbon core layer. Additionally, the components have a relatively high tempering resistance when used in relatively high temperature environments.",CATERPILLAR INC,CROW JONATHAN ROBERT;;BERG LUCY VICTORIA;;GUYER II DOUGLAS EDWARD;;PERSHING MICHAEL ALAN,CATERPILLAR INC (2021-04-28),https://lens.org/017-636-092-404-556,Granted Patent,yes,10,0,5,5,0,C23C8/22;;C23C8/80;;C21D6/04;;C22C38/04;;C22C38/24;;C22C38/22;;C22C38/02;;C22C38/002;;C22C38/46;;C21D1/06;;C21D1/25;;C21D1/76;;C21D9/08;;C21D9/14;;C21D9/42;;C22C38/44;;C21D1/06;;C21D9/0068;;C22C38/002;;C22C38/02;;C22C38/04;;C22C38/44;;C22C38/46;;F02M61/166;;F02M61/18,F02M61/16;;C21D1/06;;C21D9/00;;C22C38/00;;C22C38/02;;C22C38/04;;C22C38/44;;C22C38/46;;F02M61/18,,1,0,,,"Written Opinion and International Search Report for Int'l. Patent Appln. No. PCT/US2022/022240, dated Jun. 15, 2022 (14 pgs).",ACTIVE
179,US,A1,US 2022/0349370 A1,093-820-989-893-768,2022-11-03,2022,US 202117246146 A,2021-04-30,US 202117246146 A,2021-04-30,COMPONENTS FORMED WITH HIGH STRENGTH STEEL,"An example component of a machine includes a core layer and an outer layer encasing the core layer. The outer layer has a greater carbon concentration and hardness than the core layer. The outer layer may also be compressively stressed, while the core layer may have tensile stress. The stress and/or hardness profile of the component may enhance its resistance to cracking, particularly in applications where the component is impacted by other object and/or operates at elevated temperatures. The component, such as parts of a fuel injector, may be formed by rough forming the component, carburizing the component, quenching the component, subzero processing the component, and then performing a tempering process. The components may have relatively sharp transition from the high carbon outer layer to the lower carbon core layer. Additionally, the components have a relatively high tempering resistance when used in relatively high temperature environments.",CATERPILLAR INC,CROW JONATHAN ROBERT;;BERG LUCY VICTORIA;;GUYER II DOUGLAS EDWARD;;PERSHING MICHAEL ALAN,CATERPILLAR INC (2021-04-28),https://lens.org/093-820-989-893-768,Patent Application,yes,3,0,5,5,0,C23C8/22;;C23C8/80;;C21D6/04;;C22C38/04;;C22C38/24;;C22C38/22;;C22C38/02;;C22C38/002;;C22C38/46;;C21D1/06;;C21D1/25;;C21D1/76;;C21D9/08;;C21D9/14;;C21D9/42;;C22C38/44;;C21D1/06;;C21D9/0068;;C22C38/002;;C22C38/02;;C22C38/04;;C22C38/44;;C22C38/46;;F02M61/166;;F02M61/18,F02M61/16;;C21D1/06;;C21D9/00;;C22C38/00;;C22C38/02;;C22C38/04;;C22C38/44;;C22C38/46;;F02M61/18,,0,0,,,,ACTIVE
180,JP,A,JP 2006277732 A,182-308-508-139-830,2006-10-12,2006,JP 2006055312 A,2006-03-01,US 9642905 A,2005-03-29,CRAWLING DATABASE FOR INFORMATION RETRIEVAL,"<P>PROBLEM TO BE SOLVED: To provide a system and method for crawling databases and application documents, and a computer readable storage medium. <P>SOLUTION: The system facilitates a search engine to search for information in various databases and application documents without the need to know the specific protocols to communicate with the various databases and application documents, such as Microsoft (R) Excel documents. Despite the multitude of possible protocols which a crawler would have to use to connect to the databases, the system includes a unifying application programming interface to unify the way to access pieces of information in the databases and application documents. <P>COPYRIGHT: (C)2007,JPO&INPIT",MICROSOFT CORP,KAPADIA ARSHISH C;;HOWARD M CROW III;;BURKE JONAH S;;PARKE ROBERT D,,https://lens.org/182-308-508-139-830,Patent Application,no,2,3,8,8,0,G06F16/951;;G06F17/40;;G06F16/951,G06F17/30,,0,0,,,,INACTIVE
181,NO,L,NO 960281 L,081-469-942-718-750,1996-07-31,1996,NO 960281 A,1996-01-24,US 38157195 A,1995-01-30,Brönnkompletteringssystem,,HALLIBURTON CO,CROW ROBERT W;;GANO JOHN C;;LE NAM VAN;;LONGBOTTOM JAMES R;;HAGEN KARLUF,,https://lens.org/081-469-942-718-750,Abstract,no,0,0,8,8,0,E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
182,CA,A1,CA 2168311 A1,183-443-682-299-66X,1996-07-31,1996,CA 2168311 A,1996-01-29,US 38157195 A,1995-01-30,WELL COMPLETION SYSTEM WITH WELL CONTROL VALVE,"A system for selective production from, and stimulation of, subterranean production zones while improving productivity and enhancing control of the well. Portions of a production tubing string and an internal stimulation/shifter string are assembled and run together as completion segments. Consecutive completion segments, with each segment including packers that surround sleeves and terminate at the upper end in a well control valve, are run into the cased wellbore so that the acid flow ports operated by sleeve valve assemblies are placed proximate the perforations of prospective production zones. The production zones are then stimulated as the stimulation/shifter string is moved progressively outward placing acid at each consecutive zone. The stimulation/shifter string is then removed from the production tubing string, mechanically closing the well control valve assembly by tubing manipulation. A well control valve assembly prevents flow from or to completion segments further downhole from the well control valve assembly once the stimulation/shifter string has been removed from the production tubing string. The well control valve assembly features a shaped flapper plate which, when opened, conforms closely to the shape and size of the production tubing string's interior diameter. The flapper plate is biased toward a closed position by a compression spring arrangement that includes an arm which levers the plate upward toward a seating surface. The valve assembly's closure is mechanically induced and is not responsive to a sensed well condition. Reopening of the valve assembly is accomplished by insertion into the assembly of a tubular member, or ""stinger"", which is incorporated into a running arrangement. The stinger is described in relation to a seal assembly which is capable of reopening the well control valve and securing it in the open position. The seal assembly is incorporated into a running arrangement and inserted into the valve assembly to open the valve assembly and seal the connection between the seal assembly and the well control valve assembly. In one application, the seal assembly is incorporated onto the mating end of an adjacent completion segment. In this embodiment, a method of production becomes possible whereby completion segments are run into the borehole sequentially. As the running operation for each segment is completed, packers are set and the stimulation string is withdrawn, closing the well control valve and leaving the well control valve assembly of the emplaced segment closed against fluid flow out of the well. As adjoining segments are run into the borehole, the seal assembly on its lower end will secure the well control valve of the adjacent emplaced segment into an open position. In another application, the seal assembly is incorporated into a contingency reentry tool. The reentry tool is introduced by a running arrangement into the production tubing string of an emplaced completion segment to reopen the segment's well control valve assembly. Stimulation tools may then be introduced into the emplaced completion segment to accomplish further stimulation. When the contingency reentry tool removed from the segment, the well control valve assembly is reclosed. The utility of the well control valve, stacked completion segments, and other features make the system of the present invention desirable for use in horizontal and deviated wellbores where fluid balancing may be a problem. The system is also beneficial in situations where there are numerous potential producing sections in a single zone since each of the sections can be completed in a single run.",CROW ROBERT W;;GANO JOHN C;;LE NAM VAN;;LONGBOTTOM JAMES R;;HAGEN KARLUF,CROW ROBERT W;;GANO JOHN C;;LE NAM VAN;;LONGBOTTOM JAMES R;;HAGEN KARLUF,,https://lens.org/183-443-682-299-66X,Patent Application,no,0,2,8,8,0,E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,DISCONTINUED
183,EP,A2,EP 0724065 A2,014-369-252-434-912,1996-07-31,1996,EP 96300607 A,1996-01-29,US 38157195 A,1995-01-30,Tubing actuated valve assembly and method of placing a tubing into a borehole,A tubing-manipulated valve assembly (200) for control of fluid flow in a flowbore. The valve assembly (200) comprises a pivotable flapper plate (202) that is specially-shaped to include a semicylindrical channel which substantially aligns with a flowbore when the plate (202) is in an open position to cause the plate to conform closely to the interior profile of a wellbore. The plate (202) is operable between an open position in which the plate (202) is generally aligned with the flowbore and a closed position in which the plate (202) substantially seals the flowbore.,HALLIBURTON CO,CROW ROBERT W;;LONGBOTTOM JAMES R;;GANO JOHN C;;HAGEN KARLUF;;VAN LE NAM,,https://lens.org/014-369-252-434-912,Patent Application,yes,0,19,8,8,0,E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,DISCONTINUED
184,US,A,US 5823265 A,030-377-364-605-579,1998-10-20,1998,US 68394796 A,1996-07-19,US 68394796 A;;US 38157195 A;;US 27417594 A,1994-07-12,Well completion system with well control valve,"A system for selective production from, and stimulation of, subterranean production zones while improving productivity and enhancing control of the well. Portions of a production tubing string and an internal stimulation/shifter string are assembled and run together as completion segments. Consecutive completion segments, with each segment including packers that surround sleeves and terminate at the upper end in a well control valve, are run into the cased wellbore so that the acid flow ports operated by sleeve valve assemblies are placed proximate the perforations of prospective production zones. The production zones are then stimulated as the stimulation/shifter string is moved progressively outward placing acid at each consecutive zone. The stimulation/shifter string is then removed from the production tubing string, mechanically closing the well control valve assembly by tubing manipulation. A well control valve assembly prevents flow from or to completion segments further downhole from the well control valve assembly once the stimulation/shifter string has been removed from the production tubing string. The well control valve assembly features a shaped flapper plate which, when opened, conforms closely to the shape and size of the production tubing string's interior diameter. The flapper plate is biased toward a closed position by a compression spring arrangement that includes an arm which levers the plate upward toward a seating surface. The valve assembly's closure is mechanically induced and is not responsive to a sensed well condition. Reopening of the valve assembly is accomplished by insertion into the assembly of a tubular member, or ""stinger"", which is incorporated into a running arrangement. The stinger is described in relation to a seal assembly which is capable of reopening the well control valve and securing it in the open position. The seal assembly is incorporated into a running arrangement and inserted into the valve assembly to open the valve assembly and seal the connection between the seal assembly and the well control valve assembly.",HALLIBURTON ENERGY SERV INC,CROW ROBERT W;;GANO JOHN C;;VAN LE NAM;;LONGBOTTOM JAMES R;;HAGEN KARLUF,,https://lens.org/030-377-364-605-579,Granted Patent,yes,33,61,8,8,0,E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,166/373;;166/386;;166/110;;166/327;;166/332.4;;166/332.8,3,0,,,Otis Engineering Corporation 1974 1975 Catalog. Packers and Accessories.;;Otis Engineering Corporation 1982 Catalog pp. 44 and 47. Production Packer Equipment and Services.;;Otis Subsurface Safety Systems brochure. Otis Contoured Flapper Subsurface Safety Valve.,EXPIRED
185,NO,D0,NO 960281 D0,129-398-487-120-267,1996-01-24,1996,NO 960281 A,1996-01-24,US 38157195 A,1995-01-30,Brönnkompletteringssystem,,HALLIBURTON CO,CROW ROBERT W;;GANO JOHN C;;LE NAM VAN;;LONGBOTTOM JAMES R;;HAGEN KARLUF,,https://lens.org/129-398-487-120-267,Patent Application,no,0,0,8,8,0,E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
186,NO,B1,NO 310786 B1,149-819-598-632-095,2001-08-27,2001,NO 960281 A,1996-01-24,US 38157195 A,1995-01-30,Produksjonsrörbetjent ventilanordning for styring av fluidströmning i en strömningsboring,"Et system for selektiv produksjon fra, og stimulering av, underjordiske produksjonssoner (122) mens produktiviteten forbedres og styringen av brannen bedres. Deler av en produksjonsnzrstreng (80) og en Indre stimulering/- sjal tes treng (54) blir sammenstilt og kjøres med sammen som kompletter ingssegmenter (40). Påfølgende kcnplet-teringssegroenter (40) der hvert segment innbefatter espansjonspakninger (100) som omgir hylser og avslutter 1 den ovre ende (82) i en brønnstyreventil (200), blir kjørt ned i den forede brønnboring (42) slik syrestrøm-porter betjent med hylseventilanordninger (88) blir plassert nær perforeringene for de respektive produksjonssoner. Produksjonssonene (122) blir så stimulert etter hvert som stimuler ing/sj al testrengen (54) forflyttes progressivt utad som anbringer syren ved hver påfølgende sone. Stimulering/sjal testrengen (54) blir så tatt ut fra produksjonsarrstrengen (80), som mekanisk stenger brønn-styreventilanordnlngen (200) ved produksjonsrør-manlpulerlng.En brenn-styreventilanordning (200) hindrer strømning fra eller til kompletterlngssegmentene (40) videre ned i borehullet når stimulering/ sjal testrengen (54) har blitt fjernet fra produksj onserrstrengen (80). Brønn-styreventilanordningen (200) har en tilfonnet klaffplate (202) som, når den er åpen, har nær formen og størrel-sen av produksjonsrørstrengens innvendige boring. Klaffplaten (202) er presset mot en lukket stilling med et trykkfjær-arrangement som innbefatter en ann som hever platen oppad mot en tetnings flate. Ventilanordn ingens lukking blir mekanisk fremkalt.og reagerer ikke på en avfølt brønntilstand.",HALLIBURTON CO,CROW ROBERT W;;GANO JOHN C;;LE NAM VAN;;LONGBOTTOM JAMES R;;HAGEN KARLUF,,https://lens.org/149-819-598-632-095,Granted Patent,no,0,0,8,8,0,E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,EXPIRED
187,EP,A3,EP 0724065 A3,183-570-571-706-797,1999-03-17,1999,EP 96300607 A,1996-01-29,US 38157195 A,1995-01-30,Tubing actuated valve assembly and method of placing a tubing into a borehole,A tubing-manipulated valve assembly (200) for control of fluid flow in a flowbore. The valve assembly (200) comprises a pivotable flapper plate (202) that is specially-shaped to include a semicylindrical channel which substantially aligns with a flowbore when the plate (202) is in an open position to cause the plate to conform closely to the interior profile of a wellbore. The plate (202) is operable between an open position in which the plate (202) is generally aligned with the flowbore and a closed position in which the plate (202) substantially seals the flowbore.,HALLIBURTON CO,CROW ROBERT W;;LONGBOTTOM JAMES R;;GANO JOHN C;;HAGEN KARLUF;;VAN LE NAM,,https://lens.org/183-570-571-706-797,Search Report,yes,3,0,8,8,0,E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,,0,0,,,,DISCONTINUED
188,US,A,US 5564502 A,186-427-640-259-829,1996-10-15,1996,US 38157195 A,1995-01-30,US 38157195 A;;US 27417594 A,1994-07-12,Well completion system with flapper control valve,"A well control valve assembly prevents flow from or to completion segments further downhole from the well control valve assembly once the stimulation stimulation/shifter string has been removed from the production tubing string. The well control valve assembly features a shaped flapper plate which, when opened, conforms closely to the shape and size of the production tubing string's interior diameter. The flapper plate is biased toward a closed position by a compression spring arrangement that includes an arm which levers the plate upward toward a seating surface. The valve assembly's closure is mechanically induced and is not responsive to a sensed well condition.",HALLIBURTON CO,CROW ROBERT W;;GANO JOHN C;;LE NAM V;;LONGBOTTOM JAMES R;;HAGEN KARLUF,HALLIBURTON COMPANY (1995-03-31),https://lens.org/186-427-640-259-829,Granted Patent,yes,28,76,8,8,0,E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06;;E21B34/06;;E21B34/12;;E21B43/25;;E21B2200/05;;E21B2200/06,E21B34/00;;E21B34/06;;E21B34/12;;E21B34/14;;E21B43/25,166/386;;166/316;;166/387,3,0,,,"Otis Engineering Corporation 1974 75 Catalog. Packers and Accessories, p. 3953.;;Otis Engineering Corporation 1982 Catalog pp. 44 and 47. Production Packer Equipment and Services.;;Otis Subsurface Safety Systems brochure. Otis Contoured Flapper Subsurface Safety Valve (2 pp.).",EXPIRED
189,AT,T1,AT E262336 T1,086-964-020-964-437,2004-04-15,2004,AT 98957487 T,1998-11-13,US 6604997 P;;US 9823245 W,1997-11-14,"VERWENDUNG VON 9-DESOXY-2',9-ALPHA-METHANO-3-OXA- 4,5,6-TRINOR-3,7-(1',3'-INTERPHENYLEN)-13,14- DIHYDROPROSTAGLANDIN-F1 ZUR BEHANDLUNG VON PERIPHEREN VASKULÄREN ERKRANKUNGEN","An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,,https://lens.org/086-964-020-964-437,Granted Patent,no,0,0,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/20;;A61K9/48;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,PENDING
190,US,A1,US 2002/0125007 A1,117-349-738-903-981,2002-09-12,2002,US 92721701 A,2001-08-10,US 92721701 A;;US 80019901 A,2001-03-06,Apparatus and method for gravel packing an interval of a wellbore,"
    An apparatus and method for gravel packing an interval of a wellbore comprises an outer tubular ( 110 ), which forms a first annulus with the wellbore, and an inner tubular ( 114 ) disposed within the outer tubular ( 110 ) forming a second annulus therebetween. Within the second annulus is an axially extending production pathway ( 190 ) and an axially extending slurry passageway ( 194 ), which is defined between a channel ( 170 ) and the inner tubular ( 114 ). The outer tubular ( 110 ) has outlets ( 128 ) that are substantially aligned with outlets ( 178 ) of the channel ( 170 ). The portions of both the outer and inner tubulars ( 110, 114 ) adjacent the production pathway ( 190 ) have openings ( 122, 146 ). When a fluid slurry containing gravel is injected through the slurry passageway ( 194 ), the fluid slurry exits through the outlets ( 178, 128 ) leaving gravel in the first annulus, thereby gravel packing the interval. 
",MCGREGOR RONALD W.;;HAILEY TRAVIS T.;;HENDERSON WILLIAM DAVID;;CROW ROBERT L.;;NGUYEN PHILIP D.,MCGREGOR RONALD W;;HAILEY TRAVIS T;;HENDERSON WILLIAM DAVID;;CROW ROBERT L;;NGUYEN PHILIP D,HALLIBURTON ENERGY SERVICES INC (2001-08-22),https://lens.org/117-349-738-903-981,Patent Application,yes,0,14,10,10,0,E21B43/045;;E21B43/045;;E21B43/04;;E21B43/04,E21B43/04,166/278;;166/51;;166/236,0,0,,,,EXPIRED
191,WO,A1,WO 1999/025357 A1,155-802-032-266-192,1999-05-27,1999,US 9823245 W,1998-11-13,US 6604997 P,1997-11-14,"USE OF 9-DEOXY-2', 9- alpha -METHANO-3- OXA-4,5,6- TRINOR-3, 7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F1 TO TREAT PERIPHERAL VASCULAR DISEASE","An improved treatment for peripheral vascular disease is described using 9-deoxy-2', 9-α-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,,https://lens.org/155-802-032-266-192,Patent Application,yes,3,37,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/48;;A61K9/20;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,PATENTED
192,EP,B1,EP 1045695 B1,013-633-607-483-603,2004-03-24,2004,EP 98957487 A,1998-11-13,US 9823245 W;;US 6604997 P,1997-11-14,"USE OF 9-DEOXY-2', 9-ALPHA-METHANO-3- OXA-4,5,6- TRINOR-3, 7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F 1? TO TREAT PERIPHERAL VASCULAR DISEASE","An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,UNITED THERAPEUTICS CORPORATION (2011-03-15),https://lens.org/013-633-607-483-603,Granted Patent,yes,3,9,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/20;;A61K9/48;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,EXPIRED
193,US,A,US 6054486 A,193-229-700-195-502,2000-04-25,2000,US 19045098 A,1998-11-13,US 19045098 A;;US 6604997 P,1997-11-14,"Use of 9-Deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease","An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene) -13,14-dihydro-prostaglandin F.sub.1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN JR SHELMER D;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,UNITED THERAPEUTICS CORPORATION (1999-03-25),https://lens.org/193-229-700-195-502,Granted Patent,yes,7,112,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/48;;A61K9/72;;A61K9/20;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,514/571,6,3,048-755-526-320-373;;149-225-560-375-865;;120-227-129-367-987,10.1016/s0090-6980(96)00102-5;;8948505;;10.1016/s0002-9149(99)80380-4;;7840051;;10.1161/01.cir.95.9.2298;;9142008,"Y. Okuda et al. Prostaglandins, vol. 52 Acute Effect of Beraprost Sodium on Lower Limb Circulation in Patients with Non Insulin Dependent Diabetes Melitus Evaluation . . . Ultrasonography, pp. 375 384 (Nov. 1996).;;Patterson et al. The American Journal of Cardiology, vol. 75, Acute Hemodynamic Effects of the Prostacyclin Analog 15AU81 in Service Congestive Heart failure, pp. 26A 33A (Jan. 1995).;;Mohler, Emile R. Medical Management of Claudication, pp. 1 6, (Mar. 1997).;;Mohler, Emile R. Clinical Manifestations of Claudication, pp. 1 4 (Sep. 1996).;;Neschis et al. Surgical Indications for the Patient with Limb Threatening Ischemia, pp. 1 10.;;Belch et al. Circulation, vol. 95, No. 9, Randomized, Double Blind, Placebo Controlled Study Evaluating the the Efficacy and Safety of AS 013 . . . With Intermittent Claudication, pp. 2298 2301 (May, 1997).",EXPIRED
194,DE,T2,DE 69822665 T2,114-779-059-231-889,2005-02-17,2005,DE 69822665 T,1998-11-13,US 6604997 P;;US 9823245 W,1997-11-14,"VERWENDUNG VON 9-DESOXY-2',9-ALPHA-METHANO-3-OXA-4,5,6-TRINOR-3,7-(1',3'-INTERPHENYLEN)-13,14-DIHYDROPROSTAGLANDIN-F1 ZUR BEHANDLUNG VON PERIPHEREN VASKULÄREN ERKRANKUNGEN","An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,,https://lens.org/114-779-059-231-889,Granted Patent,no,0,0,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/20;;A61K9/48;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,EXPIRED
195,AU,A,AU 1999/013734 A,070-494-809-868-456,1999-06-07,1999,AU 1999/013734 A,1998-11-13,US 6604997 P;;US 9823245 W,1997-11-14,"Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f<sub>1</sub> to treat peripheral vascular disease","An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,,https://lens.org/070-494-809-868-456,Patent Application,no,0,0,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/20;;A61K9/48;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,DISCONTINUED
196,US,A1,US 2022/0175868 A1,129-797-779-487-675,2022-06-09,2022,US 202117540766 A,2021-12-02,US 202117540766 A;;US 202063121758 P,2020-12-04,INHIBITION OF SARS-CoV-2 VIRUS BY ARUM PALAESTINUM,"The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a formulation comprising Arum spp., particularly Arum palaestinum . Methods of inhibiting SARS-CoV-2 viral replication are also disclosed comprising contacting the virus with an Arum formulation.",ANKH LIFE SCIENCES LTD,ZAID GENE H;;WOLF BETH ANN;;MOORE ROBERT PRESTON;;CROW LARRY D;;WEST JASON H,ANKH LIFE SCIENCES LIMITED (2020-12-03),https://lens.org/129-797-779-487-675,Patent Application,yes,1,0,1,1,0,A61P31/14;;A61K36/888;;A61K2236/333;;A61K36/888;;A61K2236/333;;A61P31/14,A61K36/888;;A61P31/14,,5,2,010-790-300-564-011;;008-144-981-175-098,10.33696/pharmacol.2.014;;10.1021/je9009909,"Natural Medicine Journal (https://www.naturalmedicinejournal.com/journal/arum-palaestinum-food-medicine#:~:text=Arum%20palaestinum%20Boiss.%20is%20a,infections%2C%20and%20many%20other%20maladies.) February 6, 2019 (Year: 2019);;Farid (Phytochemical constituents of the butanol fraction of Arum palaestinum Boiss.: cytotoxic and antiviral screening, JME, 2017 Vol 8, Issue 7, p 2585-2591) (Year: 2017);;Khan et. al. (Beta-Sitosterol: As Immunostimulant, Antioxidant and Inhibitor of SARS-CoV-2 Spike Glycoprotein, Archives of Pharmacology and Therapeutics, Vol 2, Issue 1, August 24, 2020). (Year: 2020);;ThoughtCo. (https://www.thoughtco.com/lyophilization-preserving-biological-material-375590) July 15, 2019 (Year: 2019);;Wei et. al. (Beta-Sitosterol Solubility in Selected Organic Solvents, J. Chem. Eng. Data 2010, 55, 2917-2919). (Year: 2010)",PENDING
197,US,A1,US 2021/0230618 A1,071-397-519-279-188,2021-07-29,2021,US 202117218737 A,2021-03-31,US 202117218737 A;;US 201815778542 A;;US 2016/0063329 W;;US 201562260819 P,2015-11-30,PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOF,"The present disclosure relates to the field of plant molecular biology, more particularly to regulation of gene expression in plants.",PIONEER HI BRED INT;;DU PONT,CROW ANDREW CARL;;DIEHN SCOTT HENRY;;LU ALBERT LAURENCE;;SIMMONS CARL ROBERT;;SIMS LYNNE EILEEN,E. I. DU PONT DE NEMOURS AND COMPANY (2016-11-08);;CORTEVA AGRISCIENCE LLC (2022-07-28);;PIONEER HI-BRED INTERNATIONAL INC (2016-10-05),https://lens.org/071-397-519-279-188,Patent Application,yes,7,0,11,11,14,C12N15/8202;;C12N15/8242;;Y02A40/146;;C12N15/8216;;C12N15/8223,C12N15/82,,2,2,038-588-390-192-30X;;090-108-644-153-686,11448764;;10.1016/s0168-9452(01)00412-5;;pmc151215;;12468740;;10.1105/tpc.006437,Nitz et al. (2001) Plant Sci 161 :337-46;;Cho & Cosgrove (2002) Plant Cell 14:3237-53,PENDING
198,US,A,US 4448216 A,194-580-218-041-892,1984-05-15,1984,US 35831382 A,1982-03-15,US 35831382 A,1982-03-15,Subsurface safety valve,"A surface controlled subsurface safety valve having a ball type valve closure. The ball member and its associated components are protected from damage by preventing excessive control fluid pressure from applying force to the ball member. Also, rotation of the ball member is prevented until any difference in pressure across the ball member and its seating surface has decreased below a preselected safe value.",OTIS ENG CO,SPEEGLE STEVEN C;;SCHWENDEMANN KENNETH L;;VINZANT MICHAEL B;;CROW ROBERT W;;MONDON CARY G,OTIS ENGINEERING CORPORATION TX A CORP OF (1982-07-27);;HALLIBURTON COMPANY (1993-06-24),https://lens.org/194-580-218-041-892,Granted Patent,yes,3,83,8,8,0,E21B34/10;;E21B34/10;;E21B2200/04;;E21B2200/04;;Y10T137/86944;;Y10T137/86944,E21B34/00;;E21B34/10,137/630;;166/324;;166/332;;251/58,0,0,,,,EXPIRED
199,CN,A,CN 108473999 A,003-274-016-837-09X,2018-08-31,2018,CN 201680079050 A,2016-11-22,US 201562260819 P;;US 2016/0063329 W,2015-11-30,PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOF,"The present disclosure relates to the field of plant molecular biology, more particularly to regulation of gene expression in plants.",PIONEER HI BRED INT;;DU PONT,CROW ANDREW CARL;;DIEHN SCOTT HENRY;;LU ALBERT LAURENCE;;SIMMONS CARL ROBERT;;SIMS LYNNE EILEEN,,https://lens.org/003-274-016-837-09X,Patent Application,no,6,0,11,11,0,C12N15/8202;;C12N15/8242;;Y02A40/146;;C12N15/8216;;C12N15/8223,C12N15/82,,2,1,008-514-729-924-312,19309755;;pmc2704498;;10.1002/bit.22299,"ZHONG HUANG ET AL.: ""“A DNA replicon system for rapid high-level production of virus-like particles in plants”"", 《BIOTECHNOL BIOENG》;;IDRIS,A.M. ET AL.: ""“Hollyhock leaf crumple virus-[Cairo] isolate HLCrV hollyhock segment A, complete genome，GenBank: AY036009.1”"", 《GENBANK》",ACTIVE
200,CA,A1,CA 2312729 A1,018-027-980-475-902,1999-05-27,1999,CA 2312729 A,1998-11-13,US 6604997 P;;US 9823245 W,1997-11-14,"USE OF 9-DEOXY-2', 9-.ALPHA.-METHANO-3- OXA-4,5,6- TRINOR-3,7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F1 TO TREAT PERIPHERAL VASCULAR DISEASE","An improved treatment for peripheral vascular disease is described using 9deoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) 13,14-dihydro- prostaglandin F1.",UNITED THERAPEUTICS CORP,ROSCIGNO ROBERT;;WADE MICHAEL;;CROW JAMES W;;BLACKBURN SHELMER D JR;;CLOUTIER GILLES;;ROTHBLATT MARTINE,,https://lens.org/018-027-980-475-902,Patent Application,no,0,0,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/20;;A61K9/48;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,EXPIRED
201,BR,A2,BR 112018011174 A2,067-772-099-762-401,2018-11-21,2018,BR 112018011174 A,2016-11-22,US 2016/0063329 W;;US 201562260819 P,2015-11-30,"polinucleotídeo recombinante, construto de dna, célula heteróloga, planta transgênica ou célula de planta, semente da planta transgênica, método para expressar um polinucleotídeo em uma planta e método para aprimorar a transcrição de um polinucleotídeo em uma célula hospedeira","a presente revelação refere-se ao campo de biologia molecular de planta, mais particularmente à regulação de expressão de gene em plantas.",DU PONT;;PIONEER HI BRED INT,ALBERT LAURENCE LU;;ANDREW CARL CROW;;CARL ROBERT SIMMONS;;LYNNE EILEEN SIMS;;SCOTT HENRY DIEHN,,https://lens.org/067-772-099-762-401,Patent Application,no,0,0,11,11,0,C12N15/8202;;C12N15/8242;;Y02A40/146;;C12N15/8216;;C12N15/8223,C12N15/82,,0,0,,,,PENDING
202,US,A1,US 2018/0346924 A1,084-323-789-332-030,2018-12-06,2018,US 201615778542 A,2016-11-22,US 201615778542 A;;US 201562260819 P;;US 2016/0063329 W,2015-11-30,PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOF,"The present disclosure relates to the field of plant molecular biology, more particularly to regulation of gene expression in plants.",PIONEER HI BRED INT;;DU PONT,CROW ANDREW CARL;;DIEHN SCOTT HENRY;;LU ALBERT LAURENCE;;SIMMONS CARL ROBERT;;SIMS LYNNE EILEEN,E. I. DU PONT DE NEMOURS AND COMPANY (2016-11-08);;CORTEVA AGRISCIENCE LLC (2022-07-28);;PIONEER HI-BRED INTERNATIONAL INC (2016-10-05),https://lens.org/084-323-789-332-030,Patent Application,yes,4,0,11,11,14,C12N15/8202;;C12N15/8242;;Y02A40/146;;C12N15/8216;;C12N15/8223,C12N15/82,,0,0,,,,ACTIVE
203,NO,L,NO 830883 L,133-840-145-063-358,1983-09-16,1983,NO 830883 A,1983-03-14,US 35831382 A,1982-03-15,PRODUKSJONSSIKRINGSVENTIL.,,OTIS ENG CO,SPEEGLE STEVEN C;;SCHWENDEMANN KENNETH L;;VINZANT MICHAEL B;;CROW ROBERT W;;MONDON CARY G,,https://lens.org/133-840-145-063-358,Abstract,no,0,0,8,8,0,E21B34/10;;E21B34/10;;E21B2200/04;;E21B2200/04;;Y10T137/86944;;Y10T137/86944,E21B34/00;;E21B34/10,,0,0,,,,DISCONTINUED
204,US,A1,US 2019/0262416 A1,025-871-253-735-576,2019-08-29,2019,US 201916280942 A,2019-02-20,US 201916280942 A;;US 201816115284 A;;US 201862634406 P,2018-02-23,NUTRITIONAL SUPPLEMENT FOR MAMMALS,"Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala , and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum , and the supplements may contain additional beneficial ingredients, such as β-sitosterol, vanillin, garlic, and Vitamin C.",ANKH LIFE SCIENCES LTD,ZAID GENE H;;WOLF BETH ANN;;CROW LARRY D;;MOORE ROBERT PRESTON;;ROPP RACHEL ELIZABETH,ANKH LIFE SCIENCES LIMITED (2019-02-19),https://lens.org/025-871-253-735-576,Patent Application,yes,0,2,9,12,0,A61K9/48;;A61K31/575;;A61K31/375;;A61K36/9066;;A61K36/185;;A61K36/888;;A61K36/8962;;A61K36/9066;;A61K9/0053;;A61K9/48;;A61K36/8962;;A61K31/375;;A61K36/77;;A61K36/888;;A61K31/575;;A61K9/4808;;A61K2300/00;;A61K36/9066;;A61K31/375;;A61K9/0053;;A61K9/4808;;A61K36/77;;A61K36/888;;A61K36/8962;;A61K31/575;;A61K9/48,A61K36/9066;;A61K9/00;;A61K9/48;;A61K31/375;;A61K31/575;;A61K36/77;;A61K36/888;;A61K36/8962,,0,0,,,,ACTIVE
205,EP,A4,EP 3735235 A4,046-712-487-321-513,2021-11-10,2021,EP 19758169 A,2019-02-21,US 201862634406 P;;US 201816115284 A;;US 201916280942 A;;US 2019/0018880 W,2018-02-23,NUTRITIONAL SUPPLEMENT FOR MAMMALS,,ANKH LIFE SCIENCES LTD,ZAID GENE H;;WOLF BETH ANN;;MOORE ROBERT PRESTON;;ROPP RACHEL ELIZABETH;;CROW LARRY D,,https://lens.org/046-712-487-321-513,Search Report,no,2,0,9,12,0,A61K9/48;;A61K31/575;;A61K31/375;;A61K36/9066;;A61K36/185;;A61K36/888;;A61K36/8962;;A61K36/9066;;A61K9/0053;;A61K9/48;;A61K36/8962;;A61K31/375;;A61K36/77;;A61K36/888;;A61K31/575;;A61K9/4808;;A61K2300/00;;A61K36/9066;;A61K31/375;;A61K9/0053;;A61K9/4808;;A61K36/77;;A61K36/888;;A61K36/8962;;A61K31/575;;A61K9/48,A61K31/12;;A61K36/185;;A61K36/20;;A61K36/888;;A61K36/8962;;A61K36/906;;A61K36/9066;;A61P35/00,,6,3,048-055-310-489-72X;;044-734-502-573-503;;045-988-674-071-012,30111862;;10.1038/s41598-018-29683-1;;pmc6093880;;10.1158/1535-7163.targ-17-lb-b27;;10.1158/1535-7163.targ-15-b116,"VISHWAKARMA VIKALP ET AL: ""Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds"", SCIENTIFIC REPORTS, vol. 8, no. 1, 1 December 2018 (2018-12-01), pages 12163, XP055845243, Retrieved from the Internet <URL:https://www.nature.com/articles/s41598-018-29683-1.pdf> DOI: 10.1038/s41598-018-29683-1;;N.N.: ""Afaya Plus"", 1 July 2018 (2018-07-01), XP055845268, Retrieved from the Internet <URL:http://kslegislature.org/li_2020/b2019_20/committees/ctte_s_phw_1/documents/testimony/20190205_05.pdf> [retrieved on 20210928];;RODELA EMILY ET AL: ""Abstract LB-B27: Novel antitumor agent GZ17-6.02 exerts discrete effects on transcriptional regulation in pancreatic cancer cells and cancer associated fibroblasts | Molecular Cancer Therapeutics"", 1 January 2018 (2018-01-01), XP055846038, Retrieved from the Internet <URL:https://mct.aacrjournals.org/content/17/1_Supplement/LB-B27> [retrieved on 20210930];;NEW JACOB ET AL: ""Abstract B116: Mechanistic insights into the antitumor efficacy of nutraceutical GZ17-06.02, a highly effective formulation of Arum palaestinum extract, on head and neck squamous cell carcinoma"", NATURAL PRODUCTS, 1 December 2015 (2015-12-01), pages B116 - B116, XP055845703, Retrieved from the Internet <URL:http://dx.doi.org/10.1158/1535-7163.TARG-15-B116> DOI: 10.1158/1535-7163.TARG-15-B116;;2018 ET AL: ""A Combination of Three Synthetic Compounds Display Potent Antitumor Effects"", 20 November 2018 (2018-11-20), XP055845255, Retrieved from the Internet <URL:https://kuscholarworks.ku.edu/bitstream/handle/1808/30133/Arnold_ku_0099M_16252_DATA_1.pdf?sequence=1&isAllowed=y> [retrieved on 20210928];;See also references of WO 2019165023A1",DISCONTINUED
206,EP,A1,EP 3384031 A1,054-090-285-771-010,2018-10-10,2018,EP 16808882 A,2016-11-22,US 201562260819 P;;US 2016/0063329 W,2015-11-30,PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOF,,PIONEER HI BRED INT;;DU PONT,CROW ANDREW CARL;;DIEHN SCOTT HENRY;;LU ALBERT LAURENCE;;SIMMONS CARL ROBERT;;SIMS LYNNE EILEEN,,https://lens.org/054-090-285-771-010,Patent Application,yes,0,0,11,11,0,C12N15/8202;;C12N15/8242;;Y02A40/146;;C12N15/8216;;C12N15/8223,C12N15/82,,0,0,,,,DISCONTINUED
207,CN,A,CN 112118836 A,087-370-969-527-215,2020-12-22,2020,CN 201980013298 A,2019-02-21,US 201862634406 P;;US 201816115284 A;;US 201916280942 A;;US 2019/0018880 W,2018-02-23,NUTRITIONAL SUPPLEMENT FOR MAMMALS,"Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as [beta]-sitosterol, vanillin, garlic, and Vitamin C.",ANKH LIFE SCIENCES LTD,CROW LARRY D;;ZAID GENE H;;WOLF BETH ANN;;MOORE ROBERT PRESTON;;ROPP RACHEL ELIZABETH,,https://lens.org/087-370-969-527-215,Patent Application,no,0,0,9,12,0,A61K9/48;;A61K31/575;;A61K31/375;;A61K36/9066;;A61K36/185;;A61K36/888;;A61K36/8962;;A61K36/9066;;A61K9/0053;;A61K9/48;;A61K36/8962;;A61K31/375;;A61K36/77;;A61K36/888;;A61K31/575;;A61K9/4808;;A61K2300/00;;A61K36/9066;;A61K31/375;;A61K9/0053;;A61K9/4808;;A61K36/77;;A61K36/888;;A61K36/8962;;A61K31/575;;A61K9/48,A61K31/12;;A61K36/20;;A61K36/8962;;A61K36/906;;A61K36/9066;;A61P35/00,,0,0,,,,DISCONTINUED
208,ES,T3,ES 2214753 T3,100-050-549-918-793,2004-09-16,2004,ES 98957487 T,1998-11-13,US 6604997 P,1997-11-14,"USO DE 9-DESOXI-2',9-ALFA-METANO-3-OXA-4,5,6-TRINOR-3,7-(1',3'-INTERFENILEN)-13,14-DIHIDRO-PROSTAGLANDINA F1 PARA TRATAR LA ENFERMEDAD VASCULAR PERIFERICA.","An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,,https://lens.org/100-050-549-918-793,Granted Patent,no,0,0,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/20;;A61K9/48;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,EXPIRED
209,US,B2,US 11246902 B2,049-289-402-024-629,2022-02-15,2022,US 201916280942 A,2019-02-20,US 201916280942 A;;US 201816115284 A;;US 201862634406 P,2018-02-23,Nutritional supplement for mammals,"Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala , and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum , and the supplements may contain additional beneficial ingredients, such as β-sitosterol, vanillin, garlic, and Vitamin C.",ANKH LIFE SCIENCES LTD,ZAID GENE H;;WOLF BETH ANN;;CROW LARRY D;;MOORE ROBERT PRESTON;;ROPP RACHEL ELIZABETH,ANKH LIFE SCIENCES LIMITED (2019-02-19),https://lens.org/049-289-402-024-629,Granted Patent,yes,15,0,9,12,0,A61K9/48;;A61K31/575;;A61K31/375;;A61K36/9066;;A61K36/185;;A61K36/888;;A61K36/8962;;A61K36/9066;;A61K9/0053;;A61K9/48;;A61K36/8962;;A61K31/375;;A61K36/77;;A61K36/888;;A61K31/575;;A61K9/4808;;A61K2300/00;;A61K36/9066;;A61K31/375;;A61K9/0053;;A61K9/4808;;A61K36/77;;A61K36/888;;A61K36/8962;;A61K31/575;;A61K9/48,A61K36/9066;;A61K9/00;;A61K9/48;;A61K31/375;;A61K31/575;;A61K36/77;;A61K36/888;;A61K36/8962,,18,10,029-333-539-057-843;;068-750-189-048-964;;009-721-739-112-084;;016-291-993-522-296;;115-302-971-320-714;;054-391-676-526-775;;169-024-770-034-668;;048-055-310-489-72X;;044-734-502-573-503;;045-988-674-071-012,21864344;;10.1186/1297-9716-42-96;;pmc3170600;;21447617;;10.1093/annonc/mdr054;;10.12991/mpj.2018.40;;10.4103/2278-0513.99556;;9110589;;10.1111/j.1753-4887.1996.tb03832.x;;10.4103/0973-7847.120524;;24347928;;pmc3841998;;10.9735/0976-5530.3.8.235-241;;30111862;;10.1038/s41598-018-29683-1;;pmc6093880;;10.1158/1535-7163.targ-17-lb-b27;;10.1158/1535-7163.targ-15-b116,"Ducrot et al. Veterinary Research vol. 42, Article No. 96 10 pages. (Year: 2011).;;Ali-Shtayeh et al. “National List of Medicinal Plants in Palestine—West Bank and Gaza Strip” BERC, 2014, pp. 1-27.;;Ben-Arye et al. “Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer care” Annals of Oncology, 2011, vol. 23, pp. 211-221.;;Qneibi et al. “Evaluation of taste, total phenols and antioxidant for fresh, roasted, shade dried and boiled leaves of edible Arum palaestinum Bioss” Marmara Pharmaceutical Journal, 2017, vol. 22, pp. 52-58.;;Buch et al. “Interventional role of Haridra (Curcuma longa Linn) in cancer” Clinical Cancer Investigation Journal, 2012, vol. 1, Issue 2, pp. 45-50.;;International Search Report and Written Opinion in PCT/US19/18880 dated Apr. 15, 2019.;;Krishnaswamy. “Indian Functional Foods: Role in PRevention of Cancer” Nutrition Reviews, 1996, vol. 54, No. 11, pp S127-S131.;;Moloudizargari et al. “Pharmacological and Therapeutic Effects of Peganum Harmala and Its Main Alkaloids.” Pharmacogn Rev. 7.14 (Jul.-Dec. 2013): 199-212.;;Duwaul Khatateed from Kaamil-al-Sena'ah, Part II (10th century AD), Central Council for Research in Unani Medicine, 61-65 Institutional Area, Janak Puri, New Delhi-58, 2005 AD. P. 539. Retriefed from Traditional Knowledge Digital Library. 2005 (U.S. Appl. No. 16/115,284).;;Meyer-Chissick et al. “Wild Edible Plants in Israel Tradition Versus cultivation” from Medicinal and Aromatic Plants of the Middle-East. Zohara Yaniv, Nativ Dudai, Eds. pp. 18-20. 2014 (U.S. Appl. No. 16/115,284).;;Yadav et al. “Efficacy of haridra Kwath Kawai in Management of Acute Tonsillitis.” International Journal of Medical and Clinical Research, vol. 3, Issue 8, 2012, p. 2350241.;;“Human health.” Green Facts. Retrieved from the internet on Jan. 16, 2021 https://www.greenfacts.org/glossary/ghi/human-health.htm. 2021.;;Vishwakarma, Vikalp et al. “Potent Antitumor Effects of a Combination of three Nutraceutical Compounds,” Scientific Reports, vol. 8, No. 12163, 2018, pp. 1-13.;;Hyatt Life Sciences product brochure, “Afaya Plus,” rev. 2018.;;Rodela, Emily et al. “Abstract LB-B27: Novel antitumor agent GZ17-6.02 exerts discrete effects on transcriptional regulation in pancreatic cancer cells and cancer associated fibroblasts,” Molecular Cancer Therapeutics, 2018. Found online at https://mct.aacrjournals.org/content/17/1_Supplement/LB-B27, retrieved Sep. 30, 2021.;;New, Jacob et al. “Abstract B116: Mechanistic insights into the antitumor efficacy of nutraceutical GZ17-06.02, a highly effective formulation of Arum palaestinum extract, on head and neck squamous cell carcinoma,” Natural Products, 2015. found online at http://dx.doi.org/10.1158/1535-7163.TARG-15-B116.;;Arnold. “A Combination of Three Synthetic Compounds Display Potent Antitumor Effects,” 2018. Found online at https://kuscholarworks.ku.edu/bitstream/handle/1808/30133/Arnold_ku_0099M_16252_DATA_1.pdf?sequence=1&is Allowed=y, retrieved Sep. 28, 2021.;;Extended European Search Report, EP Application No. 19758169.7-1112/3735235, dated Oct. 11, 2021.",ACTIVE
210,ZA,B,ZA 9810444 B,107-403-219-770-437,1999-06-24,1999,ZA 9810444 A,1998-11-16,US 6604997 P,1997-11-14,"Use of 9-deoxy-2',9-methano-3-oxa-4,5,6-trinor-3,7-(1',3'interphenylene)-13,14-dihydroprostaglandin F1 to treat peripheral vascular disease","An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,,https://lens.org/107-403-219-770-437,Granted Patent,no,0,0,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/48;;A61K9/72;;A61K9/20;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,EXPIRED
211,MX,A,MX 2020008773 A,155-264-555-578-122,2021-01-08,2021,MX 2020008773 A,2019-02-21,US 201862634406 P;;US 201816115284 A;;US 201916280942 A;;US 2019/0018880 W,2018-02-23,NUTRITIONAL SUPPLEMENT FOR MAMMALS.,"Mammalian nutritional supplements comprising individual quantities of turmeric, <i>Peganum harmala</i>, and <i>Arum palaestinum</i> are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of <i>Peganum harmala</i> or <i>Arum palaestinum</i>, and the supplements may contain additional beneficial ingredients, such as Î²-sitosterol, vanillin, garlic, and Vitamin C.",ANKH LIFE SCIENCES LTD,ZAID GENE H;;CROW LARRY D;;WOLF BETH ANN;;MOORE ROBERT PRESTON;;ROPP RACHEL ELIZABETH,,https://lens.org/155-264-555-578-122,Patent Application,no,0,0,9,12,0,A61K9/48;;A61K31/575;;A61K31/375;;A61K36/9066;;A61K36/185;;A61K36/888;;A61K36/8962;;A61K36/9066;;A61K9/0053;;A61K9/48;;A61K36/8962;;A61K31/375;;A61K36/77;;A61K36/888;;A61K31/575;;A61K9/4808;;A61K2300/00;;A61K36/9066;;A61K31/375;;A61K9/0053;;A61K9/4808;;A61K36/77;;A61K36/888;;A61K36/8962;;A61K31/575;;A61K9/48,A61K31/12;;A61K36/20;;A61K36/8962;;A61K36/906;;A61K36/9066;;A61P35/00,,0,0,,,,PENDING
212,EP,A1,EP 1045695 A1,024-360-729-147-913,2000-10-25,2000,EP 98957487 A,1998-11-13,US 9823245 W;;US 6604997 P,1997-11-14,"USE OF 9-DEOXY-2', 9-ALPHA-METHANO-3- OXA-4,5,6- TRINOR-3, 7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F 1? TO TREAT PERIPHERAL VASCULAR DISEASE","An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,UNITED THERAPEUTICS CORPORATION (2011-03-15),https://lens.org/024-360-729-147-913,Patent Application,yes,0,1,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/20;;A61K9/48;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,EXPIRED
213,CA,A1,CA 3004913 A1,149-341-886-270-842,2017-06-08,2017,CA 3004913 A,2016-11-22,US 201562260819 P;;US 2016/0063329 W,2015-11-30,PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOF,"The present disclosure relates to the field of plant molecular biology, more particularly to regulation of gene expression in plants.",PIONEER HI BRED INT;;DU PONT,CROW ANDREW CARL;;DIEHN SCOTT HENRY;;LU ALBERT LAURENCE;;SIMMONS CARL ROBERT;;SIMS LYNNE EILEEN,,https://lens.org/149-341-886-270-842,Patent Application,no,0,0,11,11,14,C12N15/8202;;C12N15/8242;;Y02A40/146;;C12N15/8216;;C12N15/8223,C12N15/82,,0,0,,,,PENDING
214,CA,A1,CA 3091436 A1,055-604-790-832-517,2019-08-29,2019,CA 3091436 A,2019-02-21,US 201862634406 P;;US 201816115284 A;;US 201916280942 A;;US 2019/0018880 W,2018-02-23,NUTRITIONAL SUPPLEMENT FOR MAMMALS,"Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ß-sitosterol, vanillin, garlic, and Vitamin C.",ANKH LIFE SCIENCES LTD,CROW LARRY D;;ZAID GENE H;;WOLF BETH ANN;;MOORE ROBERT PRESTON;;ROPP RACHEL ELIZABETH,,https://lens.org/055-604-790-832-517,Patent Application,no,0,0,9,12,0,A61K9/48;;A61K31/575;;A61K31/375;;A61K36/9066;;A61K36/185;;A61K36/888;;A61K36/8962;;A61K36/9066;;A61K9/0053;;A61K9/48;;A61K36/8962;;A61K31/375;;A61K36/77;;A61K36/888;;A61K31/575;;A61K9/4808;;A61K2300/00;;A61K36/9066;;A61K31/375;;A61K9/0053;;A61K9/4808;;A61K36/77;;A61K36/888;;A61K36/8962;;A61K31/575;;A61K9/48,A61K36/9066;;A61K31/12;;A61P35/00,,0,0,,,,PENDING
215,US,B2,US 6702018 B2,054-758-135-979-753,2004-03-09,2004,US 92721701 A,2001-08-10,US 92721701 A;;US 80019901 A,2001-03-06,Apparatus and method for gravel packing an interval of a wellbore,"
    An apparatus and method for gravel packing an interval of a wellbore comprises an outer tubular (  110  ), which forms a first annulus with the wellbore, and an inner tubular (  114  ) disposed within the outer tubular (  110  ) forming a second annulus therebetween. Within the second annulus is an axially extending production pathway (  190  ) and an axially extending slurry passageway (  194  ), which is defined between a channel (  170  ) and the inner tubular (  114  ). The outer tubular (  110  ) has outlets (  128  ) that are substantially aligned with outlets (  178  ) of the channel (  170  ). The portions of both the outer and inner tubulars (  110, 114  ) adjacent the production pathway (  190  ) have openings (  122, 146  ). When a fluid slurry containing gravel is injected through the slurry passageway (  194  ), the fluid slurry exits through the outlets (  178, 128  ) leaving gravel in the first annulus, thereby gravel packing the interval. 
",HALLIBURTON ENERGY SERV INC,MCGREGOR RONALD W;;HAILEY TRAVIS T;;HENDERSON WILLIAM DAVID;;CROW ROBERT W;;NGUYEN PHILIP D,HALLIBURTON ENERGY SERVICES INC (2001-08-22),https://lens.org/054-758-135-979-753,Granted Patent,yes,52,20,10,10,0,E21B43/045;;E21B43/045;;E21B43/04;;E21B43/04,E21B43/04,166/278;;166/227;;166/51,7,3,159-802-522-515-353;;130-528-674-159-261;;068-598-658-441-918,10.2118/58775-ms;;10.2118/68205-ms;;10.2118/23741-ms,"""Screenless Single Trip Multizone Sand Control Tool System Saves Rig Time,"" Travis Hailey and Morris Cox of Haliburton Energy Services, Inc.; and Kirk Johnson of BP Exploration (Alaska), Inc. Society of Petroleum Engineers Inc., Feb., 2000.;;""Simultaneous Gravel Packing and Filter Cake Removal in Horizontal Wells Applying Shunt Tubes and Novel Carrier and Breaker Fluid,"" Pedro M. Saldungaray of Schlumberger; Juan C. Troncoso of Repson-YPF; Bambang T. Santoso of Repsol-YPF. Society of Petroleum Engineers, Inc., Mar., 2001.;;""Caps<SM> Concentric Annular Packing Service for Sand Control,"" Halliburton Energy Services, Inc., Aug., 2000.;;""Caps<SM> Sand Control Service for Horizontal Completions Improves Gravel Pack Reliability and Increases Production Potential from Horizontal Completions,"" Halliburton Energy Services, Inc., Aug., 2000.;;""Frac Pack Technology Still Evolving,"" Charles D. Ebinger of Ely & Associates Inc.; Oil & Gas Journal, Oct. 23, 1995.;;""Mechanical Fluid-Loss Control Systems Used During Sand Control Operations,"" H.L. Restarick of Otis Engineering Corp., 1992.;;""Sand Control Screens,"" Halliburton Energy Services, 1994.",EXPIRED
216,CA,A,CA 1085950 A,118-391-550-589-092,1980-09-16,1980,CA 287494 A,1977-09-26,US 75604276 A,1976-12-30,SELF-ALIGNING SUPPORT STRUCTURE FOR OPTICAL COMPONENTS,"SELF-ALIGNING SUPPORT STRUCTURE FOR OPTICAL COMPONENTS An optical assembly structure wherein miniature optical components such as lasers, modulators, lenses, thin-film and fiber-optic waveguides, and photodetectors are critically aligned and supported for coactive operation by means of two or more wafers which are formed with complementary grooves and mortises to support the loose optical components such as lenses and fiber-optic waveguides and to receive alignment rails to insure the relativity of the wafers, which also have formed integral therewith optical elements such as waveguides, modulators, and lasers, to produce an integrated optical assembly somewhat in the manner of an ""optical bench"", wherein the bench structure also provides an active optical element.",IBM,COMERFORD LIAM D;;CROW JOHN D;;LAFF ROBERT A;;LEAN ERIC G;;BRADY MICHAEL J,,https://lens.org/118-391-550-589-092,Granted Patent,no,0,0,8,8,0,G02B6/30;;G02B6/42;;G02B6/423;;G02B6/4249;;H01L27/153;;H01S5/005;;H01S5/4031;;H01S5/02326;;H01S5/02251;;H01S5/005;;H01L27/153;;H01S5/4031;;G02B6/423;;G02B6/42;;G02B6/30;;G02B6/4249;;H01S5/02326;;H01S5/02251,G02B6/12;;G02B6/30;;G02B6/42;;H01L27/15;;H01L33/00;;H01L33/08;;H01L33/30;;H01S5/00;;H01S5/022;;H01S5/042;;H01S5/40,345-62,0,0,,,,EXPIRED
217,WO,A1,WO 2017/095698 A1,132-568-940-521-227,2017-06-08,2017,US 2016/0063329 W,2016-11-22,US 201562260819 P,2015-11-30,PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOF,"The present disclosure relates to the field of plant molecular biology, more particularly to regulation of gene expression in plants.",PIONEER HI BRED INT;;DU PONT,CROW ANDREW CARL;;DIEHN SCOTT HENRY;;LU ALBERT LAURENCE;;SIMMONS CARL ROBERT;;SIMS LYNNE EILEEN,,https://lens.org/132-568-940-521-227,Patent Application,yes,30,0,11,11,14,C12N15/8202;;C12N15/8242;;Y02A40/146;;C12N15/8216;;C12N15/8223,C12N15/82,,156,116,008-514-729-924-312;;026-805-806-810-806;;025-834-245-974-873;;084-748-487-156-928;;144-691-161-287-610;;056-304-474-559-637;;049-427-119-219-60X;;094-087-374-443-020;;026-164-216-541-151;;032-728-154-591-070;;085-764-009-624-439;;019-779-601-634-917;;016-617-627-772-41X;;038-383-743-124-048;;043-271-014-136-772;;058-522-492-925-838;;108-511-801-833-75X;;056-201-471-905-934;;028-862-168-091-90X;;023-907-179-348-058;;032-080-166-062-142;;017-909-665-090-904;;004-431-777-410-886;;090-123-528-290-355;;063-613-645-813-285;;132-837-083-933-536;;135-448-180-114-196;;008-362-475-732-23X;;007-181-110-377-256;;012-829-656-351-98X;;037-765-779-625-044;;154-736-930-251-25X;;003-376-184-163-765;;066-507-136-470-472;;045-092-556-156-689;;019-534-798-665-120;;020-592-145-445-463;;110-907-351-143-243;;070-800-051-754-369;;041-631-145-712-657;;015-604-138-175-674;;030-018-525-511-940;;104-950-800-448-672;;004-348-383-269-261;;101-467-467-506-920;;052-061-870-358-862;;051-141-312-213-750;;003-138-523-569-265;;000-328-881-083-677;;003-884-149-749-120;;017-924-308-652-919;;070-856-398-089-073;;152-337-057-922-627;;050-782-569-178-894;;070-337-587-352-585;;075-292-561-239-74X;;073-077-887-205-828;;048-973-364-050-66X;;022-758-990-095-827;;016-774-939-007-484;;028-114-672-236-350;;118-026-067-180-937;;041-705-306-580-800;;021-028-835-594-115;;015-502-712-235-882;;045-257-819-401-010;;093-192-631-094-270;;004-087-589-661-477;;014-370-011-759-634;;024-898-864-464-879;;042-517-250-902-679;;010-988-795-150-112;;122-742-372-778-777;;000-967-810-433-044;;154-790-395-142-285;;006-142-459-514-227;;068-401-154-984-319;;021-102-192-615-113;;008-921-646-504-417;;030-044-476-441-358;;090-800-225-277-837;;031-239-523-640-242;;020-256-798-054-010;;035-567-500-345-812;;015-218-315-346-564;;010-435-283-799-76X;;041-382-525-491-409;;088-594-862-663-224;;088-557-447-605-606;;032-884-899-824-515;;039-001-042-497-730;;048-959-281-822-221;;026-470-398-032-440;;128-253-172-375-720;;027-260-446-365-364;;020-580-211-048-629;;028-232-812-228-115;;128-575-529-160-805;;000-119-475-436-229;;013-650-904-981-558;;091-974-233-818-003;;002-413-291-488-075;;005-510-992-515-885;;022-893-627-151-937;;018-761-498-153-864;;006-747-397-728-941;;002-647-886-462-407;;010-144-555-018-585;;025-412-837-175-565;;130-633-717-730-953;;005-843-483-092-779;;056-585-155-715-771;;126-800-019-522-592;;010-877-542-441-817;;036-066-745-943-950;;033-093-660-215-000,19309755;;pmc2704498;;10.1002/bit.22299;;10.1111/j.1742-4658.2006.05454.x;;16972938;;10.1073/pnas.91.22.10747;;7938023;;pmc45099;;10.1038/370389a0;;8047147;;9131621;;10.1038/nbt0597-436;;9325094;;10.1006/jmbi.1997.1252;;pmc20752;;9114019;;10.1073/pnas.94.9.4504;;10.1038/34663;;9440693;;3382986;;10.1093/bioinformatics/4.1.11;;10.1016/0022-2836(70)90057-4;;5420325;;10.1073/pnas.85.8.2444;;pmc280013;;3162770;;pmc46825;;8390686;;10.1073/pnas.90.12.5873;;10.1016/0378-1119(88)90330-7;;3243435;;10.1093/bioinformatics/5.2.151;;2720464;;10.1093/nar/16.22.10881;;pmc338945;;2849754;;10.1093/bioinformatics/8.2.155;;1591611;;8205202;;10.1385/0-89603-246-9:307;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;7973631;;10.1126/science.7973631;;10.1126/science.7902614;;7902614;;10.1016/0092-8674(94)90282-8;;7923358;;10.1016/s0167-7799(03)00053-2;;12679066;;12509131;;10.1023/a:1021182111770;;3557124;;10.1016/0378-1119(86)90357-4;;10.1038/344458a0;;2783135;;10.1016/0006-291x(89)91111-x;;10.1080/10408410490270712;;15116762;;14987072;;10.1021/np030372w;;12419503;;10.1016/s0041-0101(02)00240-4;;10.1016/j.toxicon.2004.05.005;;15302522;;10.1016/0965-1748(93)90043-r;;8353525;;8383552;;10.1007/bf00014550;;8016275;;pmc159316;;10.1104/pp.104.4.1467;;10.1038/366469a0;;8247156;;10.1046/j.1365-313x.1992.t01-35-00999.x;;1303801;;10.1111/j.1365-313x.1992.00367.x;;10.1016/s0960-9822(95)00032-7;;7743174;;15231270;;10.1016/j.pbi.2004.05.006;;10.1016/s0092-8674(03)00473-2;;12837238;;12231724;;10.1104/pp.101.3.709;;pmc158683;;24193629;;10.1007/bf00197797;;10.1007/s004250050281;;9684370;;10459002;;10.1016/s1369-5266(99)80057-0;;10.1007/bf00225375;;24177889;;16453837;;10.1002/j.1460-2075.1988.tb02937.x;;pmc458369;;10.1007/bf00226744;;24221001;;24202589;;10.1007/bf00226531;;1840907;;10.2307/3869286;;pmc159989;;10.1105/tpc.3.2.169;;pmc1132762;;10.1042/bj2850173;;1637297;;10.1007/bf00290445;;7891655;;10.1104/pp.106.1.17;;pmc159494;;7972515;;10.1093/oxfordjournals.pcp.a078937;;8589939;;1333295;;10.1007/bf00046447;;7777559;;10.1073/pnas.92.12.5620;;pmc41748;;10.1016/0378-1119(93)90620-i;;8387447;;2828325;;pmc210726;;10.1128/jb.170.2.810-816.1988;;2993818;;10.1007/bf00425427;;pmc158881;;8278524;;10.1104/pp.102.3.1045;;10.1007/bf00026787;;1627774;;10.1007/s00299-003-0616-7;;12835900;;1709718;;10.1007/bf00273597;;1671760;;10.1016/0092-8674(91)90495-k;;10.1101/gad.5.1.141;;1703507;;1983794;;pmc159971;;10.1105/tpc.2.12.1261;;10.2307/3869344;;10.1016/0378-1119(90)90082-3;;1976572;;10.1093/nar/17.19.7891;;pmc334895;;2798133;;pmc306520;;10.1093/nar/15.23.9627;;3697078;;pmc1062239;;16667228;;10.1104/pp.92.1.1;;pmc331598;;10.1093/nar/17.2.477;;2644621;;10.1073/pnas.86.16.6126;;pmc297788;;2548200;;10.1016/0042-6822(86)90425-3;;18640649;;1652694;;10.1038/353090a0;;3492677;;10.1038/325622a0;;10.1104/pp.84.4.965;;16665627;;pmc1056707;;10.1007/bf01969712;;8673150;;1313711;;10.1007/bf00020010;;10.1007/bf00282445;;1715976;;10.1128/mcb.7.2.725;;pmc365129;;3821727;;10.1128/mcb.7.2.725-737.1987;;2369901;;pmc552281;;10.1002/j.1460-2075.1990.tb07431.x;;8777060;;8805250;;10.1016/s0960-9822(02)00483-9;;10.1038/303209a0;;1713479;;10.1007/bf00015073;;24306569;;10.1007/bf00020092;;10.1016/0168-9452(95)04136-i;;10.1007/bf00337762;;10.1007/bf01969431;;2103427;;10.1007/bf00017730;;17789813;;10.1126/science.242.4877.419;;10.1126/science.233.4762.478;;17794571;;pmc553667;;10.1002/j.1460-2075.1987.tb02537.x;;16453789;;10.1007/bf02667740;;10.1126/science.8303295;;8303295;;10.1093/nar/15.19.8115;;3671076;;pmc306336;;1479911;;10.1016/0076-6879(92)16037-k;;10.1126/science.247.4941.449;;17788612;;10.1073/pnas.83.15.5602;;3016708;;pmc386336;;pmc557758;;16453573;;10.1002/j.1460-2075.1984.tb02201.x;;10.1080/02726358708904533;;pmc1054818;;16666205;;10.1104/pp.87.3.671;;10.1007/bf02632213;;10.1073/pnas.85.12.4305;;pmc280417;;16593942;;1366794;;10.1038/nbt0990-833;;10.1038/311763a0;;16593862;;10.1073/pnas.84.15.5345;;pmc298852;;10.1007/bf00232262;;24227167;;24201341;;10.1007/bf00224152;;1334743;;pmc160236;;10.2307/3869493;;10.1105/tpc.4.12.1495;;10.1007/bf00237129;;24197151;;10.1006/anbo.1995.1038;;10.1038/nbt0696-745;;9630983;;10.1007/bf02900359;;8837027;;24248039;;10.1007/bf00269239;;pmc1282333;;16292354;;10.1371/journal.pcbi.0010060;;10.1101/gad.1.10.1183;;2828168,"ZHONG HUANG ET AL: ""A DNA replicon system for rapid high-level production of virus-like particles in plants"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 103, no. 4, 1 July 2009 (2009-07-01), pages 706 - 714, XP055027289, ISSN: 0006-3592, DOI: 10.1002/bit.22299;;HEFFERON KATHLEEN L ET AL: ""Multi-tasking of nonstructural gene products is required for bean yellow dwarf geminivirus transcriptional regulation"", FEBS JOURNAL, vol. 273, no. 19, October 2006 (2006-10-01), pages 4482 - 4494, XP002766574;;STEMMER, PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 10747 - 10751;;STEMMER, NATURE, vol. 370, 1994, pages 389 - 391;;CRAMERI ET AL., NATURE BIOTECH, vol. 15, 1997, pages 436 - 438;;MOORE ET AL., J. MOL. BIOL., vol. 272, 1997, pages 336 - 347;;ZHANG ET AL., PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 4504 - 4509;;CRAMERI ET AL., NATURE, vol. 391, 1998, pages 288 - 291;;""PCR Protocols: A Guide to Methods and Applications"", 1990, ACADEMIC PRESS;;""PCR Strategies"", 1995, ACADEMIC PRESS;;""PCR Methods Manual"", 1999, ACADEMIC PRESS;;TIJSSEN: ""Laboratory Techniques in Biochemistry and Molecular Biology--Hybridization with Nucleic Acid Probes"", 1993, ELSEVIER;;""Current Protocols in Molecular Biology"", 1995, GREENE PUBLISHING AND WILEY-INTERSCIENCE;;MYERS; MILLER, CABIOS, vol. 4, 1988, pages 11 - 17;;SMITH ET AL., ADV. APPL. MATH., vol. 2, 1981, pages 482;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;PEARSON; LIPMAN, PROC. NATL. ACAD. SCI., vol. 85, 1988, pages 2444 - 2448;;ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 872, 1990, pages 264;;KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 5877;;HIGGINS ET AL., GENE, vol. 73, 1988, pages 237 - 244;;HIGGINS ET AL., CABIOS, vol. 5, 1989, pages 151 - 153;;CORPET ET AL., NUCLEIC ACIDS RES., vol. 16, 1988, pages 10881 - 10890;;HUANG ET AL., CABIOS, vol. 8, 1992, pages 155 - 165;;PEARSON ET AL., METH. MOL. BIOL., vol. 24, 1994, pages 307 - 331;;ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389;;HENIKOFF; HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1989, pages 10915;;JONES ET AL., SCIENCE, vol. 266, 1994, pages 789;;MARTIN ET AL., SCIENCE, vol. 262, 1993, pages 1432;;MINDRINOS ET AL., CELL, vol. 78, 1994, pages 1089;;MCDOWELL; WOFFENDEN, TRENDS BIOTECHNOL., vol. 21, no. 4, 2003, pages 178 - 183;;TOYODA ET AL., TRANSGENIC RES., vol. 11, no. 6, 2002, pages 567 - 582;;GEISER ET AL., GENE, vol. 48, 1986, pages 109;;HAMMOCK ET AL., NATURE, vol. 344, 1990, pages 458;;REGAN; 1994, J. BIOL. CHEM., vol. 269, pages 9;;PRATT ET AL., BIOCHEM. BIOPHYS. RES. COMM., vol. 163, 1989, pages 1243;;CHATTOPADHYAY ET AL., CRITICAL REVIEWS IN MICROBIOLOGY, vol. 30, no. 1, 2004, pages 33 - 54;;ZJAWIONY, J NAT PROD, vol. 67, no. 2, 2004, pages 300 - 310;;CARLINI; GROSSI-DE-SA, TOXICON, vol. 40, no. 11, 2002, pages 1515 - 1539;;USSUF ET AL., CURR SCI., vol. 80, no. 7, 2001, pages 847 - 853;;VASCONCELOS; OLIVEIRA, TOXICON, vol. 44, no. 4, 2004, pages 385 - 403;;KRAMER ET AL., INSECT BIOCHEM. MOLEC. BIOL., vol. 23, 1993, pages 691;;KAWALLECK ET AL., PLANT MOLEC. BIOL, vol. 21, 1993, pages 673;;BOTELLA ET AL., PLANT MOLEC. BIOL., vol. 24, 1994, pages 757;;GRIESS ET AL., PLANT PHYSIOL., vol. 104, 1994, pages 1467;;JAYNES ET AL., PLANT SCI., vol. 89, 1993, pages 43;;BEACHY ET AL., ANN. REV. PHYTOPATHOL., vol. 28, 1990, pages 451;;TAYLOR ET AL., SEVENTH INT'L SYMPOSIUM ON MOLECULAR PLANT-MICROBE INTERACTIONS, 1994;;TAVLADORAKI ET AL., NATURE, vol. 366, 1993, pages 469;;LAMB ET AL., BIO/TECHNOLOGY, vol. 10, 1992, pages 1436;;TOUBART ET AL., PLANT J., vol. 2, 1992, pages 367;;LOGEMANN ET AL., BIO/TECHNOLOGY, vol. 10, 1992, pages 305;;BRIGGS, CURRENT BIOLOGY, vol. 5, no. 2, 1995, pages 128 - 131;;PIETERSE; VAN LOON, CURR. OPIN. PLANT BIO., vol. 7, no. 4, 2004, pages 456 - 464;;SOMSSICH, CELL, vol. 113, no. 7, 2003, pages 815 - 816;;CORNELISSEN; MELCHERS, PL. PHYSIOL., vol. 101, 1993, pages 709 - 712;;PARIJS ET AL., PLANTA, vol. 183, 1991, pages 258 - 264;;BUSHNELL ET AL., CAN. J. OF PLANT PATH., vol. 20, no. 2, 1998, pages 137 - 149;;URWIN, PLANTA, vol. 204, 1998, pages 472 - 479;;WILLIAMSON, CURR OPIN PLANT BIO., vol. 2, no. 4, 1999, pages 327 - 331;;JUNG ET AL.: ""Generation-means analysis and quantitative trait locus mapping of Anthracnose Stalk Rot genes in Maize"", THEOR. APPL. GENET., vol. 89, 1994, pages 413 - 418;;LEE ET AL., EMBO J., vol. 7, 1988, pages 1241;;MIKI ET AL., THEOR. APPL. GENET., vol. 80, 1990, pages 449;;DE GREEF ET AL., BIO/TECHNOLOGY, vol. 7, 1989, pages 61;;MARSHALL ET AL., THEOR. APPL. GENET., vol. 83, 1992, pages 435;;PRZIBILLA ET AL., PLANT CELL, vol. 3, 1991, pages 169;;HAYES ET AL., BIOCHEM. J., vol. 285, 1992, pages 173;;HATTORI ET AL., MOL GEN GENET, vol. 246, 1995, pages 419;;SHIOTA ET AL., PLANT PHYSIOL., vol. 106, no. 1, 1994, pages 17 - 23;;AONO ET AL., PLANT CELL PHYSIOL, vol. 36, 1995, pages 1687;;DATTA ET AL., PLANT MOL BIOL, vol. 20, 1992, pages 619;;KNULTZON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 2624;;RIVERA-MADRID, PROC. NATL. ACAD. SCI., vol. 92, 1995, pages 5620 - 5624;;VAN HARTINGSVELDT ET AL., GENE, vol. 127, 1993, pages 87;;RABOY ET AL., MAYDICA, vol. 35, 1990, pages 383;;SHIROZA ET AL., J. BACTERIOL., vol. 170, 1988, pages 810;;MOL. GEN. GENET., vol. 200, 1985, pages 220;;PEN ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 292;;ELLIOT ET AL., PLANT MOLEC. BIOL., vol. 21, 1993, pages 515;;S0GAARD ET AL., J. BIOL. CHEM., vol. 268, 1993, pages 22480;;FISHER ET AL., PLANT PHYSIOL., vol. 102, 1993, pages 1045;;PAUL ET AL., PLANT MOL. BIOL., vol. 19, 1992, pages 611 - 622;;LYZNIK ET AL., PLANT CELL REP, vol. 21, 2003, pages 925 - 932;;""The Maize Handbook"", 1994, SPRINGER-VERLAG;;GUERINEAU ET AL., MOL. GEN. GENET., vol. 262, 1991, pages 141 - 144;;PROUDFOOT, CELL, vol. 64, 1991, pages 671 - 674;;SANFACON ET AL., GENES DEV., vol. 5, 1991, pages 141 - 149;;MOGEN ET AL., PLANT CELL, vol. 2, 1990, pages 1261 - 1272;;MUNROE ET AL., GENE, vol. 91, 1990, pages 151 - 158;;BALLAS ET AL., NUCLEIC ACIDS RES., vol. 17, 1989, pages 7891 - 7903;;JOSHI ET AL., NUCLEIC ACID RES., vol. 15, 1987, pages 9627 - 9639;;CAMPBELL; GOWRI, PLANT PHYSIOL., vol. 92, 1990, pages 1 - 11;;MURRAY ET AL., NUCLEIC ACIDS RES., vol. 17, 1989, pages 477 - 498;;ELROY-STEIN ET AL., PROC. NAT. ACAD. SCI. USA, vol. 86, 1989, pages 6126 - 6130;;ALLISON ET AL., VIROLOGY, vol. 154, 1986, pages 9 - 20;;MACEJAK ET AL., NATURE, vol. 353, 1991, pages 90 - 94;;JOBLING ET AL., NATURE, vol. 325, 1987, pages 622 - 625;;GALLIE ET AL., MOLECULAR BIOLOGY OF RNA, 1989, pages 237 - 256;;LOMMEL ET AL., VIROLOGY, vol. 81, 1991, pages 382 - 385;;DELLA-CIOPPA ET AL., PLANT PHYSIOLOGY, vol. 84, 1987, pages 965 - 968;;CHRISTENSEN; QUAIL, TRANSGENIC RES., vol. 5, 1996, pages 213 - 218;;CHRISTENSEN ET AL., PLANT MOLECULAR BIOLOGY, vol. 18, 1992, pages 675 - 689;;KYOZUKA ET AL., MOL. GEN. GENET., vol. 228, 1991, pages 40 - 48;;KYOZUKA ET AL., MAYDICA, vol. 35, 1990, pages 353 - 357;;JEFFERSON ET AL.: ""Plant Molecular Biology Manual"", 1991, KLUWER ACADEMIC PUBLISHERS, pages: 1 - 33;;DEWET ET AL., MOL. CELL. BIOL., vol. 7, 1987, pages 725 - 737;;GOFF ET AL., EMBO J., vol. 9, 1990, pages 2517 - 2522;;KAIN ET AL., BIO TECHNIQUES, vol. 19, 1995, pages 650 - 655;;CHIU ET AL., CURRENT BIOLOGY, vol. 6, 1996, pages 325 - 330;;HERRERA ESTRELLA ET AL., EMBO J., vol. 2, 1983, pages 987 - 992;;HERRERA ESTRELLA ET AL., NATURE, vol. 303, 1983, pages 209 - 213;;MEIJER ET AL., PLANT MOL. BIOL., vol. 16, 1991, pages 807 - 820;;WALDRON ET AL., PLANT MOL. BIOL., vol. 5, 1985, pages 103 - 108;;ZHIJIAN ET AL., PLANT SCIENCE, vol. 108, 1995, pages 219 - 227;;JONES ET AL., MOL. GEN. GENET., vol. 210, 1987, pages 86 - 91;;BRETAGNE-SAGNARD ET AL., TRANSGENIC RES., vol. 5, 1996, pages 131 - 137;;HILLE ET AL., PLANT MOL. BIOL., vol. 7, 1990, pages 171 - 176;;GUERINEAU ET AL., PLANT MOL. BIOL., vol. 15, 1990, pages 127 - 136;;STALKER ET AL., SCIENCE, vol. 242, 1988, pages 419 - 423;;SHAW ET AL., SCIENCE, vol. 233, 1986, pages 478 - 481;;DEBLOCK ET AL., EMBO J., vol. 6, 1987, pages 2513 - 2518;;JEFFERSON, PLANT MOL. BIOL. REP., vol. 5, 1987, pages 387;;CHALFIE ET AL., SCIENCE, vol. 263, 1994, pages 802;;RIGGS ET AL., NUCLEIC ACIDS RES., vol. 15, no. 19, 1987, pages 8115;;LUEHRSEN ET AL., METHODS ENZYMOL., vol. 216, 1992, pages 397 - 414;;LUDWIG ET AL., SCIENCE, vol. 247, 1990, pages 449;;CROSSWAY ET AL., BIOTECHNIQUES, vol. 4, 1986, pages 320 - 334;;RIGGS ET AL., PROC. NATL. ACAD. SCI. USA, vol. 83, 1986, pages 5602 - 5606;;PASZKOWSKI ET AL., EMBO J., vol. 3, 1984, pages 2717 - 2722;;TOMES ET AL.: ""Plant Cell, Tissue, and Organ Culture: Fundamental Methods"", 1995, SPRINGER-VERLAG;;MCCABE ET AL., BIOTECHNOLOGY, vol. 6, 1988, pages 923 - 926;;WEISSINGER ET AL., ANN. REV. GENET., vol. 22, 1988, pages 421 - 477;;SANFORD ET AL., PARTICULATE SCIENCE AND TECHNOLOGY, vol. 5, 1987, pages 27 - 37;;CHRISTOU ET AL., PLANT PHYSIOL., vol. 87, 1988, pages 671 - 674;;MCCABE ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 923 - 926;;FINER; MCMULLEN, IN VITRO CELL DEV. BIOL., vol. 27P, 1991, pages 175 - 182;;SINGH ET AL., THEOR. APPL. GENET., vol. 96, 1998, pages 319 - 324;;DATTA ET AL., BIOTECHNOLOGY, vol. 8, 1990, pages 736 - 740;;KLEIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 4305 - 4309;;KLEIN ET AL., BIOTECHNOLOGY, vol. 6, 1988, pages 559 - 563;;KLEIN ET AL., PLANT PHYSIOL., vol. 91, 1988, pages 440 - 444;;FROMM ET AL., BIOTECHNOLOGY, vol. 8, 1990, pages 833 - 839;;HOOYKAAS-VAN SLOGTEREN ET AL., NATURE, vol. 311, 1984, pages 763 - 764;;BYTEBIER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 5345 - 5349;;DE WET ET AL.: ""The Experimental Manipulation of Ovule Tissues"", 1985, LONGMAN, pages: 197 - 209;;KAEPPLER ET AL., PLANT CELL REPORTS, vol. 9, 1990, pages 415 - 418;;KAEPPLER ET AL., THEOR. APPL. GENET., vol. 84, 1992, pages 560 - 566;;D'HALLUIN ET AL., PLANT CELL, vol. 4, 1992, pages 1495 - 1505;;LI ET AL., PLANT CELL REPORTS, vol. 12, 1993, pages 250 - 255;;CHRISTOU; FORD, ANNALS OF BOTANY, vol. 75, 1995, pages 407 - 413;;OSJODA ET AL., NATURE BIOTECHNOLOGY, vol. 14, 1996, pages 745 - 750;;PORTA ET AL., MOLECULAR BIOTECHNOLOGY, vol. 5, 1996, pages 209 - 221;;MCCORMICK ET AL., PLANT CELL REPORTS, vol. 5, 1986, pages 81 - 84;;WEISSBACH; WEISSBACH: ""Methods for Plant Molecular Biology"", 1988, ACADEMIC PRESS, INC.;;HAFT ET AL., COMPUTATIONAL BIOLOGY, PLOS COMPUT BIOL, vol. 1, no. 6, 2005, pages E60;;CALLIS ET AL., GENES AND DEVELOPMENT, vol. 1, 1987, pages 1183 - 1200",PENDING
218,US,A1,US 2004/0221988 A1,198-456-167-032-546,2004-11-11,2004,US 79646704 A,2004-03-09,US 79646704 A;;US 92721701 A;;US 80019901 A,2001-03-06,Apparatus and method for treating an interval of a wellbore,"
    An apparatus ( 60 ) and method for treating an interval of a wellbore comprises an outer tubular ( 62 ) disposed within the wellbore. A sand control screen ( 92 ) is disposed within the outer tubular ( 62 ). A slurry passageway ( 88 ) is formed between the sand control screen ( 92 ) and outer tubular ( 62 ). In addition, a production pathway ( 90 ) is formed between the sand control screen ( 92 ) and outer tubular ( 62 ). When the apparatus ( 60 ) is in an operable position, the region between the outer tubular ( 62 ) and the wellbore serves as a primary path for delivery of a fluid slurry, the production pathway ( 90 ) serves as a secondary path for delivery of the fluid slurry if the primary path becomes blocked and the slurry passageway ( 88 ) serves as a tertiary path for delivery of the fluid slurry if the primary and secondary paths become blocked. 
",MCGREGOR RONALD W.;;HAILEY TRAVIS T.;;HENDERSON WILLIAM DAVID;;CROW ROBERT W.;;NGUYEN PHILIP D.,MCGREGOR RONALD W;;HAILEY TRAVIS T;;HENDERSON WILLIAM DAVID;;CROW ROBERT W;;NGUYEN PHILIP D,HALLIBURTON ENERGY SERVICES (2001-08-22),https://lens.org/198-456-167-032-546,Patent Application,yes,63,2,10,10,0,E21B43/045;;E21B43/045;;E21B43/04;;E21B43/04,E21B43/04,166/278;;166/227,0,0,,,,EXPIRED
219,FR,A1,FR 2376537 A1,059-008-062-994-491,1978-07-28,1978,FR 7736208 A,1977-11-24,US 75604276 A,1976-12-30,ASSEMBLAGE OPTIQUE DANS LEQUEL LES DIFFERENTS ELEMENTS SONT PLACES ET MAINTENUS DANS UNE POSITION RELATIVE DETERMINEE,"<P>L'invention concerne les assemblages optiques d'éléments discrets et intégrés. </P><P>Le support 10, en silicium, est muni de rainures 10a-10m portant des fibres optiques 12a-12m et d'une rainure 10n portant une lentille cylindrique 14. Un réseau laser 20, capable d'émettre des rayonnements parallèles définis par les électrodes 20a-20m, est placé sur le support de telle sorte que ses rainures 20p, 20r viennent se placer sur des rails cylindriques 16 et 18, eux-mêmes placés dans des rainures 10p, 10r taillées dans le support </P><P>Applicable notamment dans la fabrication d'ensembles optiques intégrés.</P>",IBM,COMERFORD LIAM D;;CROW JOHN D;;LAFF ROBERT A;;LEAN ERIC G;;BRADY MICHAEL J,,https://lens.org/059-008-062-994-491,Patent Application,no,2,0,8,8,0,G02B6/30;;G02B6/42;;G02B6/423;;G02B6/4249;;H01L27/153;;H01S5/005;;H01S5/4031;;H01S5/02326;;H01S5/02251;;H01S5/005;;H01L27/153;;H01S5/4031;;G02B6/423;;G02B6/42;;G02B6/30;;G02B6/4249;;H01S5/02326;;H01S5/02251,G02B6/12;;G02B6/30;;G02B6/42;;H01L27/15;;H01L33/00;;H01L33/08;;H01L33/30;;H01S5/00;;H01S5/022;;H01S5/042;;H01S5/40,,1,0,,,EXBK/75,EXPIRED
220,DE,A1,DE 3305273 A1,152-678-961-622-169,1983-09-15,1983,DE 3305273 A,1983-02-16,US 35831382 A,1982-03-15,SICHERHEITSVENTIL FUER BOHRLOECHER,,OTIS ENG CO,SPEEGLE STEVEN C;;SCHWENDEMANN KENNETH L;;VINZANT MICHAEL B;;CROW ROBERT W;;MONDON CARY G,,https://lens.org/152-678-961-622-169,Patent Application,no,0,0,8,8,0,E21B34/10;;E21B34/10;;E21B2200/04;;E21B2200/04;;Y10T137/86944;;Y10T137/86944,E21B34/00;;E21B34/10,,0,0,,,,DISCONTINUED
221,US,A1,US 2004/0254907 A1,067-263-614-612-630,2004-12-16,2004,US 64445803 A,2003-08-20,US 64445803 A;;US 30105799 A,1999-04-28,Versatile indirection in an extent based file system,"
   A memory storage device has a file storage operating system that uses inodes to access file segments. Each inode has a plurality of rows. A portion of the rows can store extents pointing, directly or indirectly, to data blocks. Each extent has a field to indicate whether the extent is an indirect extent or a direct extent. 
",CROW PRESTON F.;;MASON ROBERT S.;;MCCLURE STEVEN T.;;NAGY SUSAN C.;;WHEELER RICHARD G.,CROW PRESTON F;;MASON ROBERT S;;MCCLURE STEVEN T;;NAGY SUSAN C;;WHEELER RICHARD G,,https://lens.org/067-263-614-612-630,Patent Application,yes,14,152,2,9,0,G06F16/10;;G06F16/10;;Y10S707/99931;;Y10S707/99956;;Y10S707/99933,G06F17/30,707/1,0,0,,,,DISCONTINUED
222,CA,C,CA 2312729 C,114-446-794-830-954,2006-05-23,2006,CA 2312729 A,1998-11-13,US 6604997 P;;US 9823245 W,1997-11-14,"USE OF 9-DEOXY-2', 9-.ALPHA.-METHANO-3- OXA-4,5,6- TRINOR-3,7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F1 TO TREAT PERIPHERAL VASCULAR DISEASE","An improved treatment for peripheral vascular disease is described using 9- deoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;CLOUTIER GILLES;;ROTHBLATT MARTINE;;WADE MICHAEL;;ROSCIGNO ROBERT;;BLACKBURN SHELMER D JR,,https://lens.org/114-446-794-830-954,Granted Patent,no,0,0,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/20;;A61K31/5575;;A61K9/48;;A61K9/72;;A61K31/557;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,EXPIRED
223,JP,A,JP 2005225877 A,128-124-868-142-502,2005-08-25,2005,JP 2005015658 A,2005-01-24,US 6604997 P,1997-11-14,"APPLICATION OF 9-DEOXY-2', 9-alpha-METHANO-3-OXA-4, 5, 6-TRINOL-3, 7-(1', 3'-INTERPHENYLENE)-13, 14-DIHYDRO-PROSTAGLANDIN F1 FOR TREATING PERIPHERAL VASCULAR DISEASE","<P>PROBLEM TO BE SOLVED: To provide an improved method for treating peripheral vascular diseases by using 9-deoxy-2', 9-α-methano-3-oxa-4, 5, 6-trinol-3, 7-(1', 3'-interphenylene)-13, 14-dihydro-prostaglandin F<SB>1</SB>. <P>SOLUTION: 9-Deoxy-2', 9-α-methan-3-oxa-4, 5, 6-trinol-3, 7-(1', 3'-interphenylene)-13, 14-dihydro-prostaglandin F<SB>1</SB>(UT-15) is not decomposed during passing through the lung, has a long biological half life and strong vasodilating properties for peripheral blood vessels, is a remarkably strong platelet coagulation inhibitor and inhibits release of a vasoconstrictor. Therefore, UT-15 is very effective for peripheral artery occlusion diseases and peripheral blood vessel diseases including intermittent claudication when it is administered at 0.5μg-2.5mg effective dose/day/kg body weight by a peroral, an inhalational, a hypodermically muscular, a subcutaneous, an intravenous method, or the like. <P>COPYRIGHT: (C)2005,JPO&NCIPI",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,,https://lens.org/128-124-868-142-502,Patent Application,no,0,1,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/48;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61K9/20;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,DISCONTINUED
224,CA,A,CA 1192838 A,167-222-592-226-089,1985-09-03,1985,CA 417856 A,1982-12-16,US 35831382 A,1982-03-15,SUBSURFACE SAFETY VALVE,"A surface controlled subsurface safety valve having a ball type valve closure. The ball member and its associated components are protected from damage by preventing excessive control fluid pressure from applying force to the ball member. Also, rotation of the ball member is prevented until any difference in pressure across the ball member and its seating surface has decreased below a preselected safe value.",OTIS ENG CO,SPEEGLE STEVEN C;;SCHWENDEMANN KENNETH L;;VINZANT MICHAEL B;;CROW ROBERT W;;MONDON CARY G,,https://lens.org/167-222-592-226-089,Granted Patent,no,0,0,8,8,0,E21B34/10;;E21B34/10;;E21B2200/04;;E21B2200/04;;Y10T137/86944;;Y10T137/86944,E21B34/00;;E21B34/10,166-41,0,0,,,,EXPIRED
225,US,A1,US 2022/0175869 A1,180-203-657-128-63X,2022-06-09,2022,US 202117540810 A,2021-12-02,US 202117540810 A;;US 202063121767 P,2020-12-04,FORMULATIONS INHIBITING SARS-CoV-2 VIRUS,"The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a formulation comprising turmeric, Peganum harmala , and Arum palaestinum , and/or variants thereof. Methods of inhibiting SARS-CoV-2 viral replication are also described.",ANKH LIFE SCIENCES LTD,ZAID GENE H;;WOLF BETH ANN;;MOORE ROBERT PRESTON;;CROW LARRY D;;WEST JASON H,ANKH LIFE SCIENCES LIMITED (2020-12-03),https://lens.org/180-203-657-128-63X,Patent Application,yes,0,1,1,1,0,A61K31/375;;A61P31/14;;A61K31/575;;A61K36/185;;A61K36/888;;A61K36/8962;;A61K36/9066;;A61K9/0019;;A61K9/0053;;A61K9/0031;;A61K9/0043;;A61K9/0048;;A61K31/11;;A61K36/9066;;A61K36/888;;A61K36/185;;A61P31/14;;A61K31/12;;A61K36/8962;;A61K31/575;;A61K31/375,A61K36/9066;;A61K31/12;;A61K31/375;;A61K31/575;;A61K36/185;;A61K36/888;;A61K36/8962;;A61P31/14,,8,7,010-790-300-564-011;;126-047-125-141-390;;103-570-908-570-281;;006-088-987-263-834;;016-737-099-404-870;;045-310-026-269-873;;038-766-796-495-692,10.33696/pharmacol.2.014;;31763212;;10.22038/ajp.2019.13382;;pmc6823531;;10.3390/d12050175;;pmc9056388;;35520671;;10.1039/d0ra03167d;;pmc7673072;;10.1186/s12937-020-00643-8;;33208167;;10.1007/s43440-020-00176-1;;33113146;;pmc7592143;;21095222;;10.1016/j.bbagen.2010.11.004,"Farid (Phytochemical constituents of the butanol fraction of Arum palaestinum Boiss.: cytotoxic and antiviral screening, JME, 2017 Vol 8, Issue 7, p 2585-2591) (Year: 2017);;Khan et. al. (Beta-Sitosterol: As Immunostimulant, Antioxidant and Inhibitor of SARS-CoV-2 Spike Glycoprotein, Archives of Pharmacology and Therapeutics, Vol 2, Issue 1, August 24, 2020) (Year: 2020);;Iranshahy et. al. (Chemical composition and antibacterial properties of Peganum harmala L., Avicenna Journal of Phytomedicine, 2019; 9(6): 530-537) (Year: 2019);;Wink (Potential of DNA Intercalating Alkaloids and Other Plant Secondary Metabolites against SARS-CoV-2 Causing COVID-19, Diversity, April, 2020, 12, 175; 1-10) (Year: 2020);;Shanmugarajan et. al. (Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets, RSC Adv, Aug 2020, 10, 31385-31399) (Year: 2020);;Khubber (Garlic (Allium sativum L.): a potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19, Nutrition Journal, 2020, 19:124) (Year: 2020);;Abobaker (Overview of the possible role of vitamin C in management of COVID-19, Pharmacological Reports 2020, 72:1517-1528). (Year: 2020);;Tai et. al. (Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays, BiochimicaetBiophysicaActa1810(2011)170–177). (Year: 2011)",PENDING
226,DE,D1,DE 69822665 D1,187-769-412-657-581,2004-04-29,2004,DE 69822665 T,1998-11-13,US 6604997 P;;US 9823245 W,1997-11-14,"VERWENDUNG VON 9-DESOXY-2',9-ALPHA-METHANO-3-OXA-4,5,6-TRINOR-3,7-(1',3'-INTERPHENYLEN)-13,14-DIHYDROPROSTAGLANDIN-F1 ZUR BEHANDLUNG VON PERIPHEREN VASKULÄREN ERKRANKUNGEN","An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin F1.",UNITED THERAPEUTICS CORP,CROW JAMES W;;BLACKBURN SHELMER D JR;;ROSCIGNO ROBERT;;WADE MICHAEL;;CLOUTIER GILLES;;ROTHBLATT MARTINE,,https://lens.org/187-769-412-657-581,Granted Patent,no,0,0,19,19,0,A61K31/557;;A61K31/5575;;A61P1/04;;A61P11/06;;A61P11/08;;A61P7/02;;A61P9/00;;A61P9/10;;A61P9/14;;A61K31/557;;A61K31/5575;;A61K31/557,A61K9/20;;A61K9/48;;A61K9/72;;A61K31/557;;A61K31/5575;;A61P1/04;;A61P7/02;;A61P9/00;;A61P9/10;;A61P11/06;;A61P11/08,,0,0,,,,EXPIRED
227,US,B2,US 10995339 B2,050-795-505-909-419,2021-05-04,2021,US 201615778542 A,2016-11-22,US 201615778542 A;;US 201562260819 P;;US 2016/0063329 W,2015-11-30,Plant regulatory elements and methods of use thereof,"The present disclosure relates to the field of plant molecular biology, more particularly to regulation of gene expression in plants.",PIONEER HI BRED INT;;DU PONT,CROW ANDREW CARL;;DIEHN SCOTT HENRY;;LU ALBERT LAURENCE;;SIMMONS CARL ROBERT;;SIMS LYNNE EILEEN,E. I. DU PONT DE NEMOURS AND COMPANY (2016-11-08);;CORTEVA AGRISCIENCE LLC (2022-07-28);;PIONEER HI-BRED INTERNATIONAL INC (2016-10-05),https://lens.org/050-795-505-909-419,Granted Patent,yes,11,1,11,11,14,C12N15/8202;;C12N15/8242;;Y02A40/146;;C12N15/8216;;C12N15/8223,C12N15/82,,3,2,026-805-806-810-806;;008-514-729-924-312,10.1111/j.1742-4658.2006.05454.x;;16972938;;19309755;;pmc2704498;;10.1002/bit.22299,"Hefferon, Kathleen L., et al.: “Multi-tasking of nonstructural gene products is required for bean yellow dwarf geminivirus transcriptional regulation”, Febs Journal, Oct. 2006 (Oct. 2006), vol. 273, No. 19, pp. 4482-4494.;;Zhong, Huang, et al.: “A DNA replicon system for rapid high-level production of virus-like particles in plants”, Biotechnology and Bioengineering, Jul. 1, 2009 (Jul. 1, 2009), vol. 103, No. 4, pp. 706-714.;;International Search Report and Written Opinion, International Application No. PCT/US2016/063329 dated Mar. 31, 2017.",ACTIVE
228,WO,A1,WO 2019/165023 A1,074-884-351-591-633,2019-08-29,2019,US 2019/0018880 W,2019-02-21,US 201862634406 P;;US 201816115284 A;;US 201916280942 A,2018-02-23,NUTRITIONAL SUPPLEMENT FOR MAMMALS,"Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala , and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum , and the supplements may contain additional beneficial ingredients, such as β-sitosterol, vanillin, garlic, and Vitamin C.",ANKH LIFE SCIENCES LTD;;CROW LARRY D,CROW LARRY D;;ZAID GENE H;;WOLF BETH ANN;;MOORE ROBERT PRESTON;;ROPP RACHEL ELIZABETH,,https://lens.org/074-884-351-591-633,Patent Application,yes,4,0,9,12,0,A61K9/48;;A61K31/575;;A61K31/375;;A61K36/9066;;A61K36/185;;A61K36/888;;A61K36/8962;;A61K36/9066;;A61K9/0053;;A61K9/48;;A61K36/8962;;A61K31/375;;A61K36/77;;A61K36/888;;A61K31/575;;A61K9/4808;;A61K2300/00;;A61K36/9066;;A61K31/375;;A61K9/0053;;A61K9/4808;;A61K36/77;;A61K36/888;;A61K36/8962;;A61K31/575;;A61K9/48,A61K31/12;;A61K36/20;;A61K36/8962;;A61K36/906;;A61K36/9066;;A61P35/00,,1,0,,,See also references of EP 3735235A4,PENDING
229,US,A1,US 2004/0105332 A1,098-917-808-575-588,2004-06-03,2004,US 72062903 A,2003-11-24,US 72062903 A;;US 30117799 A,1999-04-28,Multi-volume extent based file system,"
   A memory storage device has a file storage operating system which uses an inode to record and find segments of each data file. The inode includes a plurality of rows. A portion of the rows are written with direct extents pointing to data blocks storing portions of file segments. At least two of the extents point to data blocks having addresses in different logical volumes. 
",CROW PRESTON F.;;MASON ROBERT S.;;MCCLURE STEVEN T.;;NAGY SUSAN C.;;WHEELER RICHARD G.,CROW PRESTON F;;MASON ROBERT S;;MCCLURE STEVEN T;;NAGY SUSAN C;;WHEELER RICHARD G,EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/098-917-808-575-588,Patent Application,yes,16,19,3,9,0,G06F16/10;;G06F16/10;;Y10S707/99932;;Y10S707/966;;Y10S707/99952;;Y10S707/99942;;Y10S707/99953;;Y10S707/99956,G06F17/30,365/202,0,0,,,,EXPIRED
230,EP,A1,EP 3735235 A1,103-691-519-828-059,2020-11-11,2020,EP 19758169 A,2019-02-21,US 201862634406 P;;US 201816115284 A;;US 201916280942 A;;US 2019/0018880 W,2018-02-23,NUTRITIONAL SUPPLEMENT FOR MAMMALS,,ANKH LIFE SCIENCES LTD,ZAID GENE H;;WOLF BETH ANN;;MOORE ROBERT PRESTON;;ROPP RACHEL ELIZABETH;;CROW LARRY D,,https://lens.org/103-691-519-828-059,Patent Application,yes,0,0,9,12,0,A61K9/48;;A61K31/575;;A61K31/375;;A61K36/9066;;A61K36/185;;A61K36/888;;A61K36/8962;;A61K36/9066;;A61K9/0053;;A61K9/48;;A61K36/8962;;A61K31/375;;A61K36/77;;A61K36/888;;A61K31/575;;A61K9/4808;;A61K2300/00;;A61K36/9066;;A61K31/375;;A61K9/0053;;A61K9/4808;;A61K36/77;;A61K36/888;;A61K36/8962;;A61K31/575;;A61K9/48,A61K31/12;;A61K36/20;;A61K36/8962;;A61K36/906;;A61K36/9066;;A61P35/00,,0,0,,,,DISCONTINUED
231,DE,A1,DE 2754923 A1,170-277-321-754-759,1978-07-06,1978,DE 2754923 A,1977-12-09,US 75604276 A,1976-12-30,SELBSTAUSRICHTENDE OPTISCHE TRAEGERANORDNUNG FUER OPTISCHE BAUELEMENTE,,IBM,COMERFORD LIAM DAVID;;CROW JOHN DAIVD;;LAFF ROBERT ALLAN;;LEAN ERIC GUNG-HWA;;BRADY MICHAEL JOHN,,https://lens.org/170-277-321-754-759,Patent Application,no,0,1,8,8,0,G02B6/30;;G02B6/42;;G02B6/423;;G02B6/4249;;H01L27/153;;H01S5/005;;H01S5/4031;;H01S5/02326;;H01S5/02251;;H01S5/005;;H01L27/153;;H01S5/4031;;G02B6/423;;G02B6/42;;G02B6/30;;G02B6/4249;;H01S5/02326;;H01S5/02251,G02B6/12;;G02B6/30;;G02B6/42;;H01L27/15;;H01L33/00;;H01L33/08;;H01L33/30;;H01S5/00;;H01S5/022;;H01S5/042;;H01S5/40,,0,0,,,,DISCONTINUED
232,US,B1,US 6654772 B1,191-366-025-553-780,2003-11-25,2003,US 30117799 A,1999-04-28,US 30117799 A,1999-04-28,Multi-volume extent based file system,"
    A memory storage device has a file storage operating system which uses an inode to record and find segments of each data file. The inode includes a plurality of rows. A portion of the rows are written with direct extents pointing to data blocks storing portions of file segments. At least two of the extents point to data blocks having addresses in different logical volumes. 
",EMC CORP,CROW PRESTON F;;MASON JR ROBERT S;;MCCLURE STEVEN T;;NAGY SUSAN C;;WHEELER RICHARD G,EMC CORPORATION (1999-10-19);;EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/191-366-025-553-780,Granted Patent,yes,18,143,3,9,0,G06F16/10;;G06F16/10;;Y10S707/99932;;Y10S707/966;;Y10S707/99952;;Y10S707/99942;;Y10S707/99953;;Y10S707/99956,G06F17/30,707/205;;707/2;;707/10;;707/100;;707/101,2,1,062-154-635-605-144,10.1109/mass.1999.829973,"""The Design and Performance of a Shared Disk File System for IRIX,"" Steve Soltis et al., Sixth NASA Goddard Space Flight Center Conference on Mass Storage and Technologies, Fifteenth IEEE Symposium on Mass Storage Systems, Mar. 23-26, 1998.;;""A 64-Bit, Shared Disk File System for Linux,"" Kenneth W. Preslan et al., Sixteenth IEEE Mass Storage Sys. Symposium, the Seventh NASA Goddard Conference on Mass Storage & Technologies, Mar. 15-18, 1999, San Diego.",EXPIRED
233,US,A,US 4079404 A,179-355-311-500-307,1978-03-14,1978,US 75604276 A,1976-12-30,US 75604276 A,1976-12-30,Self-aligning support structure for optical components,"An optical assembly structure wherein miniature optical components such as lasers, modulators, lenses, thin-film and fiber-optic waveguides, and photodetectors are critically aligned and supported for coactive operation by means of two or more wafers which are formed with complementary grooves and mortises to support the loose optical components such as lenses and fiber-optic waveguides and to receive alignment rails to insure the relativity of the wafers, which also have formed integral therewith optical elements such as waveguides, modulators, and lasers, to produce an integrated optical assembly somewhat in the manner of an ""optical bench,"" wherein the bench structure also provides an active optical element.",IBM,COMERFORD LIAM DAVID;;CROW JOHN DAVID;;LAFF ROBERT ALLAN;;LEAN ERIC GUNG-HWA;;BRADY MICHAEL JOHN,,https://lens.org/179-355-311-500-307,Granted Patent,yes,6,104,8,8,0,G02B6/30;;G02B6/42;;G02B6/423;;G02B6/4249;;H01L27/153;;H01S5/005;;H01S5/4031;;H01S5/02326;;H01S5/02251;;H01S5/005;;H01L27/153;;H01S5/4031;;G02B6/423;;G02B6/42;;G02B6/30;;G02B6/4249;;H01S5/02326;;H01S5/02251,G02B6/12;;G02B6/30;;G02B6/42;;H01L27/15;;H01L33/00;;H01L33/08;;H01L33/30;;H01S5/00;;H01S5/022;;H01S5/042;;H01S5/40,H1K KED           ED,2,0,,,"Weidel, Optics Communication, vol. 12, No. 1, Sept. 1974.;;Electronic Letters, vol. 10, No. 14, July 11, 1974, p. 280.",EXPIRED
234,US,B2,US 7085781 B2,189-526-051-288-35X,2006-08-01,2006,US 72062903 A,2003-11-24,US 72062903 A;;US 30117799 A,1999-04-28,Multi-volume extent based file system,A memory storage device has a file storage operating system which uses an inode to record and find segments of each data file. The inode includes a plurality of rows. A portion of the rows are written with direct extents pointing to data blocks storing portions of file segments. At least two of the extents point to data blocks having addresses in different logical volumes.,EMC CORP,CROW PRESTON F;;MASON JR ROBERT S;;MCCLURE STEVEN T;;NAGY SUSAN C;;WHEELER RICHARD G,EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/189-526-051-288-35X,Granted Patent,yes,16,7,3,9,0,G06F16/10;;G06F16/10;;Y10S707/99932;;Y10S707/966;;Y10S707/99952;;Y10S707/99942;;Y10S707/99953;;Y10S707/99956,G06F17/30,707/201;;707/202;;707/203;;709/217,0,0,,,,EXPIRED
235,JP,A,JP 2000353115 A,024-965-679-958-532,2000-12-19,2000,JP 2000130681 A,2000-04-28,US 30105799 A;;US 30117799 A,1999-04-28,EXTENT BASE FILE SYSTEM HAVING MULTIPURPOSE INDIRECT SPECIFICATION OR MULTIPLE VOLUMES,"PROBLEM TO BE SOLVED: To obtain a more flexible method for extending an existent file by allowing each (i) nodes to have multiple lines and storing extent indicating data blocks in some of the lines. SOLUTION: A physical structure includes directories 61 and 62 and (i) nodes 63 and 64. The directory 61 converts abstract file names and directory names to the physical addresses of the (i) nodes 63 and 64 and directory 62. The (i) nodes 63 and 64 stores a list of extents 65 to 66 wherein successive file segments are mapped to strings of physical data blocks 80 to 82, 84 to 85, and 92 to 94. The physical directories 61 and 62 and (i) nodes 63 and 64 are stored in a global cache memory. Copies of relative physical directories 61 and 62 and/or (i) nodes 63 and 64 are also locally stored in volatile memories of a processor and a driver.",EMC CORP,CROW PRESTON F;;MASON ROBERT S JR;;STEPHEN T MCCLURE;;SUSAN C NAGY;;WHEELER RICHARD G,,https://lens.org/024-965-679-958-532,Patent Application,no,3,8,4,9,0,G06F16/10,G06F12/00;;G06F17/30,,1,0,,,"SWEENEY A. ET AL.: ""Scalability in the XFS File Sytem"", PROCS. OF THE USENIX 1996 ANNUAL TECHNICAL CONFERENCE, JPN4003012754, January 1996 (1996-01-01), US, ISSN: 0000724143",EXPIRED
236,US,B1,US 6895418 B1,020-362-389-215-134,2005-05-17,2005,US 30105799 A,1999-04-28,US 30105799 A,1999-04-28,Versatile indirection in an extent based file system,"A memory storage device has a file storage operating system that uses inodes to access file segments. Each inode has a plurality of rows. A portion of the rows can store extents pointing, directly or indirectly, to data blocks. Each extent has a field to indicate whether the extent is an indirect extent or a direct extent.",EMC CORP,CROW PRESTON F;;MASON JR ROBERT S;;MCCLURE STEVEN T;;NAGY SUSAN C;;WHEELER RICHARD G,EMC CORPORATION (1999-10-19);;EMC IP HOLDING COMPANY LLC (2016-09-06),https://lens.org/020-362-389-215-134,Granted Patent,yes,28,26,2,9,0,G06F16/10;;G06F16/10;;Y10S707/99931;;Y10S707/99956;;Y10S707/99933,G06F17/30,707/205;;707/1;;707/3,4,1,062-154-635-605-144,10.1109/mass.1999.829973,"""The Design and Performance of a Shared Disk File System for IRIX,"" Steve Soltis et al., Sixth NASA Goddard Space Flight Center Conference on Mass Storage and Technologies, Fifteenth IEEE Symposium on Mass Storage Systems, Mar. 23-26, 1998.;;""A 64-Bit, Shared Disk File System for Linux,"" Kenneth W. Preslan et al., Sixteenth IEEE Mass Storage Sys. Symposium, the Seventh NASA Goddard Conference on Mass Storage & Technologies, Mar. 15-18, 1999, San Diego.;;Alexandros Biliris, ""An Efficient Database Storage for Large Dynamic Objects,"" 1992 IEEE, pp. 301-308, Computer science Department, Boston University, Boston, MA, USA.;;Adam Sweeney, ""Scalability in the XFS File System,"" USENIX 1996 Annual Technical Conference, Jan. 1996, 15 pages, San Diego, CA, USA.",EXPIRED
237,US,B2,US 6932157 B2,104-095-859-299-160,2005-08-23,2005,US 79646704 A,2004-03-09,US 79646704 A;;US 92721701 A;;US 80019901 A,2001-03-06,Apparatus and method for treating an interval of a wellbore,"An apparatus ( 60 ) and method for treating an interval of a wellbore comprises an outer tubular ( 62 ) disposed within the wellbore. A sand control screen ( 92 ) is disposed within the outer tubular ( 62 ). A slurry passageway ( 88 ) is formed between the sand control screen ( 92 ) and outer tubular ( 62 ). In addition, a production pathway ( 90 ) is formed between the sand control screen ( 92 ) and outer tubular ( 62 ). When the apparatus ( 60 ) is in an operable position, the region between the outer tubular ( 62 ) and the wellbore serves as a primary path for delivery of a fluid slurry, the production pathway ( 90 ) serves as a secondary path for delivery of the fluid slurry if the primary path becomes blocked and the slurry passageway ( 88 ) serves as a tertiary path for delivery of the fluid slurry if the primary and secondary paths become blocked.",HALLIBURTON ENERGY SERV INC,MCGREGOR RONALD W;;HAILEY JR TRAVIS T;;HENDERSON WILLIAM DAVID;;CROW ROBERT W;;NGUYEN PHILIP D,HALLIBURTON ENERGY SERVICES (2001-08-22),https://lens.org/104-095-859-299-160,Granted Patent,yes,68,20,10,10,0,E21B43/045;;E21B43/045;;E21B43/04;;E21B43/04,E21B43/04,166/278;;166/51;;166/227,7,3,068-598-658-441-918;;159-802-522-515-353;;130-528-674-159-261,10.2118/23741-ms;;10.2118/58775-ms;;10.2118/68205-ms,"Restarick; ""Mechanical Fluid-Loss Control Systems Used During Sand Control Operations""; 1992; pp. 21-36.;;""Sand Control Screens""; Halliburton Energy Services; 1994; 4 pages.;;Ebinger; ""Frac pack technology still evolving""; Oil & Gas Journal; Oct. 23, 1995; pp. 60-70.;;Hailey et al.; ""Screenless Single Trip Multizone Sand Control Tool System Saves Rig Time""; 2000 SPE International Synposium on Formation Damage Control; Feb. 2000; pp. 1-11.;;""CAPS Sand Control Service for Horizontal Completions Improves Gravel Pack Reliability and Increases Production Potential From Horizontal Completions""; Halliburton Energy Services, Inc.; Aug. 2000; 2 pages.;;""CAPS Concentric Annular Packing Service for Sand Control""; Halliburton Energy Services, Inc.; Aug. 2000; 4 pages.;;Saldungaray et al.; ""Simultaneous Gravel Packing and Filter Cake Removal in Horizontal Wells Applying Shunt Tubes and Noval Carrier and Breaker Fluid""; Mar. 2001; pp. 1-6.",EXPIRED
238,US,A1,US 2008/0164640 A1,158-933-678-866-591,2008-07-10,2008,US 65023207 A,2007-01-05,US 65023207 A,2007-01-05,Method of molding a shopping cart,A method of molding a shopping cart component includes providing a first subcomponent and then overmolding the shopping cart component as a second subcomponent about the first subcomponent. The first subcomponent acts as an obstacle to a plastic injection stream and to a gas injection stream during the overmolding of the second component to assist in defining a first hollow section of the shopping cart component adjacent the first subcomponent.,TARGET BRANDS INC,PRUITT DAVID L;;RYAN MARK T;;SHELL CHARLES E;;PEOTA ROBERT D;;CROW KENNETH R;;SAYER MATTHEW E,TARGET BRANDS INC (2006-12-22),https://lens.org/158-933-678-866-591,Patent Application,yes,99,15,2,2,0,B29C45/1704;;B29C45/1704;;B29C45/006;;B29C45/006;;B29C45/14549;;B29C45/14549;;B29C45/1711;;B29C45/1711;;B29C45/2608;;B29C45/2608;;B29L2031/463;;B29L2031/463;;B62B3/1496;;B62B3/1496;;B62B2501/04;;B62B2501/04;;B62B2501/065;;B62B2501/065,B29C45/14,264/513;;264/510;;264/523,0,0,,,,ACTIVE
239,ES,T3,ES 2278300 T3,116-713-465-484-030,2007-08-01,2007,ES 04704832 T,2004-01-23,US 44219203 P,2003-01-24,CARROCERIA MIXTA PARA UN COCHE DE GOLF O VEHICULO DE USOS DIVERSOS.,"Un vehículo (10), que comprende: un bastidor (12); y un conjunto de carrocería mixta (58) montado en el bastidor y configurado de modo que aumenta la rigidez del bastidor, incluyendo el conjunto de carrocería una sección de carrocería delantera (60a) y una sección de carrocería trasera (60b); caracterizado porque: la sección de carrocería delantera (60a) incluye un panel superior (61) y un panel inferior (63) unidos entre sí de modo que forman un armazón de concha de almeja o parecido a una caja en general (62); la sección de carrocería trasera (60b) tiene la forma de una concha (64) con un extremo inferior abierto (57) y una cámara interior (59) delimitada al menos parcialmente; y el conjunto de concha de almeja o parecido a una caja (62) y la concha de carrocería trasera (64) son sujetables independientemente al bastidor (12).",CLUB CAR INC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A,,https://lens.org/116-713-465-484-030,Granted Patent,no,0,0,12,17,0,B62D21/183;;B62D21/183;;B62D29/04;;B60L50/62;;B60L50/62;;B60L50/66;;B60L50/66;;B60L58/21;;B60L58/21;;B60L2200/22;;B60L2200/22;;B62D29/043;;B62D29/043;;B62D31/003;;B62D31/003;;Y02T10/62;;Y02T10/62;;Y02T10/70;;Y02T10/70;;Y02T10/7072,B62D29/04;;A63B55/60,,0,0,,,,EXPIRED
240,US,B2,US 7780902 B2,055-223-996-698-895,2010-08-24,2010,US 65023207 A,2007-01-05,US 65023207 A,2007-01-05,Method of molding a shopping cart,A method of molding a shopping cart component includes providing a first subcomponent and then overmolding the shopping cart component as a second subcomponent about the first subcomponent. The first subcomponent acts as an obstacle to a plastic injection stream and to a gas injection stream during the overmolding of the second component to assist in defining a first hollow section of the shopping cart component adjacent the first subcomponent.,TARGET BRANDS INC,PRUITT JR DAVID L;;RYAN MARK T;;SHELL CHARLES E;;PEOTA ROBERT D;;CROW KENNETH R;;SAYER MATTHEW E,TARGET BRANDS INC (2006-12-22),https://lens.org/055-223-996-698-895,Granted Patent,yes,102,9,2,2,0,B29C45/1704;;B29C45/1704;;B29C45/006;;B29C45/006;;B29C45/14549;;B29C45/14549;;B29C45/1711;;B29C45/1711;;B29C45/2608;;B29C45/2608;;B29L2031/463;;B29L2031/463;;B62B3/1496;;B62B3/1496;;B62B2501/04;;B62B2501/04;;B62B2501/065;;B62B2501/065,B29C49/06,264/544;;264/259;;264/500,17,0,,,"Hoover Universal Brochure, ""Structural Web gives you quality finish at reduced cost."" 1984.;;Dave Anderson et al., ""Structural Web Molding"", A New Development in Low Pressure Smooth Surface Technology, Hoover Universal, pp. 48-56. 1982.;;John Heasman, ""Cinpres-gas-assisted injection molding"", Cinpres Limited, pp. 108-110. Admitted prior art, undated.;;""Cinpress Gas-Injection Case Study"", Cinpress Ltd. Brochure. Admitted prior art, undated.;;Article, ""Nitrojection Process Description and Advantages"", Sajar Plastics, Inc. Admitted prior art, undated.;;""Engineering and Processing News"", Modern Plastics, Mar. 1980, pp. 22, 24.;;Edward Mason, ""Gas Injection Offers New Opportunities"", Canadian Plastics, Nov./Dec. 1988, pp. 42-43.;;""Two Breakthroughs in Smooth Surface Finish for Structural Foam . . . "", Injection Molding News Brief, vol. VIII, No. 43, Oct. 24, 1979.;;Cashiers' Pressure Process, A Revolutionary Development in Structural Foam Molding, Cashiers Plastic, Oct. 1981.;;Steve Ham, ""Structural Plastics, Fundamentals of Structural Plastics"", Plastics Engineering, Jun. 2001, pp. 46-57.;;Article, ""New Structural Form Injection Molding With Swirl-Free Smooth Surface and Uniform Solid Skin"", Asahi-Dow Limited, 1981.;;U.S. Appl. No. 11/231,313, filed Sep. 19, 2005, and entitled ""Seat Assembly for a Shopping Cart"".;;U.S. Appl. No. 11/231,343, filed Sep. 19, 2005, and entitled ""Shopping Cart Handle"".;;U.S. Appl. No. 11/231,344, filed Sep. 19, 2005, and entitled ""Shopping Cart Base"".;;U.S. Appl. No. 11/231,364, filed Sep. 19, 2005, and entitled ""Shopping Cart Basket"".;;U.S. Appl. No. 29/280,573, filed May 31, 2007, and entitled ""Shopping Cart"".;;U.S. Appl. No. 29/296,975, filed Oct. 31, 2007, and entitled ""Shopping Cart"".",ACTIVE
241,US,A1,US 2014/0375542 A1,066-929-043-613-585,2014-12-25,2014,US 201313926322 A,2013-06-25,US 201313926322 A,2013-06-25,ADJUSTING A NEAR-EYE DISPLAY DEVICE,"Embodiments are disclosed herein that relate to aligning a near-eye display of a near-eye display device with an eye of a user. For example, one disclosed embodiment provides, on a near-eye display device, a method comprising receiving an image of an eye from a camera via a reverse display optical path, detecting a location of the eye in the image, and determining a relative position of the eye with regard to a target viewing position of the near-eye display. The method further comprises determining an adjustment to make to the near-eye display device to align the location of the eye with the target viewing position.",ROBBINS STEVE;;MCELDOWNEY SCOTT C;;LOU XINYE;;BOHN DAVID D;;MILLER QUENTIN SIMON CHARLES;;ELDRIDGE JOHN ROBERT;;CROW WILLIAM M,ROBBINS STEVE;;MCELDOWNEY SCOTT C;;LOU XINYE;;BOHN DAVID D;;MILLER QUENTIN SIMON CHARLES;;ELDRIDGE JOHN ROBERT;;CROW WILLIAM M,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2013-06-25),https://lens.org/066-929-043-613-585,Patent Application,yes,2,211,4,4,0,G02B2027/0181;;G02B27/0176;;G06F3/011;;G02B27/0093;;G02B27/0179;;G06F3/013;;G02B27/0179;;G06F3/013;;G06T19/006;;G02B2027/0181;;G02B27/0176;;G06F3/011;;G02B27/0093,G02B27/01;;G06F3/01;;G06T19/00,345/156,0,0,,,,DISCONTINUED
242,CN,A,CN 105393159 A,103-731-482-178-622,2016-03-09,2016,CN 201480036563 A,2014-06-23,US 2014/0043548 W;;US 201313926322 A,2013-06-25,Adjusting a near-eye display device,"Embodiments are disclosed herein that relate to aligning a near- eye display of a near-eye display device with an eye of a user. For example, one disclosed embodiment provides, on a near-eye display device, a method comprising receiving an image of an eye from a camera (200a) via a reverse display optical path, detecting a location of the eye in the image, and determining a relative position of the eye with regard to a target viewing position of the near-eye display. The method further comprises determining an adjustment to make to the near-eye display device to align the location of the eye with the target viewing position.",MICROSOFT CORP,ROBBINS STEVE;;MCELDOWNEY SCOTT C;;LOU XINYE;;BOHN DAVID D;;MILLER QUENTIN SIMON CHARLES;;ELDRIDGE JOHN ROBERT;;CROW WILLIAM M,,https://lens.org/103-731-482-178-622,Patent Application,no,3,67,4,4,0,G02B2027/0181;;G02B27/0176;;G06F3/011;;G02B27/0093;;G02B27/0179;;G06F3/013;;G02B27/0179;;G06F3/013;;G06T19/006;;G02B2027/0181;;G02B27/0176;;G06F3/011;;G02B27/0093,G02B27/01,,0,0,,,,DISCONTINUED
243,EP,A1,EP 3014343 A1,124-028-853-780-901,2016-05-04,2016,EP 14744988 A,2014-06-23,US 201313926322 A;;US 2014/0043548 W,2013-06-25,ADJUSTING A NEAR-EYE DISPLAY DEVICE,,MICROSOFT TECHNOLOGY LICENSING LLC,ROBBINS STEVE;;MCELDOWNEY SCOTT C;;LOU XINYE;;BOHN DAVID D;;MILLER QUENTIN SIMON CHARLES;;ELDRIDGE JOHN ROBERT;;CROW WILLIAM M,,https://lens.org/124-028-853-780-901,Patent Application,yes,0,0,4,4,0,G02B2027/0181;;G02B27/0176;;G06F3/011;;G02B27/0093;;G02B27/0179;;G06F3/013;;G02B27/0179;;G06F3/013;;G06T19/006;;G02B2027/0181;;G02B27/0176;;G06F3/011;;G02B27/0093,G02B27/01,,0,0,,,,DISCONTINUED
244,WO,A1,WO 2014/209820 A1,148-800-682-456-235,2014-12-31,2014,US 2014/0043548 W,2014-06-23,US 201313926322 A,2013-06-25,ADJUSTING A NEAR-EYE DISPLAY DEVICE,"Embodiments are disclosed herein that relate to aligning a near- eye display of a near-eye display device with an eye of a user. For example, one disclosed embodiment provides, on a near-eye display device, a method comprising receiving an image of an eye from a camera (200a) via a reverse display optical path, detecting a location of the eye in the image, and determining a relative position of the eye with regard to a target viewing position of the near-eye display. The method further comprises determining an adjustment to make to the near-eye display device to align the location of the eye with the target viewing position.",MICROSOFT CORP,ROBBINS STEVE;;MCELDOWNEY SCOTT C;;LOU XINYE;;BOHN DAVID D;;MILLER QUENTIN SIMON CHARLES;;ELDRIDGE JOHN ROBERT;;CROW WILLIAM M,,https://lens.org/148-800-682-456-235,Patent Application,yes,3,63,4,4,0,G02B2027/0181;;G02B27/0176;;G06F3/011;;G02B27/0093;;G02B27/0179;;G06F3/013;;G02B27/0179;;G06F3/013;;G06T19/006;;G02B2027/0181;;G02B27/0176;;G06F3/011;;G02B27/0093,G02B27/01,,0,0,,,,PENDING
245,EP,A1,EP 3160247 A1,160-906-857-958-035,2017-05-03,2017,EP 15726972 A,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,,NESTEC SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,SOCIETE DES PRODUITS NESTLE S.A. (2019-07-10),https://lens.org/160-906-857-958-035,Patent Application,yes,0,1,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/12;;A23F5/22;;A23F5/24;;A23F5/28;;A23F5/40,,0,0,,,,ACTIVE
246,MX,A,MX 2016016632 A,034-459-328-871-831,2017-04-27,2017,MX 2016016632 A,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT.,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTEC SA,FEDERICO MORA;;KEVAN ELSBY;;MARIJA SRBLJIN;;ANNETTE MICHELLE BIRCH;;MAURO CAVINATO;;BRUNO CHAVEZ MONTES;;DARREN WILLIAM CROW;;JULIEN DUPAS;;ROBERT WAYNE FUSON,,https://lens.org/034-459-328-871-831,Patent Application,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/22;;A23F5/40,,0,0,,,,PENDING
247,US,B2,US 7243724 B2,160-255-198-355-161,2007-07-17,2007,US 93715204 A,2004-09-07,US 93715204 A;;US 16021602 A;;US 79646704 A;;US 92721701 A;;US 80019901 A,2001-03-06,Apparatus and method for treating an interval of a wellbore,"An apparatus ( 110 ) and method for treating an interval of a wellbore comprises an outer tubular ( 112 ) disposed within the wellbore. A sand control screen ( 118 ) is disposed within the outer tubular ( 112 ). A treatment fluid passageway ( 144 ) is formed between the sand control screen ( 118 ) and outer tubular ( 112 ). In addition, a production pathway ( 130 ) is formed between the sand control screen ( 118 ) and outer tubular ( 112 ). When the apparatus ( 110 ) is in an operable position, the region between the outer tubular ( 112 ) and the wellbore serves as a primary path for delivery of a treatment fluid, the production pathway ( 130 ) serves as a secondary path for delivery of the treatment fluid if the primary path becomes blocked and the treatment fluid passageway ( 144 ) serves as a tertiary path for delivery of the treatment fluid if the primary and secondary paths become blocked.",HALLIBURTON ENERGY SERV INC,MCGREGOR RONALD W;;HAILEY JR TRAVIS T;;HENDERSON WILLIAM DAVID;;CROW ROBERT W;;NGUYEN PHILIP D;;HEJL DAVID A;;GIBSON RONALD A,HALLIBURTON ENERGY SERVICES INC (2004-12-06),https://lens.org/160-255-198-355-161,Granted Patent,yes,71,35,6,6,0,E21B43/088;;E21B43/088;;E21B43/045;;E21B43/045;;E21B43/086;;E21B43/086,E21B43/04;;E21B43/08,166/278;;166/51;;166/227,7,3,068-598-658-441-918;;159-802-522-515-353;;130-528-674-159-261,10.2118/23741-ms;;10.2118/58775-ms;;10.2118/68205-ms,"Restarick; ""Mechanical Fluid-Loss Control Systems Used During Sand Control Operations""; 1992; pp. 21-36.;;""Sand Control Screens""; Halliburton Energy Services; 1994; 4 pages.;;Ebinger; ""Frac pack technology still evolving""; Oil & Gas Journal; Oct. 23, 1995; pp. 60-70.;;Hailey et al.; ""Screenless Single Trip Multizone Sand Control Tool System Saves Rig Time""; 2000 SPE International Synposium on Formation Damage Control; Feb. 2000; pp. 1-11.;;""CAPS Sand Control Service for Horizontal Completions Improves Gravel Pack Reliability and Increases Production Potential From Horizontal Completions""; Halliburton Energy Services, Inc.; Aug. 2000; 2 pages.;;""CAPS Concentric Annular Packing Service for Sand Control""; Halliburton Energy Services, Inc.; Aug. 2000; 4 pages.;;Saldungaray et al.; ""Simultaneous Gravel Packing and Filter Cake Removal in Horizontal Wells Applying Shunt Tubes and Noval Carrier and Breaker Fluid""; Mar. 2001; pp. 1-6.",EXPIRED
248,PH,A1,PH 12016502204 A1,132-010-995-306-96X,2017-01-09,2017,PH 12016502204 A,2016-11-07,US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTEC SA,MICHELLE BIRCH ANNETTE;;MAURO CAVINATO;;BRUNO CHAVEZ MONTES;;WILLIAM CROW DARREN;;JULIEN DUPAS;;KEVAN ELSBY;;WAYNE FUSON ROBERT;;FEDERICO MORA;;MARIJA SRBLJIN,,https://lens.org/132-010-995-306-96X,Patent Application,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/22;;A23F5/20;;A23F5/40,,0,0,,,,ACTIVE
249,NZ,A,NZ 705827 A,131-413-247-467-100,2018-07-27,2018,NZ 70582713 A,2013-09-17,US 2013/0060177 W;;US 201361790432 P;;US 201261702137 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of compounds of Formula (IV). Preferred methods according to the disclosure allow for large-scale preparation of compounds of Formula (IV) having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of compounds of Formula (IV) in better yield than previously used methods for preparing such compounds.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,TAUB REBECCA;;HESTER D;;DUGUID ROBERT;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN;;REYNOLDS CHARLES;;CHOI DUK;;SHU LIANHE;;WANG PING,,https://lens.org/131-413-247-467-100,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,PENDING
250,ES,T3,ES 2795450 T3,008-886-655-604-099,2020-11-23,2020,ES 13837402 T,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,Procedimiento para sintetizar análogos de hormonas tiroideas y polimorfos de los mismos,"Una forma mórfica de 2-(3,5-dicloro-4-((5-isopropil-6-oxo-1,6-dihidropiridazin-3-il)oxi)fenil)-3,5-dioxo-2,3,4,5- tetrahidro-1,2,4-triazina-6-carbonitrilo (""Compuesto A"") (Forma I) caracterizado por un patrón de difracción de rayos X en polvo que incluye picos A aproximadamente 10.5, 18.7, 22.9, 23.6, y 24.7 grados 2θ.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D;;DUGUID ROBERT;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN;;TAUB REBECCA;;REYNOLDS CHARLES;;CHOI DUK;;SHU LIANHE;;WANG PING,,https://lens.org/008-886-655-604-099,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
251,EP,B1,EP 3160247 B1,128-104-781-664-297,2020-04-29,2020,EP 15726972 A,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,,NESTLE SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,SOCIETE DES PRODUITS NESTLE S.A. (2019-07-10),https://lens.org/128-104-781-664-297,Granted Patent,yes,3,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/12;;A23F5/22;;A23F5/24;;A23F5/28;;A23F5/40,,4,3,029-222-563-199-380;;012-971-583-048-433;;038-178-986-207-320,10.1007/s12161-012-9387-5;;10.1007/s00217-014-2293-x;;10.1016/j.anres.2017.01.003,"SIVETZ MICHAEL: ""AROMATIZING SOLUBLE COFFEE"", COFFEE PROCESSING TECHNOLOGY, vol. 2, 1 January 1963 (1963-01-01), pages 27 - 28, XP055981249;;JOSÃ© A. SILVA; NUNO BORGES; ALEJANDRO SANTOS; ARMINDA ALVES: ""Method Validation for Cafestol and Kahweol Quantification in Coffee Brews by HPLC-DAD"", FOOD ANALYTICAL METHODS, SPRINGER-VERLAG, NEW YORK, vol. 5, no. 6, 23 March 2012 (2012-03-23), New York , pages 1404 - 1410, XP035127248, ISSN: 1936-976X, DOI: 10.1007/s12161-012-9387-5;;DIAS RAFAEL CARLOS ELOY, DE FARIA-MACHADO ADELIA FERREIRA, MERCADANTE ADRIANA ZERLOTTI, BRAGAGNOLO NEURA, BENASSI MARTA DE TOLEDO: ""Roasting process affects the profile of diterpenes in coffee"", EUROPEAN FOOD RESEARCH AND TECHNOLOGY, SPRINGER BERLIN HEIDELBERG, BERLIN/HEIDELBERG, vol. 239, no. 6, 1 December 2014 (2014-12-01), Berlin/Heidelberg , pages 961 - 970, XP055981253, ISSN: 1438-2377, DOI: 10.1007/s00217-014-2293-x;;SOMNUK KRIT, EAWLEX PICHAI, PRATEEPCHAIKUL GUMPON: ""Optimization of coffee oil extraction from spent coffee grounds using four solvents and prototype-scale extraction using circulation process"", AGRICULTURE AND NATURAL RESOURCES, vol. 51, no. 3, 1 June 2017 (2017-06-01), pages 181 - 189, XP055942723, ISSN: 2452-316X, DOI: 10.1016/j.anres.2017.01.003",ACTIVE
252,US,A1,US 2018/0206514 A1,195-541-138-082-437,2018-07-26,2018,US 201515320557 A,2015-06-05,US 201515320557 A;;US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTEC SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,NESTEC S.A (2014-07-08);;SOCIÉTÉ DES PRODUITS NESTLÉ S.A (2019-05-28),https://lens.org/195-541-138-082-437,Patent Application,yes,0,2,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/12;;A23F5/24;;A23F5/28;;A23F5/36;;A23F5/48,,0,0,,,,DISCONTINUED
253,HU,T2,HU E051152 T2,067-161-980-416-624,2021-03-01,2021,HU E15726972 A,2015-06-05,US 201462018234 P,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,,NESTLE SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/067-161-980-416-624,Amended Patent,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/12;;A23F5/22;;A23F5/24;;A23F5/28;;A23F5/40,,0,0,,,,PENDING
254,WO,A1,WO 2015/197340 A1,098-794-564-806-134,2015-12-30,2015,EP 2015062556 W,2015-06-05,US 201462018234 P,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTEC SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/098-794-564-806-134,Patent Application,yes,4,11,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/22;;A23F5/40,,1,0,,,"BELITZ H D, GROSCH W, SHIEBERLE P: ""Food Chemistry"", 15 January 2009, SPRINGER, Leipzig, ISBN: 978-3-540-69935-4, pages: 942 - 943, XP002745133, DOI: 10.1007/978-3-540-69934-7",PENDING
255,CA,C,CA 2949183 C,136-534-203-349-260,2021-10-19,2021,CA 2949183 A,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTEC SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/136-534-203-349-260,Granted Patent,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/24;;A23F5/20;;A23F5/36;;A23F5/40,,0,0,,,,ACTIVE
256,ES,T3,ES 2793902 T3,118-133-736-253-173,2020-11-17,2020,ES 15726972 T,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,Composición de bebida de café y procedimiento para la producción de ésta,"Una composición de bebida de café, la cual comprende i) por lo menos 10 %, en peso, de partículas de granos de café tostados; y ii) por lo menos 30 %, en peso, de sólidos solubles de café, extraídos de granos de café tostados; en donde, la composición, comprende menos de 1,2 mg de diterpenos, por g de sólidos de café.",NESTLE SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/118-133-736-253-173,Granted Patent,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/12;;A23F5/22;;A23F5/24;;A23F5/28;;A23F5/40,,0,0,,,,ACTIVE
257,AU,A1,AU 2015/281228 A1,164-495-377-244-932,2016-11-17,2016,AU 2015/281228 A,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,Coffee beverage composition and method of producing it,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTEC SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,SOCIETE DES PRODUITS NESTLE S.A. (2019-07-18),https://lens.org/164-495-377-244-932,Patent Application,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/22;;A23F5/40,,0,0,,,,INACTIVE
258,KR,A,KR 20170020767 A,138-055-923-242-669,2017-02-24,2017,KR 20167034493 A,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,"본 발명은 가용성 커피 고형물 및 로스팅된 커피 콩의 입자를 포함하고, 거품(scum)의 형성이 감소되고 다이테르펜 함량이 낮은 커피 음료 조성물에 관한 것이다. 본 발명은 또한 로스팅된 커피 콩의 입자의 슬러리로부터 오일을 제거함으로써 그러한 커피 음료 조성물을 생성하는 방법에 관한 것이다.",NESTEC SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/138-055-923-242-669,Patent Application,no,3,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/22;;A23F5/40,,0,0,,,,ACTIVE
259,AU,B2,AU 2015/281228 B2,128-150-837-327-511,2018-11-22,2018,AU 2015/281228 A,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,Coffee beverage composition and method of producing it,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTLE SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,SOCIETE DES PRODUITS NESTLE S.A. (2019-07-18),https://lens.org/128-150-837-327-511,Granted Patent,no,4,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/22;;A23F5/40,,0,0,,,,INACTIVE
260,CA,A1,CA 2949183 A1,149-187-287-645-988,2015-12-30,2015,CA 2949183 A,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTEC SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/149-187-287-645-988,Patent Application,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/24;;A23F5/20;;A23F5/36;;A23F5/40,,0,0,,,,ACTIVE
261,PL,T3,PL 3160247 T3,059-766-405-281-841,2020-11-02,2020,PL 15726972 T,2015-06-05,US 201462018234 P;;EP 15726972 A;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,,NESTLE SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/059-766-405-281-841,Patent Application,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/12;;A23F5/22;;A23F5/24;;A23F5/28;;A23F5/40,,0,0,,,,PENDING
262,US,A1,US 2020/0170277 A1,123-057-053-187-807,2020-06-04,2020,US 202016784974 A,2020-02-07,US 202016784974 A;;US 201615320557 A;;EP 2015062556 W;;US 201462018234 P,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTLE SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/123-057-053-187-807,Patent Application,yes,1,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/12;;A23F5/20;;A23F5/22;;A23F5/24;;A23F5/28;;A23F5/36;;A23F5/40;;A23F5/48,,1,1,133-715-118-411-676,10.1021/jf9700900,"Roos, “Levels of Cafestol, kahweol, and related diterpenoids in wild species of the coffee plant coffea”, J. Agric. Food. Chem., 1997, 45, 3065-3069 (Year: 1997)",DISCONTINUED
263,ZA,B,ZA 201700659 B,135-746-529-419-992,2018-12-19,2018,ZA 201700659 A,2017-01-26,US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,,NESTEC SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/135-746-529-419-992,Granted Patent,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,,,0,0,,,,ACTIVE
264,PH,B1,PH 12016502204 B1,184-072-233-616-38X,2017-01-09,2017,PH 12016502204 A,2016-11-07,US 201462018234 P;;EP 2015062556 W,2014-06-27,COFFEE BEVERAGE COMPOSITION AND METHOD OF PRODUCING IT,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,SOCIT DES PRODUITS NESTL S A,DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA;;BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM,,https://lens.org/184-072-233-616-38X,Granted Patent,no,0,0,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/20;;A23F5/22;;A23F5/40,,0,0,,,,ACTIVE
265,US,A1,US 2005/0103494 A1,149-787-685-478-053,2005-05-19,2005,US 93715204 A,2004-09-07,US 93715204 A;;US 16021602 A;;US 79646704 A;;US 92721701 A;;US 80019901 A,2001-03-06,Apparatus and method for treating an interval of a wellbore,"An apparatus ( 110 ) and method for treating an interval of a wellbore comprises an outer tubular ( 112 ) disposed within the wellbore. A sand control screen ( 118 ) is disposed within the outer tubular ( 112 ). A treatment fluid passageway ( 144 ) is formed between the sand control screen ( 118 ) and outer tubular ( 112 ). In addition, a production pathway ( 130 ) is formed between the sand control screen ( 118 ) and outer tubular ( 112 ). When the apparatus ( 110 ) is in an operable position, the region between the outer tubular ( 112 ) and the wellbore serves as a primary path for delivery of a treatment fluid, the production pathway ( 130 ) serves as a secondary path for delivery of the treatment fluid if the primary path becomes blocked and the treatment fluid passageway ( 144 ) serves as a tertiary path for delivery of the treatment fluid if the primary and secondary paths become blocked.",MCGREGOR RONALD W.;;HAILEY TRAVIS T.JR.;;HENDERSON WILLIAM D.;;CROW ROBERT W.;;NGUYEN PHILIP D.;;HEJL DAVID A.;;GIBSON RONALD A.,MCGREGOR RONALD W;;HAILEY TRAVIS T JR;;HENDERSON WILLIAM D;;CROW ROBERT W;;NGUYEN PHILIP D;;HEJL DAVID A;;GIBSON RONALD A,HALLIBURTON ENERGY SERVICES INC (2004-12-06),https://lens.org/149-787-685-478-053,Patent Application,yes,65,7,6,6,0,E21B43/088;;E21B43/088;;E21B43/045;;E21B43/045;;E21B43/086;;E21B43/086,E21B43/04;;E21B43/08,166/276;;166/278,0,0,,,,EXPIRED
266,CN,A,CN 106413415 A,150-886-717-621-555,2017-02-15,2017,CN 201580033166 A,2015-06-05,US 201462018234 P;;EP 2015062556 W,2014-06-27,Coffee beverage composition and method of producing it,The present invention relates to coffee beverage compositions comprising soluble coffee solids and particles of roast coffee beans and with reduced formation of scum and a low content diterpenes. The invention further relates to methods of producing such coffee beverage compositions by removal of oil from a slurry of particles of roast coffee beans.,NESTEC SA,BIRCH ANNETTE MICHELLE;;CAVINATO MAURO;;CHAVEZ MONTES BRUNO;;CROW DARREN WILLIAM;;DUPAS JULIEN;;ELSBY KEVAN;;FUSON ROBERT WAYNE;;MORA FEDERICO;;SRBLJIN MARIJA,,https://lens.org/150-886-717-621-555,Patent Application,no,3,6,21,21,0,A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483;;A23F5/20;;A23F5/22;;A23F5/405;;A23F5/20;;A23F5/24;;A23F5/20;;A23F5/405;;A23F5/22;;A23F5/12;;A23F5/243;;A23F5/28;;A23F5/36;;A23F5/483,A23F5/22;;A23F5/20;;A23F5/40,,0,0,,,,DISCONTINUED
267,NZ,A,NZ 746298 A,146-176-608-319-276,2019-11-29,2019,NZ 74629813 A,2013-09-17,US 201361790432 P;;US 201261702137 P;;NZ 73964513 A,2012-09-17,Hydrates of a phenoxypyridazinone compound and its use in the manufacture of a medicament for treating a disease characterized by resistance to thyroid hormone,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound such as 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile, wherein the morphic form is a dihydrate.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,TAUB REBECCA;;HESTER II D;;DUGUID ROBERT;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN;;REYNOLDS CHARLES;;CHOI DUK;;SHU LIANHE;;WANG PING,,https://lens.org/146-176-608-319-276,Patent Application,no,0,0,2,92,0,,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,PENDING
268,NZ,A,NZ 746295 A,085-675-097-719-950,2019-11-29,2019,NZ 74629513 A,2013-09-17,US 201361790432 P;;US 201261702137 P;;NZ 73964513 A,2012-09-17,Use of compounds of formula (iv) in the manufacture of a medicament for treating thyroid hormone resistance-associated diseases,"The disclosure describes methods of synthesis of phenoxypyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of phenoxypyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of phenoxypyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed is use of a pharmaceutical composition in the manufacture of a medicament for treating a resistance to thyroid hormone (RTH) syndrome in a subject having at least one TRβ mutation, wherein the pharmaceutical composition comprises a therapeutically effective amount of a compound of Formula (IV) wherein: R3 is H or CH2Ra, in which Ra is hydroxyl, O-linked amino acid, -OP(O)(OH)2, or –OC(O)-Rb, Rb being lower alkyl, alkoxy, alkyl acid, or cycloalkyl ; and R4 and R5 together are –N=C(Rc)-C(O)-NH-C(O)-, in which Rc is H or cyano.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,TAUB REBECCA;;HESTER II D;;DUGUID ROBERT;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN;;REYNOLDS CHARLES;;CHOI DUK;;SHU LIANHE;;WANG PING,,https://lens.org/085-675-097-719-950,Patent Application,no,0,0,2,92,0,,C07D237/16;;A61K31/50;;A61K31/501;;A61K31/53;;A61P3/00;;A61P9/00;;C07D253/075,,0,0,,,,PENDING
269,NZ,A,NZ 739645 A,199-358-805-864-249,2019-11-29,2019,NZ 73964513 A,2013-09-17,US 201361790432 P;;US 201261702137 P;;NZ 70582713 A,2012-09-17,"Form i of compound a, process for its preparation, and its use in the manufacture of a medicament for treating thyroid hormone resistance-associated diseases","The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile (Compound A) characterized by an X-ray powder diffraction pattern including peaks at about 10.5, 18.7, 22.9, 23.6, and 24.7 degrees 2theta (Form I).",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,TAUB REBECCA;;HESTER II D;;DUGUID ROBERT;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN;;REYNOLDS CHARLES;;CHOI DUK;;SHU LIANHE;;WANG PING,,https://lens.org/199-358-805-864-249,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,PENDING
270,US,B2,US 11564926 B2,020-495-257-491-654,2023-01-31,2023,US 202017118706 A,2020-12-11,US 202017118706 A;;US 201916458546 A;;US 201815949389 A;;US 201615046213 A;;US 201514660720 A;;US 2013/0060177 W;;US 201361790432 P;;US 201261702137 P,2012-09-17,Methods of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRβ mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;SHU LIANHE;;WANG PING;;CHOI DUK SOON,HOFFMANN-LA ROCHE INC (2012-11-17);;MADRIGAL PHARMACEUTICALS INC (2012-11-07),https://lens.org/020-495-257-491-654,Granted Patent,yes,32,1,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D403/02;;A61K31/50;;A61K31/53;;A61P5/14;;A61P9/00;;C07D237/16;;C07D403/12,,47,26,081-667-731-762-433;;035-367-852-415-419;;082-744-081-822-600;;009-214-187-079-899;;104-949-654-022-72X;;166-143-853-315-126;;021-857-858-225-644;;142-439-245-598-072;;017-700-622-181-294;;019-689-720-157-368;;026-723-236-497-862;;039-591-418-755-180;;080-636-950-072-485;;022-650-445-609-672;;030-909-232-481-425;;084-321-121-872-388;;006-610-750-633-787;;099-106-609-212-167;;068-451-226-147-815;;012-764-770-334-062;;009-730-437-685-316;;058-516-586-238-384;;183-744-569-999-823;;071-009-695-708-220;;034-544-272-906-295;;059-316-954-811-923,10.1016/s0140-6736(19)32517-6;;31727409;;10.1021/ar50080a006;;24637413;;10.1016/j.atherosclerosis.2014.02.021;;10.1023/a:1016241927429;;7494814;;10.1007/3-540-69178-2_5;;10.1016/s0168-8278(18)30292-7;;10.1002/3527607889.ch1;;12554782;;10.1210/me.2002-0095;;22512468;;10.1021/jm2004706;;23331062;;10.2174/18722113113079990009;;8325251;;10.1210/er.14.2.184;;10.1210/edrv-14-2-184;;21473875;;10.1016/j.steroids.2011.03.016;;pmc3129395;;pmc4750486;;25475361;;10.1038/nrd4461;;23956253;;10.1093/eurheartj/eht273;;pmc3844152;;21453273;;pmc3110519;;10.2174/138920011795495321;;8319599;;10.1210/edrv-14-3-348;;10.1210/er.14.3.348;;14962581;;10.1016/j.addr.2003.10.005;;10514356;;10.1021/js980403l;;10.1021/bi0482349;;15779888;;10.1021/cg060838j;;10.1021/ja01146a531;;10.1210/mend.15.3.0608;;10.1210/me.15.3.398;;11222741;;17154085;;11456736;;10.1021/ja003442j;;10.1152/physrev.2001.81.3.1097;;11427693;;10.1056/nejmoa0804381;;pmc2774225;;19657112,"Harrison, S.A. et al., “Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicenter, randomized, double-blind, placebo-controlled, phase 2 trial.” Lancet, Nov. 30, 2019, 394(10213), 2012-2014, 1-31, doi: 10.1016/S0140-6736(19)32517-6.;;Abel et. al., “Divergent roles for thyroid hormone receptor β isoforms in the endocrine axis and auditory system”, J. Clin. Invest. vol. 104, p. 291-300 (1999).;;Ashby, E. C. et al., “Mechanisms of Grignard reagent addition to ketones”, Acc. Chem. Res.; 7:272-280. (1974).;;Adams M. et al., “Genetic Analysis of 29 Kindreds with Generalized and Pituitary Resistance to Thyroid Hormone Identification of Thirteen Novel Mutations in the Thyroid Hormone Receptor β Gene,” J. Clin. Invest., vol. 94, p. 506-515 (1994).;;Ashizawa, K. “Physico-Chemical Studies on the Molecular Details of Drug Crystals”, Pharm Tech Japan, vol. 18, No. 10, p. 81-96 (2002).;;Beliard, S. et al. “Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects”, Atherosclerosis. May 2014;234(1):136-41.;;Byrn S. et al. Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations, Pharmaceutical Research, vol. 12, No. 7, p. 945-954 (1995).;;Caira M. R. “Crystalline Polymorphism of Organic Compounds”, Topics in Current Chemistry, vol. 198, p. 163-208 (1998).;;Charushin, V. et al. “Six-membered Rings with Three or more Heteroatoms, and their Fused Carbocyclic Derivatives”, 9.02, Comprehensive Heterocyclic Chemistry III (2008).;;Gloss, B. et. al. “Cardiac Ion Channel Expression and Contractile Function in Mice with Deletion of Thyroid Hormone Receptor α or β”, Endocrinology, vol. 142, p. 544-550 (2001).;;Goldfuss, B., “Organolithiums in Enantioselective Additions to π* and σ* Carbon-Oxygen Electrophiles”, Synthesis; (14): 2271-2280 (2005).;;Hara, Y., et al. “Thyroid hormone resistance”, Japanese Journal of Clinical Medicine, Syndrome by Reqion Series (1) Endocrine Syndrome (First volume): 254-257 (1993).;;Harrison, S. et al. “MGL-3196, a selective thyroid hormone receptor-beta agonist, significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study”; Madrigal Pharmaceuticals (Apr. 2018).;;Hickey, D. M. B. et al., “Synthesis of Thyroid Hormone Analogues”. 1-51 Part 3. Iodonium Salt Approaches to SK&F L-94901, J. Chem. Soc., p. 3103-3111 (1988).;;Hilfiker, R. et al. “Relevance of Solid-State Properties for Pharmaceutical Products”, Polymorphism in the Pharmaceutical Industry, Wiley-VCH: (Jan. 1-19, 2006).;;Huber B. R. et al. “Two Resistance to Thyroid Hormone Mutants with Impaired Hormone Binding” Molecular Endocrinology, vol. 17, No. 4, p. 643-652 (2003).;;Huber B. R. et al., “Thyroid Hormone Receptor-β Mutations Conferring Hormone Resistance and Reduced Corepressor Release Exhibit Decreased Stability in the N-terminal Ligand-Binding Domain,” Molecular Endocrinology, vol. 17, No. 1, p. 107-116 (2003).;;Johansson, C. et. al., “Evidence that decreased heart rate in thyroid hormone receptor-βl-deficient mice is an intrinsic defect”, Am. J. Physiol., vol. 275, p. R640-R646 (1998).;;Johatapurkar A. et al., “Selective Thyromimetics Using Receptor and Tissue Selectivity Approaches: Prospects for Dyslipidemia,” J. Med. Chem. vol. 55, No. 12, p. 5649-5675 (2012).;;JP 56015272, Feb. 14, 1981; CA 94 208901, 1981. CAPLUS Abstract.;;Kawaguti, Y. et al., “Drug and crystal polymorphism”, Journal of Human Environmental Engineering, vol. 4, No. 2, p. 310-317 (2002).;;Kelly, M. J. et al. “Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia”, J Med Chem., 57(10):3912-23 (May 22, 2014).;;Kumar, S. et al., “Pharmaceutical Solid Dispersion Technology: A Strategy to Improve Dissolution of Poorly Water-Soluble Drugs”, Recent Patents on Drug Delivery & Formulation, 7(2):111-121 (May 2013).;;Lazar, M.A. “Thyroid hormone receptors: multiple forms, multiple possibilities”, Endocrine Reviews, vol. 14, No. 2, p. 184-193 (1993).;;Lu, C. et al., “Steroids: Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis.” 76(9):885-91 (2001).;;Nigam, S. K. et al. “What do drug transporters really do?”, Nat Rev Drug Discov. Jan. 2015;14(1):29-44.;;Nordestgaard, B. G. et al., “Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society”, Eur Heart J. Dec. 2013;34(45):3478-90.;;Office Action dated Jun. 27, 2017 for Japanese Patent Application No. JP2015-532148: 10 pages.;;Office Action dated Sep. 10, 2019 for Japanese Patent Application No. JP2018-217045: 9 pages.;;Ooshima, Hiroshi Crystallization of Polymorphs and Pseudo-polymorphs and Its Control, Pharm Stage, vol. 6, No. 10, p. 48-53 (2007).;;Pinto, N. et al. “Clinically relevant genetic variations in drug metabolizing enzymes”, Curr Drug Metab. Jun. 2011;12(5):487-97.;;Refetoff, S. “The Syndromes of Resistance to Thyroid Hormone”, Endocrine Reviews, vol. 14, No. 3, p. 348-399 (1993).;;Rodríguez-Spong B. et al. , “General principles of pharmaceutical solid polymorphism: a supramolecular perspective”, Adv Drug Deliv Rev.;56(3):241-274 (2004).;;Serajuddin, A. T., “Solid Dispersion of Poorly Water-Soluble Drugs: Early Promises, Subsequent Problems, and Recent Breakthrouqhs”, J Pharm Sci.; 88(10):1058-66 (Oct. 1999).;;Shi et al., “Mutant-Selective Thyromimetics for the Chemical Rescue of Thyroid Hormone Receptor Mutants Associated with Resistance to Thyroid Hormone”, Biochemistry 44, p. 4612-4626 (2005).;;Stahly, G. Patrick “Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals. Crystal Growth & Design” vol. 7 (6), pp. 1007-1026; (2007).;;Swain, C. G. et al. “The Mechanism of Addition of Grignard Reagents to Ketones”, J. Am. Chem. Soc.; 73(2):870-872 (1951).;;Takata, Noriyuki API form screening and selection in drug discovery stage, Pharm Stage, vol. 6, No. 10, p. 20-25 (2007).;;Taub R. et al. “Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-tarqeted thyroid hormone receptor-β agonist”, Atherosclerosis. Oct. 2013;230(2):373-80.;;Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products, PMSB/ELD Notification No. 568, 45 pages (2001).;;Wagner R. et al., “Hormone Selectivity in Thyroid Hormone Receptors,” Molecular Endocrinology, vol. 15, No. 3, p. 398-410 (2001).;;Weiss R.E. et al. “Resistance to Thyroid Hormone (RTH) in the Absence of Abnormal Thyroid Hormone Receptor (TR) (nonTR-RTH),” Hot Thyroidology Sep. 2009, 11 pages (2009).;;Yamada, M., “Resistance to thyroid hormone”, Nihon Rinsho, 64(12): 2237-42 (Dec. 2006).;;Yamano, M. “Approach to Crystal Polymorph in Process Research of New Drug”, Journal of Synthetic Organic Chemistry, vol. 65, No. 9, p. 907-913 (2007).;;Ye, H. F. et al., “A Subtype-Selective Thyromimetic Designed to Bind a Mutant Thyroid Hormone Receptor Implicated in Resistance to Thyroid Hormone”, J Am Chem Soc, 123(7):1521-2 (Feb. 21, 2001).;;Yen, Paul M. “Physiological and Molecular Basis of Thyroid Hormone Action”, Physiological reviews, vol. 81, No. 3, p. 1097-1142 (2001).;;Ding, E.L., et al., “Sex hormone-binding globulin and risk of type 2 diabetes in women and men,” New England Journal of Medicine, Sep. 2009, 361(12): 1152-1163.",ACTIVE
271,US,B2,US 10894050 B2,141-386-381-471-823,2021-01-19,2021,US 201916458546 A,2019-07-01,US 201916458546 A;;US 201815949389 A;;US 201615046213 A;;US 201514660720 A;;US 2013/0060177 W;;US 201361790432 P;;US 201261702137 P,2012-09-17,Methods of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRβ mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;SHU LIANHE;;WANG PING;;CHOI DUK SOON,HOFFMANN-LA ROCHE INC (2012-11-17);;MADRIGAL PHARMACEUTICALS INC (2012-11-07),https://lens.org/141-386-381-471-823,Granted Patent,yes,23,2,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61K31/53;;A61P5/14;;A61P9/00;;C07D403/02;;C07D403/12,,46,23,009-214-187-079-899;;104-949-654-022-72X;;142-439-245-598-072;;017-700-622-181-294;;026-723-236-497-862;;039-591-418-755-180;;084-321-121-872-388;;068-451-226-147-815;;012-764-770-334-062;;009-730-437-685-316;;058-516-586-238-384;;034-544-272-906-295;;035-367-852-415-419;;082-744-081-822-600;;019-689-720-157-368;;080-636-950-072-485;;022-650-445-609-672;;030-909-232-481-425;;099-106-609-212-167;;183-744-569-999-823;;071-009-695-708-220;;166-143-853-315-126;;006-610-750-633-787,10.1023/a:1016241927429;;7494814;;10.1007/3-540-69178-2_5;;12554782;;10.1210/me.2002-0095;;22512468;;10.1021/jm2004706;;8325251;;10.1210/er.14.2.184;;10.1210/edrv-14-2-184;;21473875;;10.1016/j.steroids.2011.03.016;;pmc3129395;;8319599;;10.1210/edrv-14-3-348;;10.1210/er.14.3.348;;10.1021/bi0482349;;15779888;;10.1021/cg060838j;;10.1021/ja01146a531;;10.1210/mend.15.3.0608;;10.1210/me.15.3.398;;11222741;;10.1152/physrev.2001.81.3.1097;;11427693;;10.1021/ar50080a006;;24637413;;10.1016/j.atherosclerosis.2014.02.021;;23331062;;10.2174/18722113113079990009;;pmc4750486;;25475361;;10.1038/nrd4461;;23956253;;10.1093/eurheartj/eht273;;pmc3844152;;21453273;;pmc3110519;;10.2174/138920011795495321;;10514356;;10.1021/js980403l;;17154085;;11456736;;10.1021/ja003442j;;10.1016/s0168-8278(18)30292-7;;14962581;;10.1016/j.addr.2003.10.005,"JPS5615272,Feb. 14, 1981;English Translationfrom EPO site,Sep. 14, 2019.;;JP 56015272, Feb. 14, 1981; CA 94 208901,1981. CAPLUS Abstract.;;Abel et. al., “Divergent roles for thyroid hormone receptor β isoforms in the endocrine axis and auditory system”, J. Clin. Invest. vol. 104, p. 291-300 (1999).;;Adams M. et al., “Genetic Analysis of 29 Kindreds with Generalized and Pituitary Resistance to Thyroid Hormone Identification of Thirteen Novel Mutations in the Thyroid Hormone Receptor β Gene,” J. Clin. Invest., vol. 94, p. 506-515 (1994).;;Ashizawa, K. “Physico-Chemical Studies on the Molecular Details of Drug Crystals”, Pharm Tech Japan, vol. 18, No. 10, p. 81-96 (2002).;;Byrn S. et al. Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations, Pharmaceutical Research, vol. 12, No. 7, p. 945-954 (1995).;;Caira M. R. “Crystalline Polymorphism of Organic Compounds”, Topics in Current Chemistry, vol. 198, p. 163-208 (1998).;;Charushin, V. et al. “Six-membered Rings with Three or more Heteroatoms, and their Fused Carbocyclic Derivatives”, 9.02, Comprehensive Heterocyclic Chemistry III (2008).;;Gloss, B. et. al. “Cardiac Ion Channel Expression and Contractile Function in Mice with Deletion of Thyroid Hormone Receptor α or β”, Endocrinology, vol. 142, p. 544-550 (2001).;;Goldfuss, B., “Organolithiums in Enantioselective Additions to π* and σ* Carbon-Oxygen Electrophiles”, Synthesis; (14): 2271-2280 (2005).;;Hickey, D. M. B. et al., “Synthesis of Thyroid Hormone Analogues. 1-51 Part 3. Iodonium Salt Approaches to SK&F L-94901,” J. Chem. Soc., p. 3103-3111 (1988).;;Huber B. R. et al. “Two Resistance to Thyroid Hormone Mutants with Impaired Hormone Binding” Molecular Endocrinology, vol. 17, No. 4, p. 643-652 (2003).;;Huber B. R. et al., “Thyroid Hormone Receptor-β Mutations Conferring Hormone Resistance and Reduced Corepressor Release Exhibit Decreased Stability in the N-terminal Ligand-Binding Domain,” Molecular Endocrinology, vol. 17, No. 1, p. 107-116 (2003).;;Johansson, C. et. al., “Evidence that decreased heart rate in thyroid hormone receptor-α1-deficient mice is an intrinsic defect”, Am. J. Physiol., vol. 275, p. R640-R646 (1998).;;Johatapurkar A. et al., “Selective Thyromimetics Using Receptor and Tissue Selectivity Approaches: Prospects for Dyslipidemia,” J. Med. Chem. vol. 55, No. 12, p. 5649-5675 (2012).;;Kawaguti, Y. et al., “Drug and crystal polymorphism”, Journal of Human Environmental Engineering, vol. 4, No. 2, p. 310-317 (2002).;;Lazar, M.A. “Thyroid hormone receptors: multiple forms, multiple possibilities”, Endocrine Reviews, vol. 14, No. 2, p. 184-193 (1993).;;Lu, C. et al., “Steroids: Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis.” 76(9):885-91 (2001).;;Ooshima, Hiroshi Crystallization of Polymorphs and Pseudo-polymorphs and Its Control, Pharm Stage, vol. 6, No. 10, p. 48-53 (2007).;;Refetoff, S. “The Syndromes of Resistance to Thyroid Hormone”, Endocrine Reviews, vol. 14, No. 3, p. 348-399 (1993).;;Shi et al., “Mutant-Selective Thyromimetics for the Chemical Rescue of Thyroid Hormone Receptor Mutants Associated with Resistance to Thyroid Hormone”, Biochemistry 44, p. 4612-4626 (2005).;;Stahly, G. Patrick “Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals. Crystal Growth & Design” vol. 7 (6), pp. 1007-1026; (2007).;;Swain, C. G. et al. “The Mechanism of Addition of Grignard Reagents to Ketones”, J. Am. Chem. Soc.; 73(2):870-872 (1951).;;Takata, Noriyuki API form screening and selection in drug discovery stage, Pharm Stage, vol. 6, No. 10, p. 20-25 (2007).;;Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products, PMSB/ELD Notification No. 568, 45 pages (2001).;;Wagner R. et al., “Hormone Selectivity in Thyroid Hormone Receptors,” Molecular Endocrinology, vol. 15, No. 3, p. 398-410 (2001).;;Weiss R.E. et al. “Resistance to Thyroid Hormone (RTH) in the Absence of Abnormal Thyroid Hormone Receptor (TR) (nonTR-RTH),” Hot Thyroidology Sep. 2009, 11 pages (2009).;;Yamano, M. “Approach to Crystal Polymorph in Process Research of New Drug”, Journal of Synthetic Organic Chemistry, vol. 65, No. 9, p. 907-913 (2007).;;Yen, Paul M. “Physiological and Molecular Basis of Thyroid Hormone Action”, Physiological reviews, vol. 81, No. 3, p. 1097-1142 (2001).;;Ashby, E. C. et al., “Mechanisms of Grignard reagent addition to ketones”, Acc. Chem. Res.; 7:272-280. (1974).;;Beliard, S. et al. “Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects”, Atherosclerosis. May 2014;234(1):136-41.;;Hara, Y., et al. “Thyroid hormone resistance”, Japanese Journal of Clinical Medicine, Syndrome by Region Series (1) Endocrine Syndrome (First volume): 254-257 (1993).;;Hilfiker, R. et al. “Relevance of Solid-State Properties for Pharmaceutical Products”, Polymorphism in the Pharmaceutical Industry, Wiley-VCH: 1-19 (Jan. 2006).;;Kelly, M. J. et al. “Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia”, J Med Chem., 57(10):3912-23 (May 22, 2014).;;Kumar, S. et al., “Pharmaceutical Solid Dispersion Technology: A Strategy to Improve Dissolution of Poorly Water-Soluble Drugs”, Recent Patents on Drug Delivery & Formulation, 7(2):111-121 (May 2013).;;Nigam, S. K. et al. “What do drug transporters really do?”, Nat Rev Drug Discov. Jan. 2015;14(1):29-44.;;Nordestgaard, B. G. et al., “Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society”, Eur Heart J. Dec. 2013;34(45):3478-90.;;Office Action dated Jun. 27, 2017 for Japanese Patent Application No. JP2015-532148: 10 pages.;;Office Action dated Sep. 10, 2019 for Japanese Patent Application No. JP2018-217045: 9 pages.;;Pinto, N. et al. “Clinically relevant genetic variations in drug metabolizing enzymes”, Curr Drug Metab. Jun. 2011;12(5):487-97.;;Serajuddin, A. T., “Solid Dispersion of Poorly Water-Soluble Drugs: Early Promises, Subsequent Problems, and Recent Breakthroughs”, J Pharm Sci.; 88(10):1058-66 (Oct. 1999).;;Taub R. et al. “Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist”, Atherosclerosis. Oct. 2013;230(2):373-80.;;Yamada, M., “Resistance to thyroid hormone”, Nihon Rinsho, 64(12): 2237-42 (Dec. 2006).;;Ye, H. F. et al., “A Subtype-Selective Thyromimetic Designed to Bind a Mutant Thyroid Hormone Receptor Implicated in Resistance to Thyroid Hormone”, J Am Chem Soc, 123(7):1521-2 (Feb. 21, 2001).;;Harrison, S. et al. “MGL-3196, a selective thyroid hormone receptor-beta agonist, significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study”; Madrigal Pharmaceuticals (Apr. 2018).;;Rodríguez-Spong B. et al. , “General principles of pharmaceutical solid polymorphism: a supramolecular perspective”, Adv Drug Deliv Rev.;56(3):241-274 (2004).",ACTIVE
272,US,B2,US 9266861 B2,088-951-185-823-042,2016-02-23,2016,US 201514660720 A,2015-03-17,US 201514660720 A;;US 2013/0060177 W;;US 201261702137 P;;US 201361790432 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRβ mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,HOFFMANN-LA ROCHE INC (2012-11-17);;MADRIGAL PHARMACEUTICALS INC (2012-11-07),https://lens.org/088-951-185-823-042,Granted Patent,yes,6,12,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D403/12;;A61K31/50;;A61K31/53;;C07D237/16;;C07D403/02,,6,6,004-679-778-054-368;;038-009-293-044-058;;027-413-551-226-491;;142-439-245-598-072;;017-700-622-181-294;;058-516-586-238-384,10.1172/jci117362;;8040303;;pmc296123;;10.1039/p19880003103;;12511610;;10.1210/me.2002-0097;;12554782;;10.1210/me.2002-0095;;22512468;;10.1021/jm2004706;;10.1210/mend.15.3.0608;;10.1210/me.15.3.398;;11222741,"M. Adams, et al., ""Genetic Analysis of 29 Kindreds with Generalized and Pituitary Resistance to Thyroid Hormone Identification of Thirteen Novel Mutations in the Thyroid Hormone Receptor beta Gene,"" J. Clin. Invest. 94:506-515 (1994).;;Deirdre M. B. Hickey et al., ""Synthesis of Thyroid Hormone Analogues. 1-51 Part 3. lodonium Salt Approaches to SK&F L-94901,"" J. Chem. Soc., Perkin Trans. 1, pp. 3103-3111 (1988) Abstract, 1 page.;;B. R. Huber et al., ""Thyroid Hormone Receptor-beta Mutations Conferring Hormone Resistance and Reduced Corepressor Release Exhibit Decreased Stability in the N-terminal Ligand-Binding Domain,"" Molecular Endocrinology 17(1):107-116 (2003).;;B. R. Huber et al., ""Two Resistance to Thyroid Hormone Mutants with Impaired Hormone Binding"" Molecular Endocrinology 17(4):643-652 (2003).;;A. Joharapurkar et al., ""Selective Thyromimetics Using Receptor and Tissue Selectivity Approaches: Prospects for Dyslipidemia,"" J. Med. Chem. 55 (12): 5649-5675 (2012).;;R. Wagner et al., ""Hormone Selectivity in Thyroid Hormone Receptors,"" Molecular Endocrinology 15(3): 398-410 (2001).",ACTIVE
273,US,A1,US 2021/0161904 A1,065-321-256-209-285,2021-06-03,2021,US 202017118706 A,2020-12-11,US 202017118706 A;;US 201916458546 A;;US 201815949389 A;;US 201615046213 A;;US 201514660720 A;;US 2013/0060177 W;;US 201361790432 P;;US 201261702137 P,2012-09-17,METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRβ mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;SHU LIANHE;;WANG PING;;CHOI DUK SOON,HOFFMANN-LA ROCHE INC (2012-11-17);;MADRIGAL PHARMACEUTICALS INC (2012-11-07),https://lens.org/065-321-256-209-285,Patent Application,yes,0,1,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,A61K31/53;;A61K31/50;;A61P5/14;;A61P9/00;;C07D237/16;;C07D403/02;;C07D403/12,,0,0,,,,ACTIVE
274,US,A1,US 2023/0210856 A1,036-946-732-836-465,2023-07-06,2023,US 202218066677 A,2022-12-15,US 202218066677 A;;US 202017118706 A;;US 201916458546 A;;US 201815949389 A;;US 201615046213 A;;US 201514660720 A;;US 2013/0060177 W;;US 201361790432 P;;US 201261702137 P,2012-09-17,METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRβ mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;SHU LIANHE;;WANG PING;;CHOI DUK SOON,HOFFMANN-LA ROCHE INC (2012-11-17);;MADRIGAL PHARMACEUTICALS INC (2012-11-07),https://lens.org/036-946-732-836-465,Patent Application,yes,0,1,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,A61K31/50,,0,0,,,,PENDING
275,MX,A,MX 2018014924 A,153-245-037-604-275,2020-09-02,2020,MX 2018014924 A,2015-03-17,US 201261702137 P;;US 201361790432 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF.,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC,KELLY MARTHA;;DUGUID ROBERT J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;SHU LIANHE;;WANG PING;;HESTER KEITH D;;REYNOLDS CHARLES;;CHOI SOON DUK,,https://lens.org/153-245-037-604-275,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,A61K31/50;;A61P3/00;;A61P9/00;;C07D237/16,,0,0,,,,PENDING
276,CN,A,CN 105008335 A,113-904-707-357-505,2015-10-28,2015,CN 201380059943 A,2013-09-17,US 2013/0060177 W;;US 201261702137 P;;US 201361790432 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CUI DECHUN;;SHU LIANHE;;WANG PING,,https://lens.org/113-904-707-357-505,Patent Application,no,3,13,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,1,1,038-009-293-044-058,10.1039/p19880003103,"DEIRDRE M.B.HICKEY ET AL: ""Synthesis of Thyroid Hormone Analogues.Part 3.Iodonium Salt Approaches to SK&F L-94901"", 《J.CHEM.SOC.PERKIN TRANS.I》",ACTIVE
277,JP,A,JP 2018080188 A,024-821-776-778-098,2018-05-24,2018,JP 2017249107 A,2017-12-26,US 201361790432 P;;US 201261702137 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"PROBLEM TO BE SOLVED: To provide polymorphism of pyridazinone compounds as thyroid hormone analogs, useful for the treatment of resistance to thyroid hormone, and an efficient production method thereof.SOLUTION: A production method includes the steps of (a) bringing RMgX or RLi into contact with a compound of formula (I), to form a compound of formula (II) and (b) converting the compound of formula (II) into a compound of formula (III) (where R1 is isopropyl or isopropenyl; X is halo; R2 is H or an amine protective group).SELECTED DRAWING: Figure 1",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,D KEITH HESTER;;ROBERT J DUGUID;;MARTHA KELLY;;ANNA CHASNOFF;;DONG GANG;;EDWIN L CROW;;REBECCA TAUB;;CHARLES H REYNOLDS;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/024-821-776-778-098,Patent Application,no,1,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P5/14,,0,0,,,,ACTIVE
278,TW,B,TW I652260 B,045-757-606-902-461,2019-03-01,2019,TW 102133687 A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/045-757-606-902-461,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,,,0,0,,,,ACTIVE
279,DK,T3,DK 2895466 T3,079-863-642-219-750,2020-06-08,2020,DK 13837402 T,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,FREMGANGSMÅDE TIL SYNTESE AF THYREOIDEAHORMONANALOGER OG POLYMORFER DERAF,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING;;CHASNOFF ANNA,,https://lens.org/079-863-642-219-750,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
280,JP,A,JP 2020109090 A,192-007-738-513-764,2020-07-16,2020,JP 2020020343 A,2020-02-10,US 201361790432 P;;US 201261702137 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"To provide thyroid hormone analogs such as pyridazinone compounds.SOLUTION: The invention provides a crystal form of 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile for use in treatment of non-alcoholic steatohepatitis in a subject, where the crystal form has an X-ray powder diffraction pattern including peaks satisfying 2θ=10.5°, 18.7°, 22.9°, 23.6° and 24.7°.SELECTED DRAWING: Figure 1",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,D KEITH HESTER;;ROBERT J DUGUID;;MARTHA KELLY;;ANNA CHASNOFF;;DONG GANG;;EDWIN L CROW;;REBECCA TAUB;;CHARLES H REYNOLDS;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/192-007-738-513-764,Patent Application,no,2,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D403/10;;A61K31/53;;A61P1/16;;A61P3/06;;A61P29/00;;A61P43/00,,0,0,,,,ACTIVE
281,TW,B,TW I804870 B,038-109-124-829-602,2023-06-11,2023,TW 110117935 A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/038-109-124-829-602,Granted Patent,no,1,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,,,0,0,,,,ACTIVE
282,AU,B2,AU 2013/315017 B2,056-946-286-507-770,2017-07-27,2017,AU 2013/315017 A,2013-09-17,US 201361790432 P;;US 201261702137 P;;US 2013/0060177 W,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",F HOFFMANN-LA ROCHE LTD;;MADRIGAL PHARMACEUTICALS INC,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/056-946-286-507-770,Granted Patent,no,1,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
283,CA,A1,CA 2884481 A1,101-052-750-333-098,2014-03-20,2014,CA 2884481 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/101-052-750-333-098,Patent Application,no,0,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
284,KR,A,KR 20200023528 A,081-281-229-995-897,2020-03-04,2020,KR 20207005528 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"본원은 갑상선 호르몬 유사체 및 그들의 프로드러그로서 피리다지논 화합물을 합성하는 방법을 기술한다. 본원에 따른 바람직한 방법은 순도가 높은 피리다지논 화합물을 대규모로 제조할 수 있게 한다. 일부 실시양태에서, 본원에 따른 바람직한 방법은 또한 이러한 화합물을 제조하기 위해 이전에 사용된 방법 보다 양호한 수율로 피리다지논 화합물을 제조할 수 있게 한다. 본원은 또한 피리다지논 화합물의 형태를 개시한다. 본원은 또한 1 이상의 TRβ 돌연변이를 갖는 피험체에서 갑상선 호르몬 저항을 치료하는 방법을 개시한다.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/081-281-229-995-897,Patent Application,no,0,0,90,92,4,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/14;;A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12,,0,0,,,,DISCONTINUED
285,EP,B1,EP 3689853 B1,117-620-362-781-001,2021-11-24,2021,EP 20157696 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;EP 13837402 A;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/117-620-362-781-001,Granted Patent,yes,1,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
286,DK,T3,DK 3689853 T3,151-995-397-263-021,2022-03-07,2022,DK 20157696 T,2013-09-17,US 201261702137 P;;US 201361790432 P;;EP 13837402 A,2012-09-17,FREMGANGSMÅDE TIL SYNTESE AF THYREOIDEAHORMONANALOGER OG POLYMORFER DERAF,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/151-995-397-263-021,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
287,TW,A,TW 201906835 A,002-956-166-352-313,2019-02-16,2019,TW 107137798 A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TR[beta] mutation.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/002-956-166-352-313,Patent of Addition,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D403/12;;A61K31/53;;A61P1/16;;A61P3/06;;A61P5/14,,0,0,,,,ACTIVE
288,EP,A1,EP 3689853 A1,035-142-384-316-85X,2020-08-05,2020,EP 20157696 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;EP 13837402 A;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"A morphic form of 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile for use in a method of treating non-alcoholic steatohepatitis, fatty liver disease and hypercholesterolemia.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/035-142-384-316-85X,Patent Application,yes,4,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,19,14,034-544-272-906-295;;084-321-121-872-388;;064-897-844-678-593;;071-269-440-983-985;;138-313-236-939-930;;017-700-622-181-294;;077-295-491-167-117;;068-451-226-147-815;;058-516-586-238-384;;078-923-120-523-291;;068-575-607-507-743;;066-267-606-418-768;;069-586-021-408-49X;;004-679-778-054-368,10.1152/physrev.2001.81.3.1097;;11427693;;8319599;;10.1210/edrv-14-3-348;;10.1210/er.14.3.348;;10430610;;pmc408418;;10.1172/jci6397;;10.1210/en.142.2.544;;10.1210/endo.142.2.7935;;11159823;;10.1152/ajpregu.1998.275.2.r640;;22512468;;10.1021/jm2004706;;10.1002/0471220574;;10.1021/bi0482349;;15779888;;10.1210/mend.15.3.0608;;10.1210/me.15.3.398;;11222741;;10.1038/324641a0;;2879243;;10.1021/jo071232k.s003;;17999518;;10.1021/jo071232k;;17055251;;10.1016/j.gde.2006.10.009;;10.1101/gr.088013.108;;pmc2694485;;19420381;;10.1172/jci117362;;8040303;;pmc296123,"PAUL M. YEN, PHYSIOLOGICAL REVIEWS, vol. 81, no. 3, 2001, pages 1097 - 1126;;M. A. LAZAR, ENDOCRINE REVIEWS, vol. 14, 1993, pages 348 - 399;;ABEL, J. CLIN. INVEST., vol. 104, 1999, pages 291 - 300;;B. GLOSS, ENDOCRINOLOGY, vol. 142, 2001, pages 544 - 550;;C. JOHANSSON, AM. J. PHYSIOL., vol. 275, 1998, pages R640 - R646;;JOHARAPURKAR ET AL., J. MED. CHEM., vol. 55, no. 12, 2012, pages 5649 - 5675;;T. W. GREENEP. G. M. WUTS: ""Protective Groups in Organic Synthesis"", 1999, JOHN WILEY AND SONS;;SHI ET AL., BIOCHEMISTRY, vol. 44, 2005, pages 4612 - 4626;;R. L. WAGNER ET AL., MOLECULAR ENDOCRINOLOGY, vol. 15, no. 3, 2001, pages 398 - 410;;C. WEINBERGER ET AL., NATURE, vol. 324, 1986, pages 641 - 646;;C.C.TOMPSON ET AL., SCIENCE, vol. 237, 1986, pages 1610 - 1614;;""Genbank"", Database accession no. NM_000461.4;;J. ORG. CHEM., vol. 72, 2007, pages 9757 - 9760;;BUNDEGAARD, H.: ""Design of Prodrugs"", 1985, ELESEVIER, pages: 1 - 92;;""Remington: the Science and Practice of Pharmacy"", 1995, MACK PUBLISHING CO.;;BENTLEY, CURR OPIN GENET DEV., vol. 16, 2006, pages 545 - 52;;LI ET AL., GENOME RES, vol. 19, 2009, pages 1124 - 32;;M. ADAMS ET AL., J CLIN INVEST., vol. 94, no. 2, 1994, pages 506 - 515;;B. R. HUBER ET AL., MOL ENDOCRINOL, vol. 17, no. 1, 2003, pages 107 - 116",ACTIVE
289,TW,A,TW 201425300 A,141-472-739-035-091,2014-07-01,2014,TW 102133687 A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TR β mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER II;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/141-472-739-035-091,Patent of Addition,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/14;;A61K31/53;;A61P5/14;;C07D403/12,,0,0,,,,ACTIVE
290,JP,A,JP 2019048856 A,146-461-638-403-965,2019-03-28,2019,JP 2018217045 A,2018-11-20,US 201361790432 P;;US 201261702137 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"To provide: a method of synthesis of thyroid hormone analogs, such as pyridazinone compounds, and their prodrugs; and pharmaceutical compositions for use in treating a resistance to thyroid hormone (RTH) that contain the compound.SOLUTION: A pharmaceutical composition for use in treating a resistance to thyroid hormone (RTH) in a subject having at least one TRβ mutation contains a pyridazinone compound having a specific chemical structure represented by 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile.SELECTED DRAWING: Figure 1",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,D KEITH HESTER;;ROBERT J DUGUID;;MARTHA KELLY;;ANNA CHASNOFF;;DONG GANG;;EDWIN L CROW;;REBECCA TAUB;;CHARLES H REYNOLDS;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/146-461-638-403-965,Patent Application,no,1,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,A61K31/50;;A61K31/53;;A61P1/16;;A61P3/04;;A61P3/06;;A61P3/10;;A61P5/14;;A61P9/00;;A61P9/06;;A61P9/10;;A61P19/08;;A61P25/14;;A61P25/18;;A61P27/16;;A61P35/00;;C07D237/14;;C07D403/12,,3,1,071-009-695-708-220,11456736;;10.1021/ja003442j,"山田 正信 MASANOBU YAMADA: ""甲状腺ホルモン不応症 Resistance to thyroid hormone"", 日本臨牀 ＶＯＬ．６４（１２） THE JAPANESE JOURNAL OF CLINICAL MEDICINE, vol. 第64巻, JPN6019034537, 2006, ISSN: 0004250334;;J. AM. CHEM. SOC., vol. 123, no. 7, JPN6019034538, 2001, pages 1521 - 1522, ISSN: 0004250335;;原 義人 YOSHIHITO IIARA: ""甲状腺ホルモン不応症 Thyroid hormone resistance"", 日本臨床（別冊）領域別症候群シリーズ１ 内分泌症候群 （上）, JPN6019034541, 1993, ISSN: 0004250336",ACTIVE
291,EP,A2,EP 4023641 A2,028-470-157-111-95X,2022-07-06,2022,EP 21209827 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;EP 20157696 A;;EP 13837402 A;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER KEITH D;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/028-470-157-111-95X,Patent Application,yes,5,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,18,14,034-544-272-906-295;;084-321-121-872-388;;064-897-844-678-593;;071-269-440-983-985;;138-313-236-939-930;;017-700-622-181-294;;077-295-491-167-117;;068-451-226-147-815;;058-516-586-238-384;;078-923-120-523-291;;068-575-607-507-743;;066-267-606-418-768;;069-586-021-408-49X;;004-679-778-054-368,10.1152/physrev.2001.81.3.1097;;11427693;;8319599;;10.1210/edrv-14-3-348;;10.1210/er.14.3.348;;10430610;;pmc408418;;10.1172/jci6397;;10.1210/en.142.2.544;;10.1210/endo.142.2.7935;;11159823;;10.1152/ajpregu.1998.275.2.r640;;22512468;;10.1021/jm2004706;;10.1002/0471220574;;10.1021/bi0482349;;15779888;;10.1210/mend.15.3.0608;;10.1210/me.15.3.398;;11222741;;10.1038/324641a0;;2879243;;10.1021/jo071232k.s003;;17999518;;10.1021/jo071232k;;17055251;;10.1016/j.gde.2006.10.009;;10.1101/gr.088013.108;;pmc2694485;;19420381;;10.1172/jci117362;;8040303;;pmc296123,"PAUL M. YEN, PHYSIOLOGICAL REVIEWS, vol. 81, no. 3, 2001, pages 1097 - 1126;;M. A. LAZAR, ENDOCRINE REVIEWS, vol. 14, 1993, pages 348 - 399;;ABEL, J. CLIN. INVEST., vol. 104, 1999, pages 291 - 300;;B. GLOSS, ENDOCRINOLOGY, vol. 142, 2001, pages 544 - 550;;C. JOHANSSON, AM. J. PHYSIOL., vol. 275, 1998, pages R640 - R646;;JOHARAPURKAR ET AL., J. MED. CHEM., vol. 55, no. 12, 2012, pages 5649 - 5675;;T. W. GREENEP. G. M. WUTS: ""Protective Groups in Organic Synthesis"", 1999, JOHN WILEY AND SONS;;SHI ET AL., BIOCHEMISTRY, vol. 44, 2005, pages 4612 - 4626;;R. L. WAGNER ET AL., MOLECULAR ENDOCRINOLOGY, vol. 15, no. 3, 2001, pages 398 - 410;;C. WEINBERGER ET AL., NATURE, vol. 324, 1986, pages 641 - 646;;C.C.TOMPSON ET AL., SCIENCE, vol. 237, 1986, pages 1610 - 1614;;""Genbank"", Database accession no. NM_000461.4;;J. ORG. CHEM., vol. 72, 2007, pages 9757 - 9760;;""Remington: the Science and Practice of Pharmacy"", 1995, MACK PUBLISHING CO.;;BENTLEY, CURR OPIN GENET DEV, vol. 16, 2006, pages 545 - 52;;LI ET AL., GENOME RES, vol. 19, 2009, pages 1124 - 32;;M. ADAMS ET AL., J CLIN INVEST., vol. 94, no. 2, 1994, pages 506 - 515;;B. R. HUBER ET AL., MOL ENDOCRINOL, vol. 17, no. 1, 2003, pages 107 - 116",PENDING
292,KR,A,KR 20210083381 A,013-581-161-373-95X,2021-07-06,2021,KR 20217019940 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;KR 20207005528 A;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"본원은 갑상선 호르몬 유사체 및 그들의 프로드러그로서 피리다지논 화합물을 합성하는 방법을 기술한다. 본원에 따른 바람직한 방법은 순도가 높은 피리다지논 화합물을 대규모로 제조할 수 있게 한다. 일부 실시양태에서, 본원에 따른 바람직한 방법은 또한 이러한 화합물을 제조하기 위해 이전에 사용된 방법 보다 양호한 수율로 피리다지논 화합물을 제조할 수 있게 한다. 본원은 또한 피리다지논 화합물의 형태를 개시한다. 본원은 또한 1 이상의 TRβ 돌연변이를 갖는 피험체에서 갑상선 호르몬 저항을 치료하는 방법을 개시한다.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/013-581-161-373-95X,Patent Application,no,2,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/14;;A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12,,0,0,,,,ACTIVE
293,TW,B,TW I681957 B,045-274-328-317-29X,2020-01-11,2020,TW 107137798 A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/045-274-328-317-29X,Granted Patent,no,2,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,,,0,0,,,,ACTIVE
294,CA,C,CA 3111317 C,083-715-888-195-12X,2023-08-29,2023,CA 3111317 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;CA 2884481 A,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"Abstract THE DISCLOSURE DESCRIBES A MORPHIC FORM OF 2-(3,5-DICHLOR0-445-ISOPROPYL- 6-0X0- 1,6-DIHYDROPYRIDAZIN- 3 -YL)OXYPHENYL)-3 ,5 -DI OX0-2,3 ,4,5 - TETRAHYDRO- 1,2,4- TRIAZINE-6-CARBONITRILE (""COMPOUND A""), WHEREIN THE MORPHIC FORM IS A HYDRATE. ALSO DESCRIBED IS A PHARMACEUTICAL COMPOSITION COMPRISING THE MORPHIC FORM AND A PHARMACEUTICALLY ACCEPTABLE CARRIER. Date Recue/Date Received 2021-03-05",F HOFFMANN LA ROCHE LTD;;MADRIGAL PHARMACEUTICALS INC,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/083-715-888-195-12X,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/53;;A61P5/14;;C07D237/14;;C07D403/12,,0,0,,,,PENDING
295,CA,A1,CA 3111317 A1,001-494-844-364-920,2014-03-20,2014,CA 3111317 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;CA 2884481 A,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"Abstract THE DISCLOSURE DESCRIBES A MORPHIC FORM OF 2-(3,5-DICHLOR0-445-ISOPROPYL- 6-0X0- 1,6-DIHYDROPYRIDAZIN- 3 -YL)OXYPHENYL)-3 ,5 -DI OX0-2,3 ,4,5 - TETRAHYDRO- 1,2,4- TRIAZINE-6-CARBONITRILE (""COMPOUND A""), WHEREIN THE MORPHIC FORM IS A HYDRATE. ALSO DESCRIBED IS A PHARMACEUTICAL COMPOSITION COMPRISING THE MORPHIC FORM AND A PHARMACEUTICALLY ACCEPTABLE CARRIER. Date Recue/Date Received 2021-03-05",F HOFFMANN LA ROCHE LTD;;MADRIGAL PHARMACEUTICALS INC,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/001-494-844-364-920,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/53;;A61P5/14;;C07D237/14;;C07D403/12,,0,0,,,,PENDING
296,IN,A,IN 3133DEN2015 A,106-791-913-722-321,2015-10-02,2015,IN 3133DEN2015 A,2015-04-14,US 201361790432 P;;US 201261702137 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large- scale preparation of pyridazinone compounds having high purity. In some embodiments , preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/106-791-913-722-321,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00,,0,0,,,,PENDING
297,WO,A1,WO 2014/043706 A1,099-988-338-222-079,2014-03-20,2014,US 2013/0060177 W,2013-09-17,US 201361790432 P;;US 201261702137 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/099-988-338-222-079,Patent Application,yes,6,23,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,18,12,038-009-293-044-058;;034-544-272-906-295;;084-321-121-872-388;;064-897-844-678-593;;071-269-440-983-985;;138-313-236-939-930;;017-700-622-181-294;;077-295-491-167-117;;068-451-226-147-815;;058-516-586-238-384;;078-923-120-523-291;;004-679-778-054-368,10.1039/p19880003103;;10.1152/physrev.2001.81.3.1097;;11427693;;8319599;;10.1210/edrv-14-3-348;;10.1210/er.14.3.348;;10430610;;pmc408418;;10.1172/jci6397;;10.1210/en.142.2.544;;10.1210/endo.142.2.7935;;11159823;;10.1152/ajpregu.1998.275.2.r640;;22512468;;10.1021/jm2004706;;10.1002/0471220574;;10.1021/bi0482349;;15779888;;10.1210/mend.15.3.0608;;10.1210/me.15.3.398;;11222741;;10.1038/324641a0;;2879243;;10.1172/jci117362;;8040303;;pmc296123,"HICKEY, DEIRDRE M. B. ET AL.: ""Synthesis of Thyroid Hormone Analogues. Part 3. lodonium Salt Approaches to SK&F L-94901"", J. CHEM. SOC. PERKIN TRANS. I, 1988, pages 3103 - 3111, XP001084408;;PAUL M. YEN, PHYSIOLOGICAL REVIEWS, vol. 81, no. 3, 2001, pages 1097 - 1126;;M. A. LAZAR, ENDOCRINE REVIEWS, vol. 14, 1993, pages 348 - 399;;ABEL, J. CLIN. INVEST., vol. 104, 1999, pages 291 - 300;;B. GLOSS, ENDOCRINOLOGY, vol. 142, 2001, pages 544 - 550;;C. JOHANSSON, AM. J. PHYSIOL., vol. 275, 1998, pages R640 - R646;;JOHARAPURKAR ET AL., J. MED. CHEM., vol. 55, no. 12, 2012, pages 5649 - 5675;;T. W. GREENEP. G. M. WUTS: ""Protective Groups in Organic Synthesis"", 1999, JOHN WILEY AND SONS;;SHI ET AL., BIOCHEMISTRY, vol. 44, 2005, pages 4612 - 4626;;R. L. WAGNER ET AL., MOLECULAR ENDOCRINOLOGY, vol. 15, no. 3, 2001, pages 398 - 410;;C. WEINBERGER ET AL., NATURE, vol. 324, 1986, pages 641 - 646;;C.C.TOMPSON ET AL., SCIENCE, vol. 237, 1986, pages 1610 - 1614;;""Genbank"", Database accession no. NM_000461.4;;BUNDEGAARD, H.: ""Design of Prodrugs"", 1985, ELESEVIER, pages: l-92;;""Remington: the Science and Practice of Pharmacy"", 1995, MACK PUBLISHING CO.;;M. ADAMS ET AL., J CLIN INVEST, vol. 94, no. 2, 1994, pages 506 - 515;;B. R. HUBER ET AL., MOL ENDOCRINOL, vol. 17, no. 1, 2003, pages 107 - 116;;See also references of EP 2895466A4",PENDING
298,EP,A1,EP 2895466 A1,041-201-991-825-802,2015-07-22,2015,EP 13837402 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,,MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,"F. HOFFMANN-LA ROCHE LTD. (2020-03-18);;MADRIGAL PHARMACEUTICALS, INC. (2020-03-18)",https://lens.org/041-201-991-825-802,Patent Application,yes,0,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
299,AU,C1,AU 2013/315017 C1,074-043-337-440-20X,2017-11-23,2017,AU 2013/315017 A,2013-09-17,US 201361790432 P;;US 201261702137 P;;US 2013/0060177 W,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",F HOFFMANN LA ROCHE LTD;;MADRIGAL PHARMACEUTICALS INC,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/074-043-337-440-20X,Amended Patent,no,1,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
300,EP,A3,EP 4023641 A3,198-292-589-383-751,2022-09-14,2022,EP 21209827 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;EP 20157696 A;;EP 13837402 A;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER KEITH D;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/198-292-589-383-751,Search Report,yes,2,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,PENDING
301,HK,A1,HK 1212682 A1,013-809-487-496-560,2016-06-17,2016,HK 16100496 A,2016-01-18,US 2013/0060177 W;;US 201361790432 P;;US 201261702137 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,,MADRIGAL PHARMACEUTICALS INC,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/013-809-487-496-560,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D/;;A61K/;;A61P/,,0,0,,,,PENDING
302,ES,T3,ES 2907926 T3,023-998-806-707-213,2022-04-27,2022,ES 20157696 T,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,Procedimiento para sintetizar análogos de hormonas tiroideas y polimorfos de los mismos,"Una forma mórfica de 2-(3,5-dicloro-4-((5-isopropil-6-oxo-1,6-dihidropiridazin-3-il)oxi)fenil)-3,5-dioxo-2,3,4,5- tetrahidro-1,2,4-triazino-6-carbonitrilo (""Compuesto A"") para su uso en un procedimiento de tratamiento de esteatohepatitis no alcohólica en un sujeto que lo necesita, en donde la forma mórfica se caracteriza por un patrón de difracción de rayos X en polvo que incluye picos a aproximadamente 10,5, 18,7, 22,9, 23,6, y 24,7 grados 2θ.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/023-998-806-707-213,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
303,EP,B1,EP 2895466 B1,048-228-766-048-44X,2020-03-25,2020,EP 13837402 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,"F. HOFFMANN-LA ROCHE LTD. (2020-03-18);;MADRIGAL PHARMACEUTICALS, INC. (2020-03-18)",https://lens.org/048-228-766-048-44X,Granted Patent,yes,4,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,2,0,,,"CAIRA M R: ""CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS"", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163-208, XP001156954, ISSN: 0340-1022, DOI: 10.1007/3-540-69178-2_5;;HICKEY, DEIRDRE M. B. ET AL.: 'Synthesis of Thyroid Hormone Analogues. Part 3. lodonium Salt Approaches to SK&F L-94901' J. CHEM. SOC. PERKIN TRANS. I 1988, pages 3103 - 3111, XP001084408",ACTIVE
304,CN,A,CN 108101851 A,133-305-233-531-882,2018-06-01,2018,CN 201810077707 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;CN 201380059943 A,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previouslyused methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having atleast one TRP mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/133-305-233-531-882,Patent Application,no,3,3,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61K31/53;;A61P1/16;;A61P3/00;;A61P3/04;;A61P3/06;;A61P3/10;;A61P5/00;;A61P9/00;;A61P9/10;;A61P19/08;;A61P25/00;;A61P25/14;;A61P25/18;;A61P25/28;;A61P27/16;;A61P35/00;;C07D403/12,,1,0,,,"DEIRDRE M. 6. HICKEY等: ""Synthesis of Thyroid Hormone Analogues. Part 3."" lodonium Salt Approaches to SK&F L-94901"", 《JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1》",PENDING
305,KR,A,KR 20180131647 A,154-229-997-434-88X,2018-12-10,2018,KR 20187034908 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"본원은 갑상선 호르몬 유사체 및 그들의 프로드러그로서 피리다지논 화합물을 합성하는 방법을 기술한다. 본원에 따른 바람직한 방법은 순도가 높은 피리다지논 화합물을 대규모로 제조할 수 있게 한다. 일부 실시양태에서, 본원에 따른 바람직한 방법은 또한 이러한 화합물을 제조하기 위해 이전에 사용된 방법 보다 양호한 수율로 피리다지논 화합물을 제조할 수 있게 한다. 본원은 또한 피리다지논 화합물의 형태를 개시한다. 본원은 또한 1 이상의 TRβ 돌연변이를 갖는 피험체에서 갑상선 호르몬 저항을 치료하는 방법을 개시한다.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/154-229-997-434-88X,Patent Application,no,3,0,90,92,4,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/14;;A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12,,0,0,,,,ACTIVE
306,TW,A,TW 201946917 A,168-595-458-507-523,2019-12-16,2019,TW 108132827 A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TR[beta] mutation.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/168-595-458-507-523,Patent of Addition,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D403/12;;A61K31/53;;A61P1/16;;A61P3/06;;A61P5/14,,0,0,,,,ACTIVE
307,AU,A1,AU 2013/315017 A1,196-046-233-985-990,2015-04-02,2015,AU 2013/315017 A,2013-09-17,US 201361790432 P;;US 201261702137 P;;US 2013/0060177 W,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",HOFFMANN LA ROCHE;;MADRIGAL PHARMACEUTICALS INC,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/196-046-233-985-990,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
308,CA,A1,CA 3090070 A1,095-595-259-795-335,2014-03-20,2014,CA 3090070 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;CA 2884481 A,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"Abstract The disclosure describes a morphic form of 2-(3,5-dichloro-44(5-isopropy1-6- oxo- 1,6-dihydropyridazin-3-yl)oxy)pheny1)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4- triazine-6- carbonitrile (""Compound A""), wherein the morphic form is a hydrate. Also described is a pharmaceutical composition comprising the morphic form and a pharmaceutically acceptable carrier. Date Recue/Date Received 2020-08-14",F HOFFMANN LA ROCHE LTD;;MADRIGAL PHARMACEUTICALS INC,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/095-595-259-795-335,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D403/12;;A61K31/53;;A61P1/16;;A61P3/06;;A61P5/14,,0,0,,,,PENDING
309,TW,A,TW 202134217 A,113-741-770-230-650,2021-09-16,2021,TW 110117935 A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TR[beta] mutation.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/113-741-770-230-650,Patent of Addition,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/14;;C07D237/16,,0,0,,,,ACTIVE
310,ZA,B,ZA 201501795 B,177-176-645-904-428,2021-10-27,2021,ZA 201501795 A,2015-03-16,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;KELLY MARTHA;;DONG GANG;;TAUB REBECCA;;CHOI DUK SOON;;WANG PING;;DUGUID ROBERT J;;CHASNOFF ANNA;;CROW EDWIN L;;REYNOLDS CHARLES H;;SHU LIANHE,,https://lens.org/177-176-645-904-428,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,,,0,0,,,,ACTIVE
311,EP,A4,EP 2895466 A4,018-030-081-808-272,2016-08-10,2016,EP 13837402 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,,MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,"F. HOFFMANN-LA ROCHE LTD. (2020-03-18);;MADRIGAL PHARMACEUTICALS, INC. (2020-03-18)",https://lens.org/018-030-081-808-272,Search Report,no,1,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,2,1,104-949-654-022-72X,10.1007/3-540-69178-2_5,"CAIRA M R: ""CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS"", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, DOI: 10.1007/3-540-69178-2_5;;See also references of WO 2014043706A1",ACTIVE
312,JP,A,JP 2020015739 A,020-559-521-372-006,2020-01-30,2020,JP 2019154299 A,2019-08-27,JP 2015532148 A;;US 201361790432 P;;US 201261702137 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"To provide methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs.SOLUTION: A method of preparing a crystal of Form I of 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile (""Compound A"") comprises: heating a mixture comprising a solvent and a sample containing Compound A to a first temperature; and cooling the mixture to a second temperature that is lower than the first temperature to obtain the crystal of Form I; where the solvent is ethanol, isopropanol, or a combination thereof.SELECTED DRAWING: Figure 1",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,D KEITH HESTER;;ROBERT J DUGUID;;MARTHA KELLY;;ANNA CHASNOFF;;DONG GANG;;EDWIN L CROW;;REBECCA TAUB;;CHARLES H REYNOLDS;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/020-559-521-372-006,Patent Application,no,2,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D403/12,,0,0,,,,ACTIVE
313,TW,B,TW I755628 B,028-932-516-254-121,2022-02-21,2022,TW 108132827 A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,Method of synthesizing thyroid hormone analogs and polymorphs thereof,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/028-932-516-254-121,Granted Patent,no,2,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,,,0,0,,,,ACTIVE
314,MX,B,MX 364661 B,081-145-754-194-100,2019-05-03,2019,MX 2015003418 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF.,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC,MARTHA KELLY;;D KEITH HESTER;;ROBERT J DUGUID;;ANNA CHASNOFF;;GANG DONG;;EDWIN L CROW;;REBECCA TAUB;;CHARLES H REYNOLDS;;DUK SOON CHOI;;LIANHE SHU;;PING WANG,,https://lens.org/081-145-754-194-100,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
315,SG,A,SG 11201501907Y A,150-361-243-847-867,2015-04-29,2015,SG 11201501907Y A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,,MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/150-361-243-847-867,Unknown,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,PENDING
316,CA,C,CA 2884481 C,186-430-526-173-797,2021-04-27,2021,CA 2884481 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"Abstract The disclosure describes methods of synthesis of pyridazinone compounds such as 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile (""Compound A""), as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound such as Form I, processes for preparing same, and pharmaceutical compositions comprising same. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRr3 mutation, nonalcoholic steatohepatitis, fatty liver disease, or hypercholesterolemia. Date Recue/Date Received 2020-08-10",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/186-430-526-173-797,Granted Patent,no,0,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,,,0,0,,,,ACTIVE
317,MX,A,MX 2015003418 A,182-637-573-998-110,2016-04-04,2016,MX 2015003418 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF.,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC,KELLY MARTHA;;HESTER D KEITH;;DUGUID ROBERT J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/182-637-573-998-110,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,ACTIVE
318,KR,A,KR 20150056630 A,015-223-555-544-435,2015-05-26,2015,KR 20157009807 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;US 2013/0060177 W,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"본원은 갑상선 호르몬 유사체 및 그들의 프로드러그로서 피리다지논 화합물을 합성하는 방법을 기술한다. 본원에 따른 바람직한 방법은 순도가 높은 피리다지논 화합물을 대규모로 제조할 수 있게 한다. 일부 실시양태에서, 본원에 따른 바람직한 방법은 또한 이러한 화합물을 제조하기 위해 이전에 사용된 방법 보다 양호한 수율로 피리다지논 화합물을 제조할 수 있게 한다. 본원은 또한 피리다지논 화합물의 형태를 개시한다. 본원은 또한 1 이상의 TRβ 돌연변이를 갖는 피험체에서 갑상선 호르몬 저항을 치료하는 방법을 개시한다.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/015-223-555-544-435,Patent Application,no,3,0,90,92,4,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12,,0,0,,,,ACTIVE
319,CA,C,CA 3090070 C,194-057-237-908-125,2023-01-24,2023,CA 3090070 A,2013-09-17,US 201261702137 P;;US 201361790432 P;;CA 2884481 A,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"Abstract The disclosure describes a morphic form of 2-(3,5-dichloro-44(5-isopropy1-6- oxo- 1,6-dihydropyridazin-3-yl)oxy)pheny1)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4- triazine-6- carbonitrile (""Compound A""), wherein the morphic form is a hydrate. Also described is a pharmaceutical composition comprising the morphic form and a pharmaceutically acceptable carrier. Date Recue/Date Received 2020-08-14",F HOFFMANN LA ROCHE LTD;;MADRIGAL PHARMACEUTICALS INC,HESTER D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/194-057-237-908-125,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D403/12;;A61K31/53;;A61P1/16;;A61P3/06;;A61P5/14,,0,0,,,,PENDING
320,BR,A2,BR 112015005891 A2,195-195-913-359-857,2017-08-08,2017,BR 112015005891 A,2013-09-17,US 2013/0060177 W;;US 201261702137 P;;US 201361790432 P,2012-09-17,método de sintetizar análogos do hormônio da tireoide e polimorfos destes,"resumo método de sintetizar análogos do hormônio da tireoide e polimorfos destes a divulgação descreve métodos de síntese de compostos de piridazinona como análogos do hormônio da tireoide e seus pró-medicamentos. métodos preferidos de acordo com a divulgação levam em consideração preparação em grande escala de compostos de piridazinona tendo pureza alta. em algumas formas de realização, métodos preferidos de acordo com a divulgação também levam em consideração a preparação de compostos de piridazinona em melhor rendimento do que métodos previamente usados para preparar tais compostos. também divulgadas são formas mórficas de um composto de piridazinona. ainda divulgado é um método para tratar resistência ao hormônio da tireoide em um indivíduo tendo pelo menos uma mutação de trß.",F HOFFMANN LA ROCHE LTD;;MADRIGAL PHARMACEUTICALS INC,ANNA CHASNOFF;;CHARLES H REYNOLDS;;D KEITH HESTER;;DUK SOON CHOI;;EDWIN L CROW;;GANG DONG;;LIANHE SHU;;MARTHA KELLY;;PING WANG;;REBECCA TAUB;;ROBERT J DUGUID,,https://lens.org/195-195-913-359-857,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,A61K31/50;;A61P3/00;;A61P9/00;;C07D237/16,,0,0,,,,DISCONTINUED
321,MY,A,MY 170520 A,095-324-094-322-630,2019-08-08,2019,MY PI2015000591 A,2013-09-17,US 2013/0060177 W;;US 201261702137 P;;US 201361790432 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TR{J mutation. (Figure 1)",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/095-324-094-322-630,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,,,0,0,,,,ACTIVE
322,WO,A8,WO 2014/043706 A8,155-079-703-887-919,2017-10-19,2017,US 2013/0060177 W,2013-09-17,US 201361790432 P;;US 201261702137 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRP mutation.",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN-LA ROCHE LTD,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/155-079-703-887-919,Amended Application,yes,0,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,PENDING
323,BR,B1,BR 122021024202 B1,198-917-167-757-925,2022-05-17,2022,BR 122021024202 A,2013-09-17,US 2013/0060177 W;;US 201261702137 P;;US 201361790432 P;;BR 112015005891 A,2012-09-17,Processo sintético compreendendo compostos de piridazinona bem como os ditos compostos,"a divulgação descreve métodos de síntese de compostos de piridazinona como análogos do hormônio da tireoide e seus pró-medicamentos. métodos preferi-dos de acordo com a divulgação levam em consideração preparação em grande es-cala de compostos de piridazinona tendo pureza alta. em algumas formas de reali-zação, métodos preferidos de acordo com a divulgação também levam em conside-ração a preparação de compostos de piridazinona em melhor rendimento do que métodos previamente usados para preparar tais compostos. também divulgadas são formas mórficas de um composto de piridazinona. ainda divulgado é um método para tratar resistência ao hormônio da tireoide em um indivíduo tendo pelo menos uma mutação de trß.",F HOFFMANN LA ROCHE LTD;;MADRIGAL PHARMACEUTICALS INC,CHASNOFF ANNA;;CHARLES H REYNOLDS;;D KEITH HESTER II;;DUK SOON CHOI;;EDWIN L CROW;;DONG GANG;;SHU LIANHE;;KELLY MARTHA;;WANG PING;;TAUB REBECCA;;ROBERT J DUGUID,,https://lens.org/198-917-167-757-925,Granted Patent,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,A61K31/50;;A61P3/00;;A61P9/00;;C07D237/16,,0,0,,,,ACTIVE
324,SG,A,SG 10202006058Q A,192-422-764-256-835,2020-08-28,2020,SG 10202006058Q A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,,MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/192-422-764-256-835,Unknown,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,,,0,0,,,,PENDING
325,US,A1,US 2015/0203473 A1,042-956-414-691-498,2015-07-23,2015,US 201514660720 A,2015-03-17,US 201514660720 A;;US 2013/0060177 W;;US 201261702137 P;;US 201361790432 P,2012-09-17,METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF,"The disclosure describes methods of synthesis of pyridazinone compounds as thyroid hormone analogs and their prodrugs. Preferred methods according to the disclosure allow for large-scale preparation of pyridazinone compounds having high purity. In some embodiments, preferred methods according to the disclosure also allow for the preparation of pyridazinone compounds in better yield than previously used methods for preparing such compounds. Also disclosed are morphic forms of a pyridazinone compound. Further disclosed is a method for treating resistance to thyroid hormone in a subject having at least one TRβ mutation.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,HOFFMANN-LA ROCHE INC (2012-11-17);;MADRIGAL PHARMACEUTICALS INC (2012-11-07),https://lens.org/042-956-414-691-498,Patent Application,yes,0,0,90,92,2,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D403/12;;C07D237/16,,0,0,,,,ACTIVE
326,AR,A2,AR 117739 A2,055-529-573-085-837,2021-08-25,2021,AR P190103876 A,2019-12-27,AR P190103876 A,2019-12-27,PROCESO PARA SINTETIZAR UN COMPUESTO QUE ES ÚTIL COMO INTERMEDIARIO PARA PREPARAR COMPUESTOS DE PIRIDAZINONA COMO ANÁLOGOS DE LA HORMONA TIROIDEA,"Reivindicación 1: Un dihidrato de 2-(3,5-dicloro-4-((5-isopropil-6-oxo-1,6-dihidropiridazin-3-il)oxi)fenil)-3,5-dioxo-2,3,4,5-tetrahidro-1,2,4-triazin-6-carbonitrilo (“Compuesto A”).",MADRIGAL PHARMACEUTICALS INC;;F HOFFMANN LA ROCHE LTD,HESTER II D KEITH;;DUGUID ROBERT J;;KELLY MARTHA J;;CHASNOFF ANNA;;DONG GANG;;CROW EDWIN L;;TAUB REBECCA;;REYNOLDS CHARLES H;;CHOI DUK SOON;;SHU LIANHE;;WANG PING,,https://lens.org/055-529-573-085-837,Amended Application,no,0,0,1,1,0,,C07D213/73;;A01N43/40,,0,0,,,,PENDING
327,AR,A1,AR 092872 A1,106-937-759-570-84X,2015-05-06,2015,AR P130103332 A,2013-09-17,US 201261702137 P;;US 201361790432 P,2012-09-17,METODO PARA SINTETIZAR ANALOGOS DE LA HORMONA TIROIDEA Y POLIMORFOS DE LOS MISMOS,"Reivindicación 1: Un proceso de síntesis caracterizado porque comprende: (a) hacer contactar R¹MgX o R¹Li con un compuesto de la fórmula (1) para formar un compuesto de la fórmula (2), donde R¹ es isopropilo o isopropenilo, X es halo y R² es H o un grupo protector de amina; y (b) convertir el compuesto de la fórmula (2) en un compuesto de la fórmula (3) en presencia de una base donde R¹ es isopropenilo o en presencia de un agente oxidante donde R¹ es isopropilo. Reivindicación 2: El proceso de la reivindicación 1, caracterizado porque además comprende: (c), cuando está presente, retirar el grupo protector de amina R² del compuesto de la fórmula (3) para formar 6-(4-amino-2,6-diclorofenoxi)-4-isopropilpiridazin-3-(2H)-ona. Reivindicación 18: El proceso de la reivindicación 2, caracterizado porque además comprende: (d) convertir la 6-(4-amino-2,6-diclorofenoxi)-4-isopropilpiridazin-3(2H)-ona en el compuesto de la fórmula (4), donde R³ es H o CH₂Rᵃ, donde Rᵃ es hidroxilo, amino ácido ligado a O, OP(O)(OH)₂ o -OC(O)-Rᵇ, siendo Rᵇ alquilo inferior, alcoxi, ácido de alquilo, cicloalquilo, arilo, heteroarilo o -(CH₂)ₙ-heteroarilo y siendo n = 0 ó 1; R⁴ es H; y R⁵ es CH₂COOH, C(O)CO₂H, o un éster o amida del mismo, o R⁴ y R⁵ juntos son - N=C(Rᶜ)-C(O)-NH-C(O)-; donde Rᶜ es H o ciano. Reivindicación 21: El proceso de la reivindicación 18, caracterizado porque el compuesto de la fórmula (4) tiene la fórmula (5), donde R³ es CH₂Rᵃ, y el paso (d) se realiza haciendo contactar 6-(4-amino-2,6-diclorofenoxi)-4-isopropilpiridazin-3(2H)-ona con etil (2-cianoacetil)carbamato para formar 2-(3,5-dicloro-4-((5-isopropil-6-oxo-1,6-dihidropiridazin-3-il)oxi)fenil)-3,5-dioxo-2,3,4,5-tetrahidro-1,2,4-triazina-6-carbonitrilo (Compuesto A) y convirtiendo el Compuesto A en el compuesto de la fórmula (5) en una condición adecuada.",MADRIGAL PHARMACEUTICALS INC;;HOFFMANN LA ROCHE,D KEITH II HESTER;;ROBERT J DUGUID;;MARTHA J KELLY;;ANNA CHASNOFF;;GANG DONG;;EDWIN L CROW;;REBECCA TAUB;;CHARLES H REYNOLDS;;DUK SOON CHOI;;LIANHE SHU;;PING WANG,,https://lens.org/106-937-759-570-84X,Patent Application,no,0,0,90,92,0,A61K31/50;;A61K31/53;;C07D237/16;;C07D403/12;;C07B2200/13;;A61K31/50;;C07D237/16;;C07D403/02;;A61P9/00;;A61P5/14;;C07D403/12;;A61K31/53;;Y02P20/55;;A61K31/53;;C07D237/16;;C07B2200/13;;C07D403/12;;A61K31/50;;C07D403/02;;A61P5/14;;A61P9/00;;A61K31/50;;A61K31/53;;C07D237/14;;C07D237/16;;C07D403/12;;A61K31/501;;A61K31/53;;C07D237/16;;C07D403/12;;C07D403/02;;A61P9/00;;A61P5/14;;A61K31/50;;C07D237/16;;Y02P20/55;;A61K31/53;;C07B2200/13;;C07D403/12,C07D237/16;;A61K31/50;;A61P3/00;;A61P9/00,,0,0,,,,PENDING
328,WO,A1,WO 2004/067360 A1,076-487-692-528-986,2004-08-12,2004,US 2004/0001760 W,2004-01-23,US 44219203 P,2003-01-24,COMPOSITE BODY FOR A GOLF CAR AND UTILITY VEHICLE,"A golf car (10) or utility vehicle having a composite body (58). In some aspects of the invention, the golf car or utility vehicle has a composite body assembly that includes a front clam shell assembly (62) and a rear shell-like body (64). In other aspects, the golf car or utility vehicle includes a composite body assembly having a periphery (118) and one or more decorative body panels (106, 108), the decorative body panels being recessed inwardly relative to the composite body assembly periphery to prevent impacts to the panels.",CLUB CAR INC;;BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAEL L,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAEL L,,https://lens.org/076-487-692-528-986,Patent Application,yes,5,8,12,17,0,B62D21/183;;B62D21/183;;B62D29/04;;B60L50/62;;B60L50/62;;B60L50/66;;B60L50/66;;B60L58/21;;B60L58/21;;B60L2200/22;;B60L2200/22;;B62D29/043;;B62D29/043;;B62D31/003;;B62D31/003;;Y02T10/62;;Y02T10/62;;Y02T10/70;;Y02T10/70;;Y02T10/7072,A63B55/60;;B62D29/04,,0,0,,,,PATENTED
329,ES,T3,ES 2384463 T3,121-995-457-978-355,2012-07-05,2012,ES 06022935 T,2004-01-23,US 44219203 P,2003-01-24,Carrocería mixta para un coche de golf o vehículo de usos diversos,"Un vehículo (10), que comprende:un conjunto de carrocería mixta moldeada de alta resistencia (58) formada a partir de al menos un panel (61;63; 64) de polímero reforzado con fibras moldeado, el conjunto de carrocería mixta teniendo una periferia; yuna pluralidad de ruedas (16a, 16b) que soportan al conjunto de carrocería mixta para moverse por el suelo;en el que un panel frontal (102) y un salpicadero (104) están montados de manera fija a una parte frontal delvehículo (10), estando el salpicadero fijado a/y extendiéndose hacia delante desde el panel frontal y que tieneuna periferia (105), y un panel decorativo de carrocería delantero (106) está fijado sobre el panel frontal yestá rebajada hacia el interior desde la periferia para que esté protegido de los daños por el salpicadero,caracterizado porqueel conjunto de carrocería mixta (58) incluye una sección de carrocería trasera (60b) que tiene una concha (64)con una parte superior (64a) y una parte inferior (64b), estando la periferia de la parte superior rebajada haciael interior en relación con la periferia de la parte inferior y un panel decorativo de carrocería trasero (108) estádispuesto en el conjunto de carrocería mixta alrededor de la parte superior de la misma, estando el paneldecorativo de carrocería trasero rebajado hacia el interior en relación con la periferia del conjunto decarrocería mixta de manera que la parte inferior del conjunto de carrocería mixta tiene una periferia (114) quese extiende hacia fuera de la periferia (118) del panel decorativo de carrocería trasero para así evitar losimpactos con el panel decorativo de carrocería trasero, en donde el conjunto de carrocería mixta (58) incluyeuna sección de carrocería delantera (60a), la sección de carrocería delantera (60a) incluyendo al menos dospaneles (61, 63) de polímero reforzado con fibras moldeados conectados conjuntamente para formar así unconjunto de concha de almeja (62) y una sección de carrocería trasera (60b) formada de polímero reforzadocon fibras.",CLUB CAR INC;;CLUB CAR LLC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAL L,,https://lens.org/121-995-457-978-355,Granted Patent,no,0,0,12,17,0,B62D21/183;;B62D21/183;;B62D29/04;;B60L50/62;;B60L50/62;;B60L50/66;;B60L50/66;;B60L58/21;;B60L58/21;;B60L2200/22;;B60L2200/22;;B62D29/043;;B62D29/043;;B62D31/003;;B62D31/003;;Y02T10/62;;Y02T10/62;;Y02T10/70;;Y02T10/70;;Y02T10/7072,B62D29/04;;A63B55/60,,0,0,,,,EXPIRED
330,EP,A1,EP 1592604 A1,022-505-723-001-229,2005-11-09,2005,EP 04704832 A,2004-01-23,US 2004/0001760 W;;US 44219203 P,2003-01-24,COMPOSITE BODY FOR A GOLF CAR AND UTILITY VEHICLE,,CLUB CAR INC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAEL L,,https://lens.org/022-505-723-001-229,Patent Application,yes,0,0,12,17,0,B62D21/183;;B62D21/183;;B62D29/04;;B60L50/62;;B60L50/62;;B60L50/66;;B60L50/66;;B60L58/21;;B60L58/21;;B60L2200/22;;B60L2200/22;;B62D29/043;;B62D29/043;;B62D31/003;;B62D31/003;;Y02T10/62;;Y02T10/62;;Y02T10/70;;Y02T10/70;;Y02T10/7072,A63B55/60;;B62D29/04,,1,0,,,See references of WO 2004067360A1,EXPIRED
331,EP,B8,EP 1772356 B8,180-008-665-206-219,2012-05-02,2012,EP 06022935 A,2004-01-23,EP 04704832 A;;US 44219203 P,2003-01-24,Composite body for a golf car and utility vehicle,,CLUB CAR LLC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAL L,"CLUB CAR, LLC (2012-04-25)",https://lens.org/180-008-665-206-219,Amended Patent,yes,5,0,5,17,0,B62D29/043,B62D29/04,,0,0,,,,EXPIRED
332,EP,A9,EP 1772356 A9,023-505-171-949-236,2009-02-11,2009,EP 06022935 A,2004-01-23,EP 04704832 A;;US 44219203 P,2003-01-24,Composite body for a golf car and utility vehicle,"A vehicle (10), such as a golf car or a utility vehicle, comprises a high-strength molded composite body assembly (58) formed from at least one molded fiber-reinforced polymer panel (61, 63; 64). A plurality of wheels (16a, 16b) support the composite body assembly for movement along the ground. At least one decorative body panel (106, 108) is disposed on the composite body assembly. The at least one decorative body panel is recessed inwardly relative to the periphery of the composite body assembly such that the composite body assembly extends outwardly of the decorative body panel so as to prevent impact with the decorative body panel.
",CLUB CAR INC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAL L,"CLUB CAR, LLC (2012-04-25)",https://lens.org/023-505-171-949-236,Amended Application,yes,0,0,5,17,0,B62D29/043,B62D29/04,,0,0,,,,EXPIRED
333,AU,A1,AU 2004/207788 A1,053-788-281-276-600,2004-08-12,2004,AU 2004/207788 A,2004-01-23,US 44219203 P;;US 2004/0001760 W,2003-01-24,Composite body for a golf car and utility vehicle,,CLUB CAR INC,LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAEL L;;BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R,,https://lens.org/053-788-281-276-600,Patent Application,no,0,0,12,17,0,B62D21/183;;B62D21/183;;B62D29/04;;B60L50/62;;B60L50/62;;B60L50/66;;B60L50/66;;B60L58/21;;B60L58/21;;B60L2200/22;;B60L2200/22;;B62D29/043;;B62D29/043;;B62D31/003;;B62D31/003;;Y02T10/62;;Y02T10/62;;Y02T10/70;;Y02T10/70;;Y02T10/7072,A63B55/60;;B62D29/04,,0,0,,,,EXPIRED
334,EP,B1,EP 1592604 B1,129-979-485-478-447,2006-12-20,2006,EP 04704832 A,2004-01-23,US 2004/0001760 W;;US 44219203 P,2003-01-24,COMPOSITE BODY FOR A GOLF CAR AND UTILITY VEHICLE,,CLUB CAR INC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAEL L,,https://lens.org/129-979-485-478-447,Granted Patent,yes,5,0,12,17,0,B62D21/183;;B62D21/183;;B62D29/04;;B60L50/62;;B60L50/62;;B60L50/66;;B60L50/66;;B60L58/21;;B60L58/21;;B60L2200/22;;B60L2200/22;;B62D29/043;;B62D29/043;;B62D31/003;;B62D31/003;;Y02T10/62;;Y02T10/62;;Y02T10/70;;Y02T10/70;;Y02T10/7072,B62D29/04;;A63B55/60,,0,0,,,,EXPIRED
335,KR,A,KR 20060014024 A,067-382-862-744-861,2006-02-14,2006,KR 20057013689 A,2005-07-25,US 44219203 P,2003-01-24,COMPOSITE BODY FOR A GOLF CAR AND UTILITY VEHICLE,"A golf car (10) or utility vehicle having a composite body (58). In some aspects of the invention, the golf car or utility vehicle has a composite body assembly that includes a front clam shell assembly (62) and a rear shell-like body (64). In other aspects, the golf car or utility vehicle includes a composite body assembly having a periphery (118) and one or more decorative body panels (106, 108), the decorative body panels being recessed inwardly relative to the composite body assembly periphery to prevent impacts to the panels.",CLUB CAR INC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAEL L,,https://lens.org/067-382-862-744-861,Patent Application,no,0,1,12,17,0,B62D21/183;;B62D21/183;;B62D29/04;;B60L50/62;;B60L50/62;;B60L50/66;;B60L50/66;;B60L58/21;;B60L58/21;;B60L2200/22;;B60L2200/22;;B62D29/043;;B62D29/043;;B62D31/003;;B62D31/003;;Y02T10/62;;Y02T10/62;;Y02T10/70;;Y02T10/70;;Y02T10/7072,B62D29/04;;A63B55/60,,0,0,,,,DISCONTINUED
336,EP,B1,EP 1772356 B1,107-636-071-124-953,2012-03-28,2012,EP 06022935 A,2004-01-23,EP 04704832 A;;US 44219203 P,2003-01-24,Composite body for a golf car and utility vehicle,,CLUB CAR INC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAL L,"CLUB CAR, LLC (2012-04-25)",https://lens.org/107-636-071-124-953,Granted Patent,yes,5,0,5,17,0,B62D29/043,B62D29/04,,0,0,,,,EXPIRED
337,AU,B2,AU 2004/207788 B2,182-973-182-416-059,2009-10-08,2009,AU 2004/207788 A,2004-01-23,US 44219203 P;;US 2004/0001760 W,2003-01-24,Composite body for a golf car and utility vehicle,,CLUB CAR INC,LEWIS GARY L;;CROW DOUGLAS T;;WELSH MICHAEL L;;SKELTON GERALD C;;MULGREW PETER A;;NEWMAN DUANE E;;BATAILLE STEVEN ROBERT;;HARDY DAVID R;;STEWART GEOFF D;;MORGAN PAUL E,,https://lens.org/182-973-182-416-059,Granted Patent,no,2,0,12,17,0,B62D21/183;;B62D29/043;;B62D31/003;;B60L2200/22;;B60L50/62;;B60L58/21;;B60L50/66;;Y02T10/62;;Y02T10/70;;B62D29/04;;B62D21/183;;B62D29/043;;B62D31/003;;B60L2200/22;;B60L58/21;;B60L50/66;;B60L50/62;;Y02T10/62;;Y02T10/70;;Y02T10/7072,B62D29/04;;A63B55/60,,0,0,,,,EXPIRED
338,EP,B9,EP 1772356 B9,186-794-826-450-773,2012-07-18,2012,EP 06022935 A,2004-01-23,EP 04704832 A;;US 44219203 P,2003-01-24,Composite body for a golf car and utility vehicle,,CLUB CAR LLC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAL L,"CLUB CAR, LLC (2012-04-25)",https://lens.org/186-794-826-450-773,Amended Patent,yes,5,0,5,17,0,B62D29/043,B62D29/04,,0,0,,,,EXPIRED
339,EP,A1,EP 1772356 A1,194-713-114-313-335,2007-04-11,2007,EP 06022935 A,2004-01-23,EP 04704832 A;;US 44219203 P,2003-01-24,Composite body for a golf car and utility vehicle,"A vehicle (10), such as a golf car or a utility vehicle, comprises a high-strength molded composite body assembly (58) formed from at least one molded fiber-reinforced polymer panel (61, 63; 64). A plurality of wheels (16a, 16b) support the composite body assembly for movement along the ground. At least one decorative body panel (106, 108) is disposed on the composite body assembly. The at least one decorative body panel is recessed inwardly relative to the periphery of the composite body assembly such that the composite body assembly extends outwardly of the decorative body panel so as to prevent impact with the decorative body panel.
",CLUB CAR INC,BATAILLE STEVEN ROBERT;;CROW DOUGLAS T;;HARDY DAVID R;;LEWIS GARY L;;MORGAN PAUL E;;MULGREW PETER A;;NEWMAN DUANE E;;SKELTON GERALD C;;STEWART GEOFF D;;WELSH MICHAL L,"CLUB CAR, LLC (2012-04-25)",https://lens.org/194-713-114-313-335,Patent Application,yes,5,2,5,17,0,B62D29/043,B62D29/04,,0,0,,,,EXPIRED
